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Abstract 
 
Lysosomes are essential cellular organelles known to be the main site for 
the breakdown and recycling of endocytosed macromolecules within cells. 
However, our knowledge of lysosomal function has changed considerably 
over the last decade with the lysosome now being a recognized Ca2+ 
signaling organelle with additional roles in plasma membrane repair, 
clearance of defective organelles and mediating cell death as well as 
established roles in clearing infection. Our ability to study these unique 
organelles has however been stymied by a dearth of good techniques for 
the purification of functional lysosomes not contaminated by other 
organelles. 
Utilising superparamagnetic iron oxide nanoparticles we have devised a 
technique based on previous studies that incubated cells with iron oxide-
dextran particles to purify lysosomes magnetically. Whilst these early 
studies suffered from cellular toxicity and low yields our nanoparticles 
have proven to be stable and relatively non-toxic to cells allowing for the 
first time the rapid purification of high yields of ultra-pure functional 
lysosomes from normal and lysosomal disease cells. 
We have utilized this assay to assist in the characterization of basic 
lysosomal disease cell biology questions that would otherwise have 
perhaps remained unanswered. We have confirmed that lysosomal Ca2+ 
uptake is indeed the cause of the lysosomal Ca2+ homeostatic defect in 
Niemann-Pick C disease and have used the assay to characterse the first 
function for the lysosomal CLN3 protein as a lysosomal Ca2+ leak channel. 
! iii!
The purification assay has the potential to lead to major breakthroughs in 
the field of lysosomal research. 
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1.1 The Endocytic pathway 
 
Endocytosis is as an important cellular mechanism where molecules are 
internalized into the cell via either clathrin-dependent or independent 
processes (such as macropinocytosis) before being delivered to their 
targeted location via a complex system of organelles known as the 
endocytic system (Mayor and Pagano, 2007). Endocytic organelles are 
generally divided up into early and late compartments (Mukherjee et al., 
1997). Early endosomes are often found around the periphery of the cell 
and they receive most types of vesicles coming from the plasma 
membrane. The slightly acidic pH of ~6 (Lloyd-Evans et al., 2010) inside 
these early endosomes causes the dissociation of cell surface receptors 
from their respective bound endocytosed molecules. These receptors are 
then recycled back to the surface of the cell (Brooks, 2009). If a molecule 
is directed along the endocytic pathway through the early endosome, and 
it is not redirected back to the plasma membrane via the recycling 
endosome, then it reaches the late endosome (Brooks, 2009). Currently it 
is unclear how material from the early endosome reaches the late 
endosome, but two different models have been proposed. The first is 
called the maturation model where the early endosome matures into a 
late endosome (Murphy, 1991, Stoorvogel et al., 1991), while the second 
model proposes that there are endocytic carrier vesicles that act as an 
intermediate step between the early and late endsosomes (Stoorvogel et 
al., 1991). Late endosomes have a pH of about ~5 when compared with 
the early endosomes and can traffic molecules to either the trans Golgi 
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Network, the plasma membrane (via the Endoplasmic Reticulum (ER)) or, 
if the molecule is to be degraded, the lysosome (Brooks, 2009). 
 
1.2 Endocytic mechanisms: Clathrin mediated endocytosis 
 
Clathrin mediated endocytosis is one of the main mechanisms for cellular 
internalisation of molecules through the assembly of clathrin coated 
vesicles that encapsulate membranes containing the molecule to be 
endocytosed before it is brought into the cell for processing at the 
designated site (Mulcahy et al., 2014). This process is highly dependent 
on a large range of transmembrane receptors and their respective ligands 
that are first involved in the nucleation of clathrin to the plasma 
membrane where internalisation is to occur (Boucrot and McMahon, 
2011, Farsad et al., 2003) as well as being mediated by the phospholipid 
phosphatidylinositol (4,5)-bisphosphate, PI(4,5)P (Farsad et al., 2003). 
The cargo-dependent recruitment of the assembly protein 2 (AP-2) is 
then needed to form links with adaptor proteins and the clathrin coat to 
the molecule that is to be internalised (Puertollano, 2004). The plasma 
membrane then undergoes deformation of the cellular membrane that 
results in the formation of the clathrin coated bud that surrounds the 
molecule, with the bud then undergoing maturation before it is pinched off 
from the membrane (Mulcahy et al., 2014). The large GTPase membrane 
scission protein dynamin is recruited to the plasma membrane via the 
BAR (Bin Amphiphysin Rvs) domain containing membrane bending 
protein SNX-9 (Sorting nexin 9). The dynamin protein then undergoes 
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hydrolysis to promote the fusion of this newly formed clathrin vesicle with 
the plasma membrane, allowing for the release of clathrin coated vesicle 
into the cell. 
The sorting of the internalised cargo occurs rapidly following clathrin 
mediated endocytosis (Szaszi et al., 2002). The internalised molecule 
may be destined for degradation so therefore it must be targeted towards 
the lysosome, while other internalised molecules may need to be recycled 
so they therefore need to be processed via the correct endocytic route. 
The trafficking of the endocytosed molecules is usually determined by the 
receptors bound to them. 
The internalised clathrin coated vesicles are quickly fused with early 
endosomes where the contents of the vesicles are trafficked to further 
endocytic vesicles with the aid of a family of GTPase proteins known as 
Rabs. Endocytosed cargo that is to undergo recycling back to the plasma 
membrane is regulated by the Rab4 GTPase, or via Rab11 if the cargo is 
to be trafficked to the recycling endosome (Smit et al., 1993). Cargo that 
is to be trafficked further into the endocytic pathway requires Rab5 as 
well as Rab7 so that the cargo can be delivered to the late 
endosome/multi-vesicular body (MVB) for further sorting (Bucci et al., 
1992). Cargo that makes it to the late endosome can then further undergo 
more sorting, with certain cargo being trafficked to the Trans Golgi 
Network (TGN), where Golgi apparatus enzymes modify the cargo 
depending on where it is to reside in the cell, via processes requiring 
Sorting Nexins or Rab9 dependent pathways (Carlton et al., 2004, 
Lombardi et al., 1993). Cargoes that have thus far not been trafficked out 
! 5!
of the endocytic pathway are then typically sorted to the end point of the 
endocytic pathway, the lysosome, for degradation.  
 
1.3 Endocytic mechanisms: Clathrin independent endocytosis 
 
One of the other major endocytic mechanisms cells use for the 
endocytosis of external molecules is known as clathrin independent 
endocytosis. The mechanisms behind this form of endocytosis are similar 
to that of clathrin mediated endocytosis but are defined by the lack of 
clathrin coated pits present during the endocytosis of molecules. One of 
the most commonly reported means of clathrin independent endocytosis 
is that which include the cholesterol and glycolipid rich plasma membrane 
buds known as caveolae (Parton et al., 1994). These caveolae domains 
consist of the 3 members of the caveolin family of proteins. Caveolin 1 
and 2 are found in abundance in non-muscle cells while caveolin 3 is 
found predominantly in skeletal muscle and smooth muscle cells (Nassar 
et al., 2013, Tang et al., 1996). The endocytic mechanisms that utilise 
caveolae, as stated previously, are similar to that seen in clathrin 
mediated endocytosis as the caveolae form a bud around the molecules 
that are to be endocytosed, via receptors found in the caveolae, before 
this bud is internalised in a dynamin (a GTPase involved in the scission of 
newly formed vesicles) dependent manner (Oh et al., 1998, Yao et al., 
2005). The internalised caveolae bud can then fuse with an endosome 
known as the caveosome in a Rab5 independent manner where the 
cargo can then be recycled back to the plasma membrane. The 
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internalised cargo can also be trafficked to the early endosome via the 
use of the Rab5 GTPase where the cargo can be further trafficked in a 
manner similar to molecules endocytosed via clathrin mediated 
endocytosis when they reach this stage of the endocytic pathway 
(Pelkmans and Zerial, 2005). 
 
Recent evidence has emerged of a new major endocytic pathway 
involved in up to three times the volume internalised by clathrin mediated 
endocytosis known as Clathrin independent Carriers (CLICs) which is 
indicated to be involved in bulk inflow into the cell (Howes et al., 2010). 
CLICs have been identified as complex, multicomponent carriers which 
can interact in either a dynamin dependent or independent manner as it 
appears that dynamin is not necessary for the internalisation of molecules 
taken up via CLIC endocytosis (Kirkham et al., 2005, Sabharanjak et al., 
2002). While dynamin is not necessarily needed for CLIC mediated 
endocytosis, it appears that GRAF-1 (GTPase regulator associated with 
focal adhesion kinase 1) is needed (Doherty and Lundmark, 2009, Howes 
et al., 2010). This protein has been shown to interact with cellular 
cytoskeletal components (Taylor et al., 1999) and thus be involved in the 
recruitment of the G-protein cell division control protein 42 (Cdc42) and 
ADP-ribosylation factor 1 (ARF1) which aids in the formation of the 
tubular and ring like structures that are utilised for the fluid phase uptake 
used in this form of endocytosis (Kirkham et al., 2005, Kumari and Mayor, 
2008, Sabharanjak et al., 2002). The rapid recruitment of Rab11 and 
Rab5 following CLIC endocytosis helps facilitate the bulk of endocytosed 
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material to either early endosomes or recycling endosomes where the 
endocytosed material can be processed (Howes et al., 2010). 
 
1.4 Endocytic mechanisms: Macropinocytosis (Fluid phase 
endocytosis) 
 
Macropinocytosis (also known as fluid phase endocytosis) is an endocytic 
mechanism cells use to take in large solutes from the extracellular fluid 
(e.g. dextrans) (Bohdanowicz and Grinstein, 2013). This process is 
clathrin independent and requires the remodelling of actin as well as the 
activity of the phospholipid PtdInsP3K (Araki et al., 1996). The large 
molecules are taken into the cell as the plasma membrane forms an 
extension around them, causing fusion into the intracellular space. These 
large fluid filled vacuoles are then pinched into the cell.  The vesicles 
formed in this manner can be from 0.2µM-2µM in size (Bohdanowicz and 
Grinstein, 2013). While not much is understood behind the mechanisms 
of how fluid phase endocytosis works, in comparison to other endocytic 
pathways, it is suggested that Rab5 plays an important role as loss of 
Rab5 function results in the inhibition of fluid phase endocytosis (Li et al., 
1997).  
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Figure 1: An overview of the different mechanisms of endocytosis the cell 
incorporates to bring in external cargo. Exogenous material is taken up into the 
cell via their respective endocytosis mechanisms into intra-cellular vesicles. The 
vesicles are transported to the early endosome and the material is then 
transported through the endocytic system. As the material passes through the 
different endocytic organelles they are processed and trafficked to their 
respective cellular destinations. Material that is not transported out of the 
endocytic system ends up in the in the terminal point of the endocytic system, 
the lysosome. 
 
1.5 Late endosomal-lysosomal fusion 
 
For a long time there was dispute about how macromolecules designated 
for transport to lysosome reached there once they were in the late 
endosome. Multiple different methods have been proposed such as 
kissing, vesicular transport, maturation and direct fusion (Luzio et al., 
2000, Mullins and Bonifacino, 2001). Recent work carried out with the use 
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of fluorescent dextrans in normal rat kidney fibroblasts, have found that 
kissing and direct fusion was responsible for content mixing in late 
endosomes to lysosomes (Bright et al., 2005). The very first evidence of 
direct late endosome-lysosome fusion was found when an organelle that 
had a density intermediate of that of lysosomes and late endosomes also 
contained markers found from both organelles (Mullock et al., 1998). 
Following the fusion between the two organelles the hybrid organelle 
formed eventually undergoes a maturation process to become a 
lysosome again where the recycling of non-lysosomal proteins are 
transported back out of the maturing lysosome (Luzio et al., 2009). What 
has been found to be important in the fusion between late endosomes 
and lysosomes is the presence of soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor (SNARE). Vesicle associated 
membrane protein 7 (VAMP7) is an important SNARE necessary for 
correct late endosome-lysosome fusion to occur (Luzio et al., 2009), as 
its correct localisation to the lysosomal membrane is important for other 
factors to be recruited to mediate fusion between the two compartments 
in a Ca2+ dependent manner (Luzio et al., 2009). Following fusion the 
SNARE proteins are recycled off the hybrid organelle as it slowly matures 
back into a lysosome until they are required for late endosome-lysosome 
fusion again (Luzio et al., 2009).  
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1.6 The Lysosome: An overview 
 
The lysosome was first discovered by Belgium cytologist Christian de 
Duve in the 1960’s when he was investigating carbohydrate liver 
metabolism and discovered that cells exposed to greater centrifugal force 
released more of the enzyme acid phosphatase as a direct result of the 
amount of damage the cell received. He theorized that there was a 
membrane bound organelle within the cell that encased these digestive 
enzymes, and this was confirmed when a technique called Density 
Gradient Centrifugation (DGC) was used to separate out the organelles 
based on their respective densities (de Duve, 1969). A lysosome is a 
membrane-bound organelle that is present in animal cells and has for a 
long time been described as the “stomach of the cell” as it has important 
roles in the breakdown and recycling of receptor molecules, plasma 
membrane repair, autophagy and the degradation of macromolecules 
(Luzio et al., 2007). With the advent of electron microscopy (EM) the 
lysosome could be described in further detail. EM showed that lysosomes 
make up about 5% of the total intracellular volume and are 
heterogeneous in morphology and size as well as being very electron 
dense (E, 1989).  
 
1.7 Lysosomal pH 
 
The inside of the lysosome itself has a very low pH of ~4.5, maintained by 
proton pumps (Lloyd-Evans et al., 2010). The proton pumps in question 
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are the Vacuolar-type H+-ATPase (V-ATPase) proteins which are an 
endosomal membrane pump found through all the different endocytic 
organelles which utilises the free energy provided from the hydrolysis of 
adenosine triphosphate (ATP) to drive protons from the cytosol, against 
the electrochemical gradient, into the organelles lumen (Ohkuma et al., 
1982). This proton channel is especially important in lysosomes as it 
needs to maintain its acidic pH, which it does in conjunction with pumping 
out K+ ions via either a cation channel or transporter. However, the 
mechanisms behind this are still not fully characterised (Mindell, 2012). 
Other work has shown that lysosomal pH homeostasis may be 
maintained via a Cl-/H+ antiporter known as Chloride channel 7 (ClC-7) 
found on the lysosomal membrane (Mindell, 2012). ClC-7 belongs to a 
family of proteins that have been shown to have a role in the movement 
of two Cl- ions against the movement of a single proton (Picollo and 
Pusch, 2005, Scheel et al., 2005). While it is proposed to be found on the 
lysosomal membrane, the true role of ClC-7 antiporters is still not fully 
understood on how it may help regulate lysosomal pH (Kornak et al., 
2001).  
While it is still not fully understood how the lysosome maintains it’s pH 
homeostasis via the influx and efflux of cations, the function of the 
lysosomal V-ATPases and any potential Cl-/H+ antiporter is integral as it 
provides an optimum acidic environment for the hydrolytic enzymes the 
lysosome contains. This acidic optima results in the lysosomal enzymes 
being able to cleave the ingested macromolecules such as proteins, 
polysaccharides and phospholipids (Kolter and Sandhoff, 2005).  
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1.8 Lysosomal enzyme transport and activation 
 
Lysosomal enzymes are synthesized in the ER and there they are 
glycosylated on their asparagine residues so that they can be recognised 
by the GlcNAc-1-phsophotransferase, thus enabling a two-step reaction 
where the first step involves a mannose-6-phosphate tag is attached to 
specific N-linked oligosaccharides. The next step involves the use of the 
enzyme N-acetylglucosamine-1-phosphodiester alpha-N-acetyl-
glucosaminidase that removes the N-Acetylglucosamine (GlcNAc), 
exposing the mannose-6-receptor tag that acts as a signal (Braulke and 
Bonifacino, 2009). Once the newly synthesised protein reaches the TGN, 
it results in the binding of the mannose-6-phosphate receptor to the tag 
on the protein. This interaction allows the bound proteins to be 
transported to the endosome via adaptor proteins such as activator 
protein 1 (AP-1) (Doray et al., 2002). The acidic content of the late 
endosome causes the dissociation of the mannose phosphate receptor, 
which is then recycled back to the TGN (Seaman, 2004). The proteins are 
then further transported to lysosomes by vesicular transport or fusion. 
Non-soluble lysosomal membrane proteins are transported to the 
lysosome by either an indirect route involving the plasma membrane or 
by a direct intracellular route (Peden et al., 2004). Recent work has 
highlighted a mannose-6-phosphate in-dependent pathway for the 
trafficking of lysosomal enzymes via the vacuolar protein sorting 10 
(VPS10) domain of family of receptors (Canuel et al., 2009). This family 
include the multiligand receptors sortilin as well as SorLA (Sortilin related 
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Receptor) (Coutinho et al., 2012), which are proposed to be responsible 
for the lysosomal targeting of non-enzymatic co-factors such as 
sphingolipid activator proteins that are necessary for the breakdown of, 
for example, glucosylceramide or sphingomyelin in the lysosome. It is 
proposed that VPS10 mediated lysosomal enzyme trafficking does not 
require the enzyme to be glycosylated, unlike the mannose-6-phosphate 
dependant pathway (Reczek et al., 2007).  
Once the lysosomal enzymes reach the lysosome they become active. 
An example of this is how the lysosomal cathepsin enzymes become 
active due to the proteolytic removal of their respective propeptides in the 
acidic lysosomal environment (Lutgens et al., 2007). 
A more direct pathway of proteins being trafficked to lysosomes is 
through two dileucine motifs found on the C-terminus of some lysosomal 
proteins (Mattera et al., 2011).  
  
1.9 Lysosomal Membrane 
 
The inner lumen of the lysosome is coated with a heavily glycosylated 
glycocalyx to prevent self-digestion of the lysosome. This modification is 
primarily composed of integral lysosomal membrane proteins (LMPs) all 
of which have multiple glycosylation sites (Saftig and Klumperman, 2009). 
While the exact number of LMPs has still not been revealed, currently 
~25 have been identified, with most of those identified reside in the 
lysosomal limiting membrane (Lubke et al., 2009), The most abundant of 
these LMPs are the lysosomal-associated membrane proteins 1 and 2 
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(LAMP1/2), which comprise of the majority of the lysosomal glycocalyx 
membrane. Recent studies have highlighted the important contribution of 
LAMPs to lysosomal integrity as decreased levels of LAMP1/2 have been 
found to result in a higher sensitivity to anti-cancer drugs in tumour cells 
due to an increase in lysosomal mediated cell death (Fehrenbacher et al., 
2008).  
 
1.10 Phagocytosis 
 
Phagocytosis is a highly conserved important cellular mechanism which 
is involved in engulfing invading pathogens as well as apoptotic cells 
>0.5mm in diameter (Luzio et al., 2007). Autophagasomes are activated 
when the cell undergoes highly stressful conditions such as amino acid 
depletion and unfolded protein response (Saftig and Klumperman, 2009). 
The phagosome that has engulfed this material then fuses with the 
lysosome, maturing into a hybrid organelle called the phagolysosome. 
This fusion enables the phagolysosome to degrade the engulfed material. 
Work carried out has found that the lysosomal membrane proteins 
LAMP1/2 also play an important role in phagosome-lysosomal fusion as 
depleted levels of LAMP result in the retardation of Rab7 recruitment to 
phagosomes and their subsequent fusion with lysosome (Huynh et al., 
2007, Tanaka et al., 2000). 
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1.11 Autophagy 
 
Autophagy, derived from the Greek to eat oneself, is the process by 
which cells will degrade their long-lived cellular components, including 
organelles, in order to maintain cellular energy levels (Luzio et al., 2007, 
Levine et al., 2004). Autophagy is involved in cellular processes such as 
starvation, cell growth, innate immunity, cellular and tissue remodelling 
and cell death (Luzio et al., 2007, Levine et al., 2004). There are three 
types of autophagy in mammalian cells, macroautophagy (associated 
with the degradation of large cytosolic components such as 
mitochondrion), chaperone mediated autophagy (associated with the 
direct transport of unfolded proteins into the lysosome through LAMP2A), 
and microautophagy (associated with the direct lysosomal uptake of 
material by invaginations and internalisation of the lysosome’s limiting 
membrane) (Parzych et al., 2014). Macrophagy, is the main pathway 
during which autophagic material will be isolated by a double membrane 
to form an autophagosome (which can reach ~1µm in diameter), and 
subsequently fuse with lysosomes where the autophagic material can be 
degraded (Luzio et al., 2007, Hamasaki et al., 2013). The 
macroautophagy of mitochondria, or mitophagy as it is also known, is a 
continuous process that is vital for cell survival, and perhaps one of the 
most important roles for autophagy. Mitochondria are the energy source 
of the cell and thus maintaining functional mitochondria is vital for 
maintaining cellular energy (Campello et al., 2014). Furthermore, the 
longer lived the mitochondrion, the more reactive oxygen species (ROS) 
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it produces, which are capable of detrimental damage to other cellular 
components, and thus the catabolism of mitochondria via autophagy 
plays a vital role in maintaining cell function (Campello et al., 2014). 
 
1.12 The lysosome: Emerging roles 
 
For a long time it was believed that the lysosome acted primarily as a site 
of digestion in the cell, but recent research has shown that the lysosome 
is much more than just the stomach of the cell. It has been shown in 
many cell types that lysosomes might fuse with the cellular plasma 
membrane for wound repair. This occurs when the lysosome reacts to an 
increase in cytosolic Ca2+, causing lysosomal exocytosis (Rodriguez et 
al., 1997). It has also recently emerged in the last ten years that the 
lysosome has a role in intracellular signalling, as it is the second largest 
Ca2+ store in the cell after the ER, containing ~500µM Ca2+ (Lloyd-Evans 
and Platt, 2011). This evidence shows that the lysosome possesses 
many different, dynamic interactions with other cellular compartments that 
are key for correct cellular function and viability.  
 
1.13 The lysosome as an important Ca2+ store 
 
Ca2+ is an important ion for cells as it is a major component for 
intracellular signalling that is needed for key functions such as 
fertilisation, enzyme activity, gene expression, membrane fusion, cellular 
motility and apoptosis (Berridge et al., 2003). As Ca2+ is such a potent 
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signalling ion it is important that its levels are tightly regulated inside the 
cell. This is done via a number of different mechanisms such as the use 
of cation exchangers and transporters and the intracellular buffering of 
Ca2+ via its storage inside organelles (Pozzan et al., 1994).  
Three major intracellular messengers have been discovered to act on the 
mobilisation of Ca2+ inside the cell by acting upon specific Ca2+ release 
channels located on organelle membranes. The three messengers are 
inositol trisphosphate (IP3), cyclic adenosine disphosphate ribose 
(cADPR) and nicotinic acid adenine di-nucleotide disphosphate (NAADP) 
(Bootman et al., 2002, Clapham, 1995). These secondary messengers 
are important for key Ca2+ signalling events as they receive signals at 
receptors located on the cell surface and then serve to greatly amplify the 
strength of that signal to induce major biological changes in the cell. 
Work done on sea urchin egg homogenates showed that while IP3 and 
cADPR were potent Ca2+ releasing messengers from the ER/microsome 
stores, NAADP was found to still release high Ca2+ levels in the sea 
urchin eggs after treatment with thapsigargin (a sarco-endoplasmic 
reticulum Ca2+ aTPase (SERCA) inhibitor) when compared with the other 
Ca2+ messengers indicating that its primary target was on another Ca2+ 
store (Churchill and Galione, 2001, Clapper et al., 1987, Genazzani and 
Galione, 1996). Resulting work using subcellular fractionation found that 
NAADP was involved in Ca2+ release from lysosomal-related organelles 
inside the sea urchin eggs, and it was thus implicated that NAADP works 
primarily as a lysosomal Ca2+ release messenger (Churchill et al., 2002). 
Again, additional work using the lysosomtropic agent glycyl-phenyl-
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alanine 2-naphthylamide (GPN) caused disruption of the lysosomal 
membrane allowing for the release of the Ca2+ stored inside the 
lysosome. Subsequent treatment with NAADP displayed a diminished 
Ca2+ mediated response from lysosomal stores, further showing that 
NAADP is highly specific to inducing lysosomal Ca2+ release (Morgan and 
Galione, 2007).  
Only recently the target for NAADP has been identified on the lysosomal 
membrane, this being a member of the Two Pore Channel (TPC) family. 
TPCs were first hypothesised to be  endosomal Ca2+ release channels as 
their plant counterpart was found to be localised on the acidic vacuole 
Ca2+ store inside plant cells as well as the family of proteins having 
significant similarity to voltage gated Ca2+ and Na+ channels (Larisch et 
al., 2012, Marchant and Patel, 2013). The overexpression of green 
fluorescent protein (GFP) tagged TPCs in cell lines resulted in lysosomal 
localisation and a greater NAADP induced Ca2+ release in these cells, 
while pre-treatment with bafilomycin (an inhibitor of vATPase which de-
protonates the lysosome, leading to an inability to maintain its Ca2+ levels) 
diminished the Ca2+ release that was seen previously, leading to the 
authors conclusions that NAADP acts upon TPCs to induce Ca2+ release 
from acidic stores (Marchant and Patel, 2013). Other work carried out 
found that TPC1 and 2 both contain dileucine motifs which are needed for 
correct sorting to the endo-lysosomal system (Brailoiu et al., 2010). 
Mutations in this targeting motif in the TPC2 protein however resulted in 
the mislocalisation of this channel to the plasma membrane of the cell 
(Brailoiu et al., 2010). 
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1.14 Why study lysosomal function? 
 
It is important that we continue to study lysosomal function, particularly 
trafficking and degradation mechanisms of macromolecules, the process 
regulating their degradation and recycling and their emerging roles in 
Ca2+ signalling as defects in any of these events can potentially result in 
the development of lysosomal storage diseases (LSD) or loss of normal 
cellular function (e.g. Alzheimer’s disease, talked about later). 
 
1.15 Lipids, and their role in health and disease 
 
Lipids are a group of molecules that are essential to cellular viability and 
have important roles signalling, and storing energy as integral 
components of cellular membranes (van Meer et al., 2008). Lipids 
themselves can be characterised into different groups, based on their 
biochemical properties, such as cholesterol, sphingolipids and 
phospholipids. However they have been shown to accumulate and be 
mistrafficked in many lysosomal storage diseases. 
 
1.16 Lysosomal Storage diseases: An overview 
 
LSDs are a group of >50 inherited heterogeneous disorders which are 
relatively rare individually, but as a group of disorders they have an 
incidence of 1 in 7500 births (Meikle et al., 1999, Poupetova et al., 2010). 
They are mainly caused by loss of activity of a soluble intra-lumenal 
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lysosomal enzyme leading to accumulation of its substrate, however 
there is a growing group of LSDs caused by loss of function of lysosomal 
transmembrane proteins whose functions are largely unknown and which 
have a broader range of consequences on lysosomal function and 
greater complexity of storage molecules. LSDs are the major cause of 
childhood neurological disease, although some forms of LSD exist that 
are non-neurological or manifest only during adulthood. Once these 
symptoms manifest, they continue to become progressively detrimental to 
the patients quality of life (Cox and Cachon-Gonzalez, 2012).  
The term lysosomal storage disease itself is used to describe the main 
clinical feature observed in cells with defective lysosomal proteins. In 
many LSDs there is the accumulation of lipids as either a primary or 
secondary storage material, however this is not the case for all LSDs. 
While there seems to be a clear increase in the amount of intra-lysosomal 
storage material in a particular given disease, the causes of 
neurobiological defects (with or without cell death), inflammation, 
hypertrophy or hyperplasia, visceral fibrosis, are very difficult to 
understand. The recent advent of research into the development of 
therapies for these lysosomal disorders has resulted in a change in their 
clinical and pathological description for these diseases (Cox and Cachon-
Gonzalez, 2012). The sheer number of different cellular mechanisms that 
become defected in each lysosomal storage disease means it is difficult 
to categorise them all under one banner (Walkley et al., 2010).  
As mentioned previously, major roles of the lysosome in the cell is the 
autophagic clearance of other organelles and cellular components. This 
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process is critical for cellular survival, growth and development. The 
process itself is highly conserved and numerous autophagy related 
proteins have been found due to work on yeast models (Levine and 
Klionsky, 2004). Components to be digested are taken up by 
phagophores, which then merge with lysosomes to form 
autophagosomes. A good example of how this process is important for 
cellular viability is shown in the lysosomal disorder called Danon disease. 
Patients with Danon disease exhibit cardio- and skeletal myopathy as 
well as neurodegenerative disorders in heterozygous males (Nishino, 
2006). This disorder arises from a gene mutation on the X-chromosome 
that encodes for the lysosomal protein LAMP 2. LAMP 2 as stated 
previously is important in maintaining lysosomal membrane integrity as 
well as it being implicated in phagosome-lysosome fusion as well as 
chaperone mediated autophagy (Lubke et al., 2009). In Danon disease, 
due to the defective LAMP-2 protein it results in an impaired fusion 
between lysosomes and phagophores. This results in a loss in cellular 
clearance of organelles and other molecules that are to be broken down, 
leading to a reduction in cellular viability giving rise to this fatal lysosomal 
disease. The disease’s pathogenesis helps illustrate the importance of 
lysosomal mediated cellular clearance, and how the need for autophagy 
is necessary for life (Nishino, 2006). 
As cells age they accumulate more and more damage to their organelles 
through factors such as oxidative stress. Because cells like neurons do 
not divide in adult life the cell has compensated for this by having an 
expansive lysosomal network for membrane recycling. Autophagic 
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vacuoles are trafficked along the axons of neuronal cells so to maintain 
an even distribution, while the lysosomes are maintained within the cell 
body of the axon. This is an important neural cellular function as it helps 
to improve autophagic clearance (Tsukita and Ishikawa, 1980). In several 
neurodegenerative lysosomal diseases it has been observed using 
electron microscopy that there is an increase in the levels of vacuoles, 
along with other evidence that there is disturbed autophagic clearance 
within the cell (Walkley et al., 2010).  In some lysosomal diseases such 
as GM2 gangliosidosis this results in a knock on effect within the cell. 
This is because the cell tries to compensate for this reduced clearance by 
mediating the expansion of its autophagic apparatus, which further 
reduces the effectiveness of the autophagy process.  
Defects in the regulation of intracellular Ca2+ have been found to give rise 
to neurodegeneration in some lysosomal diseases. However lysosomal 
diseases that share a defect in Ca2+ signaling each exhibit distinctly 
different phenotypes. An increase in the release of Ca2+ from the 
endoplasmic reticulum into the cytosol due to a defect in the ryanodine 
receptor (somehow caused by the storage molecule glucosylceramide) 
has been found in murine models of Gaucher’s disease (and post-mortem 
patient material) due to an excess of glucosylceramide found in these 
lysosomal diseased cells (Pelled et al., 2005). Another LSD, GM2 
gangliosidosis has increased levels of cytosolic Ca2+ that induces a 
reduced uptake of Ca2+ by SERCA. This is most likely due to the excess 
levels of the gangliosides attributed to this lysosomal disorder potentially 
being transported out of lysosomes to the ER (Pelled et al., 2005). Other 
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lysosomal disorders such as Niemann-Pick type C (NPC) show a severe 
effect on endosomal-lysosomal trafficking due to defects in the levels of 
lysosomal Ca2+ (Vanier, 2010). 
 
1.17 Current methods for treating lysosomal storage diseases 
 
Classically there are two methods to try and alleviate the onset of 
lysosomal storage diseases in patients by either replacing the defective 
enzyme with a working one or to reduce the levels of the substrate the 
defective enzyme breaks down, these two forms of treatment are known 
as enzyme replacement therapy (ERT) and substrate reduction therapy 
(SRT) respectively. The first US food and drug administration (FDA) 
approved treatment for an LSD was for Gaucher disease (an autosomal 
recessive disease caused by mutations on the GBA1 gene), where the 
lysosomal enzyme glucocerebrosidase is defective giving rise to the 
accumulation of the glycolipid glucocylceramide (Platt et al., 2012). This 
therapy works by using purified recombinant wild type 
glucocerebrosidase which is then typically given to the patient 
intravenously every two weeks (Brady, 2010, Charrow, 2009). This initial 
success gave rise to similar forms of ERT for other LSDs such as Fabry 
disease, Pompe disease and several mucopolysaccharide storage 
disorders (Charrow, 2009, Kakkis, 2002, Schiffmann and Brady, 2006). 
However this method of treatment has its caveats. The replacement 
enzyme does not cross the blood brain barrier so it therefore can only be 
used to treat the peripheral pathology of the disease (e.g. 
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hepatosplenomegaly), not the central nervous system. As well as this, the 
procedure itself is highly invasive, as it requires the patient to receive an 
infusion every two weeks (with treatment taking about a few hours) for the 
rest of their lives (Platt et al., 2012). However patients can develop 
antibodies against the enzyme, reducing the efficacy of the treatment. 
Another therapy developed for the treatment of lysosomal storage 
diseases is substrate reduction therapy. Miglustat (OGT 918, N-butyl-
deoxynojirimycin), an oral small molecule imino sugar, has so far been 
approved for the treatment of type 1 Gaucher disease worldwide as well 
as for NPC (in most countries with the exception of the USA) (Platt et al., 
2012). This form of treatment targets the Golgi ceramide specific 
glucosyltransferase where it prevents the synthesis of glucosylceramide, 
the first step in glycosphingolipids biosynthesis, therefore reducing the 
levels of these lipids being stored inside the lysosome (Platt et al., 2012). 
The benefit of this treatment compared with ERT is that it can cross the 
blood brain barrier so that it can be used to treat the neurological 
manifestations present in NPC (Patterson et al., 2007), however it does 
have some side effects such as inhibiting disaccharide synthesis resulting 
in gastrointestinal problems (Platt et al., 2012). New evidence highlights a 
potential inhibitory effect of miglustat on non-lysosomal 
glucosylceramidase, leading to elevation of glucosylceramide in all 
tissues. 
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1.18 Recent research implicates impaired lysosomal function in 
common major diseases 
 
New data has shown that the lysosome has a direct role in a whole host 
of other major neurodegenerative diseases.  
Recent work has found that mutations in the Presenilin 1 gene, PSEN1, 
that encodes for the ER associated Alzheimer’s disease related protein 
Presenilin 1 (PS1) results in the onset of lysosomal dysfunction that may 
contribute to disease pathogenesis seen in Alzheimer patients (Lee et al., 
2010). PS1 is an ER transmembrane protein that has a diverse role 
inside cells, including cell adhesion, apoptosis and Ca2+ homeostasis 
(Shen and Kelleher, 2007). It is believed that PS1 becomes active once it 
is cleaved to form a catalytic subunit of the γ-secretase enzyme complex 
which is known to be involved in the cleavage of many type 1 membrane 
proteins such as amyloid precursor protein (APP) (which is implicated in 
the accumulation of β-amyloid in Alzheimers disease) and Notch (Citron 
et al., 1997, De Strooper et al., 1998). Mutations in the PS1 protein have 
been shown to result in the mis-trafficking of the V-ATPase subunit V0a1 
to the lysosomal proton pump (Lee et al., 2010). The result of this is that 
the V-ATPase cannot function properly, causing the lysosome to 
alkalinize. This results in defects in the degradation of 
autophagic/lysosomal substrates, giving rise to the accumulation of β-
amyloid that is the main pathogenic hallmark of Alzheimer’s disease (Lee 
et al., 2010). 
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The roles of lysosomes in Parkinson disease have also started to garner 
more attention after it was found that there was a 6-11 fold increase in the 
rate of developing sporadic Parkinson disease for people who were 
heterozygous for GBA1 mutations (Rosenbloom et al., 2011). Currently 
mutations in the GBA gene are designated as the number one risk factor 
for the development of Parkinson disease (Sidransky et al., 2009).  
Other well established diseases such as the tri-nucleotide repeat disorder 
Huntington’s disease have been found to possess dysfunctional 
lysosomes, possibly resulting in a reduction in the degradation of 
polyglutamine residue aggregates, giving rise to the pathogenesis seen in 
this disease. Even prion disease such Creutzfeldt-Jakob disease have 
also been implicated to possess dysfunctional lysosomes (Lee et al., 
2011). Due to recent research in these common neurological diseases, 
the role of lysosomes in cellular homeostasis, particularly clearance of 
defective aged cellular aggregates or organelles, has been highlighted to 
be important for correct cellular viability.  
 
1.19 Niemann-Pick type C: An overview 
 
Niemann-Pick disease type C (NPC) is a severe autosomal recessive 
neurodegenerative disorder. Patients with NPC often die in young 
infancy, but those with a severe disease progression survive until late 
adolescence (Maceyka et al., 2005). However some NPC patients with a 
much slower progression of symptoms live into adulthood. The 
predominant trait NPC sufferers present are cererbellar atrophy, 
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characterized by a selective loss of purkinje neurons, which results in 
ataxia (Ko et al., 2001). Other symptoms include respiratory problems, 
learning difficulties as well as presenting with the earliest onset of 
Alzheimer disease like pathology (~10 years of age) (Davies et al., 2000, 
Liscum, 2000). While NPC is a member of the Niemann-Pick group of 
LSDs, the cellular pathogenesis and patient phenotypes differ greatly 
from those observed in Niemann-Pick types A and B which both occur 
due to deficiencies in the lysosomal enzyme acid sphingomyelinase 
(Ikonen and Holtta-Vuori, 2004, Sturley et al., 2004). However it should 
be noted that acid sphingomyelinase activity is reduced in NPC disease, 
it is not the main cause of disease progression (Lloyd-Evans and Platt, 
2010). 
 
1.20 NPC gene mutations 
 
NPC disease arises from autosomal recessive mutations in the genes 
that encode either the NPC1 (95% of cases) or NPC2 (5% of cases) 
proteins. A mutation in either results in a completely indistinguishable 
NPC phenotype. Human NPC1 gene is localised to chromosome 18q11-
12 and encodes a 1278 amino acid glycoprotein that consists of 13 
transmembrane domains (Park et al., 2003).  
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1.21 The NPC Proteins 
 
NPC1 is a protein that is localized to the membrane of late 
endosomes/lysosomes and has a weak homology to mediators of 
cholesterol homeostasis (Patched, HMG CoA reductase), while NPC2 is 
a soluble protein located within the lysosome itself that acts as a 
cholesterol shuttle (Lloyd-Evans and Platt, 2010). Due to this it has been 
proposed that the NPC1 and 2 proteins must act in the same cellular 
pathway to deliver cholesterol out of the lysosome. So far, however, there 
is no direct evidence for this hypothesis and the function of the NPC1 
protein function has remained largely inconclusive (Erickson et al., 2000). 
While the true purpose of NPC1 remains unclear, it is currently 
understood that NPC2 transfers cholesterol to (or away from) NPC1 via 
its cholesterol-binding site located on its N-terminal. This would suggest 
that NPC1 has a role in cholesterol regulation (Erickson et al., 2000). This 
would seem an appropriate hypothesis as one of the key characteristics 
of NPC lysosomes is the storage of multiple lipids of different classes 
including cholesterol, sphingomyelin and glycosphingolipid (Ginzburg et 
al., 2004). However, it should be noted that cholesterol transport out of 
lysosomes can be achieved in NPC1 null cells by a variety of cellular 
treatments (such as curcumin (Lloyd-Evans et al., 2008)) casting doubt 
on the absolute requirement for the NPC1 protein in mediating lysosomal 
cholesterol efflux. It has been found that the reason for the accumulation 
of these macromolecules in NPC cells arises from the impaired ability for 
lysosomal/late endosomal fusion as well as vesicular transport leading to 
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an accumulation of the endocytic cargo in the late endosomes (Bach et 
al., 1999, Christensen et al., 2002). This is believed to be because late 
endosome/lysosome fusion is a Ca2+ dependent process and that the 
storage of the simple sphingolipid sphingosine inside lysosomes, a 
specific defect of NPC disease, impairs lysosomal ability to uptake Ca2+, 
leading to reduced lysosomal Ca2+ levels and release, impaired 
endosomal-lysosomal fusion and retarded endocytic trafficking and 
ultimately lipid storage in the cell (Lloyd-Evans et al., 2008). While the 
true role of NPC1 may remain elusive, recent homology studies have 
found that the NPC1 protein has strong homology with the RND 
(resistance-nodulation division) permease family of proteins which are a 
group of highly conserved proteins involved in the transport of complex 
lipids, antibiotics and metal ions in bacteria (Scott and Ioannou, 2004). 
The reduced Ca2+ levels in NPC lysosomes has resulted in the 
hypothesis that NPC1 is acting as a sphingosine transporter, however 
recent work has shown evidence that NPC is involved in viral efflux out of 
the endocytic system (Carette et al., 2011). The unknown function of 
NPC1 protein as well as many other lysosomal membrane proteins helps 
highlight the need to identify their roles so that we can fully understand 
how certain lysosomal storage diseases arise and how lysosomes 
regulate their function. However it is important to note that without LSDs 
we would not know about several lysosomal proteins such as TRPML1 
and CLN3. 
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1.22 Neuronal Ceroid Lipofuscinosis 
 
With an incidence of 1 in 12,500 live births, the Neuronal Ceroid 
Lipofuscinoses (NCL) are a group of autosomal recessive diseases that 
result in the onset of neurodegeneration in children/young adults followed 
by death (Bennett and Rakheja, 2013). Collectively this group of diseases 
is known as Batten(s) disease after Sir Frederick Batten who first 
characterized the disease in the early 1900’s (Persaud-Sawin et al., 
2007). So far 14 clinical variants have been identified (CLN1-CLN14) and 
the genes for all, except CLN7, have been identified (Persaud-Sawin et 
al., 2007). They are commonly classified into four subtypes depending on 
the age onset of the disease, Known as: Infantile (INCL), Late-infantile 
(LINCL), Juvenile (JNCL) and adult types (Kang et al., 2013).   
Despite the fact that different gene mutations determine the onset of the 
disease, the phenotypes observed between all the NCLs are very similar 
which is why they are grouped together. Initial symptoms such as vision 
and hearing loss are first observed, followed by impaired motor function 
and a serious decline in the patients mental capacity as a result of 
neurodegeneration. By the end of the disease’s progression there is 
widespread neuron loss followed by death.  Cells present with the 
lysosomal accumulation of the fluorescent material called lipofuscin, 
specific protein accumulation such as subunit c of the mitochondrial 
ATPase, cell cycle dysregulation, abnormal sphingolipid/phospholipid 
accumulation and an increase in apoptosis in the mutant CLN cells 
(Palmer et al., 2013).While one of the most prominent phenotypes in 
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NCLs is the loss of neurons, the cellular increase in protein accumulation 
and lipofuscin, this is not just confined to neurons as storage bodies have 
been found in many different cell tissues including those outside of the 
central nervous system (Bennett and Rakheja, 2013).  
 
While many of the disease causing genes have been identified it is still 
unclear whether there is a common link in the pathogenic mechanisms 
between each of the different CLN mutations. 
 
1.23 CLN gene products 
 
Multiple different genes that encode different proteins have been 
identified to have defects in NCL. The roles of these proteins have been 
found to differ from one another, as does their respective cellular 
localization.  
 
The CLN proteins that are best understood are those that are expressed 
by the CLN1, CLN2, CLN3, CLN5, CLN6 and CLN8 genes (Persaud-
Sawin et al., 2007). The protein products that are encoded by CLN1 and 
CLN2 are lysosomal enzymes involved in the removal of long fatty acids 
and tri-peptides respectively (Palmer et al., 2013). CLN6 and 8 encode 
membrane bound proteins while the protein that is encoded by CLN5 is a 
membrane glycoprotein. The protein products of CLN4,7,9 and 10 are still 
poorly understood and their respective proteins function is only 
speculated.  
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1.24 Theory on NCL disease mechanisms 
 
While numerous studies have been carried out to try and further 
understand the pathogenic mechanisms in NCLs, it is still unclear what 
the major cellular defect is. A recent theory has attributed NCL 
pathogenesis to the accumulation of subunit c of mitochondrial ATP 
synthase (observed in CLN2, CLN3, CLN5, CLN6 and CLN7). Subunit c 
is the pore forming, membrane spanning subunit of the mitochondrial 
ATP synthase complex (Palmer et al., 1992). Subunit C is an important 
component of the ATP synthase enzyme, which is responsible for the 
synthesis of ATP inside the cell. The turn over of this subunit is important 
for correct mitochondrial function and its transport to the lysosome for 
degradation and its subsequent recycling as component parts back into 
the cell is important for cellular viability. Correct autophagy and 
intracellular trafficking are central to this process (Palmer et al., 2013). 
Problems in the trafficking and the degradation of subunit c has often 
been attributed to a breakdown in the catabolic pathway for this molecule 
resulting in a higher chance that the cell will become apoptotic due to a 
decrease in the cells ability to generate ATP.  
 
The NCLs share phenotypes that are similar at the clinical level as well as 
the biochemical level. For this reason they are classified together as a 
group of storage diseases. While much research has been carried out on 
the different types of NCLs, most reports only concentrate on one aspect 
of the disease exclusively with little information on up-stream or down-
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steam events or the affects on other intracellular pathways. However, one 
thing that a lot of researchers seem to agree on is that the NCL genes 
most likely belong to a common metabolic pathway (Weimer et al., 2002). 
 
1.25 Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) 
 
 JNCL (or CLN3) is the most common form of the heterogenous group of 
NCLs with overlapping symptoms of other NCLs. Initial symptoms of 
hearing loss typically present from the ages of 4-8 years old, followed by 
gradual loss of vision resulting in complete blindness within 2-4 years 
(Bennett and Rakheja, 2013). Further symptoms such as seizures, motor 
disorders and mental regression present themselves in the second 
decade of the patients’ life. Patients typically live to their early 20’s, 
however some rare cases have reported patients living into their 30’s. 
While neuronal loss is attributed as the cause of death, some emerging 
evidence has suggested that other factors such as the loss defects in the 
patient’s cardiovascular system have been reported in a growing number 
of cases (Kousi et al., 2012). Some evidence has shown that female 
patients with the same type of CLN3 mutation as males have a milder 
disease progression, with many outperforming males in fine motor control 
(Augustine et al., 2013). While the reasons behind this are still unclear, 
some have speculated that this is due to hormonal differences between 
males and females. 
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1.26 The CLN3 gene 
 
Mutations in the CLN3 gene results in the onset of JNCL. The gene itself 
has been found to be located on chromosome 16p11.2. The majority of 
JNCL patients (~74%) have been found to have a homozygous mutation 
that is the result of a 1kb genomic deletion that occurs between introns 6 
and 8 (Kousi et al., 2012). A further ~22% of patients have been found to 
be heterozygous for this mutation. This 1kb deletion induces a frameshift 
mutation resulting in a premature stop codon. Exons 7 and 8, which are 
excised as a result of the mutation, have been predicted to encode the 
amphipathic helix on the luminal face of the CLN3 protein. The result of 
this defect in protein translation has been predicted to have an impact on 
the CLN3 proteins ability to form strong protein/ligand binding critical for 
mediating CLN3 protein function and trafficking (Golabek et al., 2001, 
Haskell et al., 2000). 
 
1.27 The CLN3 protein 
 
The CLN3 protein, encoded by the CLN3 gene, is a 438 amino acid 
transmembrane protein, which is predicted to possess 6 transmembrane 
domains (Mao et al., 2003). The protein itself is highly conserved and 
ubiquitously expressed in different cell types and has an ortholog in yeast 
known as CLN3p that encodes for the Btn1p protein (also called battenin) 
(Jarvela et al., 1999). The CLN3p gene in yeast has been found to be 
39% identical and 59% similar to its mammalian counterpart, however 
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work done on yeast models often find Golgi abnormalities which are not 
present in mammalian CLN3 mutant cells. In silico analysis of the CLN3 
protein has been used to find sequence similarity in other types of 
proteins. This analysis found that the CLN3 protein bears a similarity to 
members of the major facilitator superfamily (MFS). The MFS is a large 
family of transmembrane transporters that are involved in the transport of 
small solute uniporters, symporters and antiporters (Pao et al., 1998). 
These permeases play an important role in the cellular transport of simple 
sugars, oligosaccharides, organic and inorganic cations. 
 
1.28 CLN3 protein trafficking and its potential role in the endo-
lysosomal pathway 
 
The CLN3 protein is synthesized in the ER and is then further processed 
in the Golgi apparatus where it is then transported to its cellular location. 
The protein has been found to have two dileucine lysosomal targeting 
motifs that have been hypothesized to mediate the lysosomal targeting of 
the CLN3 protein once it has left the Golgi apparatus (Kyttala et al., 2004, 
Storch et al., 2004).  Another theory on CLN3 trafficking is that it is 
localized to the plasma membrane before being taken up by early 
endosomes. It is then processed along the endocytic pathway towards 
the lysosome (Nijssen et al., 2003, Sleat et al., 2007). In vivo work has 
been done to suggest that the Cln3 protein is expressed within the 
endosomes and lysosomes. Fractions taken from mouse liver found that 
the Cln3 protein was highly enriched in the lysosomal fraction when 
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compared to the ER and Golgi fractions following density gradient 
centrifugation (Cao et al., 2006, Ezaki et al., 2003). However the method 
they used does not produce pure lysosomes, so it is possibly 
contaminated with other organelles. 
  
1.29 The importance for studying lysosomal proteins in an isolated 
system 
 
The severe pathogenesis and poor prognosis of patients with a lysosomal 
storage disease helps highlight the need to understand key lysosomal 
regulation and function so that it may help in the development of more 
suitable forms of treatment in the future. While advancements have been 
made in recent years on our understanding of the lysosome and how it is 
so much more than just the stomach of the cell (which is too simplistic a 
terminology) many components of the lysosome are still unknown or their 
functions not fully characterised. This is in part due to out of date 
techniques used to isolate lysosomes so that they can be examined in an 
isolated environment, free of contamination from other organelles, and 
are still structurally intact and functional. The means to purify lysosomes 
that are functional is especially an important feature as many lysosomes 
in LSDs have defects in their Ca2+ levels or pH. Unfortunately methods 
such as density gradient centrifugation cannot produce functional 
lysosomes due to the high levels of gravitational force exerted on them 
during the centrifugation process.  
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1.30 Lysosomal purification with the use of magnetic nanoparticles 
 
One of the main problems facing lysosomal researchers is the difficulty in 
purifying out lysosomes from cells without contamination from other 
organelles. The current method most often used is density gradient 
centrifugation, which is a method that separates organelles based on 
their respective buoyant density (Liu et al., 2012). However, the majority 
of lysosomal storage disorders result in primary or secondary storage of 
lipids in the lysosome. This accumulation results in a change in the 
buoyant density of the lysosome, thus leading to a heterogeneous 
sampling of the lysosomal population from Density Gradient 
Centrifugation as well as subsequent contamination by other organelles 
(Graham, 2001). 
Previous work utilising iron based nanoparticles and a magnetic field has 
been done in an attempt to purify out lysosomes from cells. However, due 
to the instability of these nanoparticles and their poor magnetic potential 
led to an increase in cellular toxicity and a poor lysosomal yield obtained 
(Diettrich et al., 1998). The recent advancement in nanoparticle 
technology has resulted in the production of highly magnetic iron based 
nanoparticles known as Super Paramagnetic Iron Oxide Nanoparticles 
(SPIONs) that consist of a magnetite core functionalised with a large 
dextran coat (Wahajuddin and Arora, 2012). These particles offer greater 
potential in purifying lysosomes via magnetic separation as they have a 
much greater magnetic potential than the iron based nanoparticles used 
previously and a reduction in cellular toxicity due to stability of the dextran 
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coat. The importance of stable nanoparticles to purify lysosomes will be 
discussed further in chapter 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! 39!
1.31 Aims 
 
Chapter 3: To test for any increase in the levels of cellular toxicity 
following treatment with super paramagnetic nanoparticles. The least 
toxic SPIONs will be the most ideal magnetic particle to purify lysosomes. 
 
Chapter 4: To develop an improved lysosomal magnetic purification 
assay, where lysosomes can be purified with high yield, low 
contamination from other organelles and still be functional. 
 
Chapter 5: To observe any key phenotypic changes in Cln3∆ex7/8 
cerebellar cells to help further our understanding of the role CLN3 may 
have in the cell. 
 
Chapter 6: To analyse Cln3∆ex7/8 cerebellar Ca2+ levels to determine if 
there is a defect in Ca2+ homeostasis in these cells. Also to try and 
identify the function of CLN3. 
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Chapter 2:  
Material and Methods 
 
 
 
 
 
 
 
 
 
 
 !
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2.1 Cell culture of CHO-H1 and CHO M12 cell lines 
 
CHO-H1 cell lines were obtained from Dr. Emyr Lloyd-Evans, Cardiff 
University, Cardiff. NPC1 null CHO M12 were provided as a gift from 
Professor Daniel Ory (St.Louis hospital). Cho-H1 and CHO M12 cells 
were grown in DMEM-F12 medium with supplemented 10% FCS (Sigma) 
and 1% L-Glutamine (Lonza) as monolayers in T75 flasks (Fisher) at 37 
°C with 5% CO2 in a humidified incubator. 
 
2.2 Cell culture of Cln3 cerebellar cells and CLN3 mutant patient 
fibroblast cell lines 
 
Precursor cerebellar cells were provided as a gift by Dr Cotman (Harvard 
university) and grown in DMEM (Sigma) supplemented with 24mM KCL 
(Sigma), 85.5µg/ml Genetecin (Gibco), 10% FCS (Sigma) and 1% L-
Glutamine (Lonza) as monolayers in T75 Flasks (Fisher) at 33 °C with 5% 
CO2 in a humidified incubator. 
Wild type fibroblast and CLN3 mutant fibroblast cell lines were provided 
as a gift from Dr Sarah Mole (University College London, London). These 
cells were grown in DMEM medium (Sigma) supplemented with 10% FCS 
(Sigma) and 1% L-Glutamine (Lonza) as monolayers in T75 flasks 
(Fisher) at 37 °C with 5% CO2 in a humidified incubator. 
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2.3 Lysosomal purification 
 
This method was adapted from (Duvvuri and Krise, 2005). 
 
2.3.1 SPION treatment of cells 
 
Cells to be purified are grown in a T75 Flask (FISHER) under normal 
tissue culture conditions. When the cells are ~80% confluent the 
nanoparticle containing pulse medium is ready to be added. Cell culture 
media is removed from the cells and replaced with pulse media 
containing 1ml of Dextran stabilized 45nm magnetite particles in dH2O 
(provided by Liquids Research Ltd unless stated otherwise), 9ml of cell 
culture medium and 100µl of 1M HEPES pH 7.2 (LONZA) before 
incubated under normal cell culture conditions for the designated pulse 
time (24 hours unless stated otherwise). A sufficient pulse time is 
important so to give time for the magnetic nanoparticles to reach the 
lysosome. Once these particles have reached the lysosome it now 
possesses a magnetic potential. 
 
The pulse medium is then removed and the cells are washed once in 
10ml Dulbecco’s Phosphate Buffered Saline (DPBS) (SIGMA ALDRICH). 
Normal cell culture medium is then added to the cells where they are 
incubated under normal culture conditions for the appropriate chase time 
(24 hours unless stated otherwise). After the allotted chase time the 
media is removed and the cells are washed once in 10ml of DPBS and 
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the cells are trypsined off the flask by incubating in 1ml of 1x Trypsin 
(SIGMA ALDRICH) for 5 minutes at 37°C. 9ml of medium is added to the 
trypsinised cells to quench the Trypsin and they are then transferred to a 
15ml Falcon tube (GREINER) before undergoing a low speed 
centrifugation (1000rpm) to pellet the cells. The medium is discarded 
before the pelleted cells are resuspended in 10ml of DPBS, to remove 
excess medium, and are again pelleted at low speed centrifugation. 
During this time the two buffers used are prepared and kept on ice till 
required.  
 
Hypotonic buffer A consists of: 15mM Potassium Chloride (SIGMA 
ALDRICH), 1.5mM Magnesium Acetate (Sigma Aldrich), 1mM 
Dithiothreitol (FISHER), 10mM HEPES pH 7.2 and 1µl of protease 
inhibitor cocktail III (FISHER) and dH2O.  
Isotonic buffer B consists of: 375mM Potassium Chloride, 22.5mM 
Magnesium Acetate, 1mM DTT, 100µM Sucrose (SIGMA ALDRICH), 
220mM HEPES pH 7.2 and 20U/mg of DNAse1 (ROCHE) and dH2O. 
 
2.3.2 Homogenisation of SPION treated cells 
 
After the low speed centrifugation the DPBS is discarded and the pelleted 
cells are resuspended in 4ml of buffer A to rupture the cellular membrane 
via osmotic swelling to release the cellular organelles. The suspension is 
then transferred to a Dounce homogeniser (FISHER) where it is 
homogenised for 30 strokes to further break open the cells. The 
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homogenised solution is then transferred to a 50ml Falcon tube 
(GREINER) and passed through a 23G needle (BECTON DICKINSON) 
attached to a 5ml syringe to break open more cells via shear force. After 
this, 1ml of buffer B is added to the homogenised solution to prevent 
damage to the cellular organelles that had been released from the 
homogenised cells, and the solution is transferred to a 15ml Falcon tube. 
The solution is then centrifuged at 1500rpm for 10 minutes to pellet out 
unbroken cells.  
 
2.3.3 Passing homogenised cell content over the LS column 
 
After the homogenised solution has been centrifuged, the supernatant 
was passed over a 5ml QuadroMACS™ LS column (MILTENYI) that is 
attached to a 2 tesla QuadroMACS™ separation unit (MILTENYI) which 
has been pre-equilibrated with 1ml 0.5% Bovine Serum Albumin (SIGMA 
ALDRICH) in DPBS.  
 
 The supernatant is allowed to pass through the LS column where 
organelles (i.e. magnetite containing lysosomes) that possess a magnetic 
potential are retained in the column due to the magnetic field the 2-tesla 
magnet generates. The Supernatant that passes through the column is 
collected at the bottom in a 5ml tube (STAR LABS). This collected 
fraction is called the post nucleic supernatant (PNS) and contains 
material that does not possess a magnetic potential and is not retained 
on the column.  
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The pelleted, unbroken cells can be re-homogenised by repeating the 
homogenisation steps done in 2.3.2 to further improve the protein yield 
obtained from the lysosomal purification assay. Following the re-
homogenisation steps the solution is then centrifuged again and the 
supernatant is passed through the LS column again. The supernatant that 
passes through the column is collected and is termed PNS2 fraction. 
 
2.3.4 LS column Wash steps 
 
1ml of 20U /mg DNase1 in DPBS is passed through the LS column to 
remove any DNA that might be causing organelles other than lysosomes 
to stick to the column due to DNA’s sticky nature. The DNase1 solution 
that passes through the column is then collected in a 5ml tube. This is 
called the DNase1 fraction. 2ml of DPBS is then passed through the LS 
column to remove any remaining DNase1. The DPBS is collected in a 
5ml tube and is termed the PBS fraction. 
 
2.3.5 Elution of magnetically retained material 
 
The LS column is then removed from the QuadroMACS™ separation unit 
and the magnetically retained material was eluted off the column in 0.5ml 
of DPBS using a plunger supplied with the columns. This eluted material 
is called the lysosomal fraction, due to it being enriched with lysosomes 
(and late-endosomes). 
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1µl of protease inhibitor cocktail III is then added to the lysosomal fraction 
to prevent degradation of the protein. For functional assays, the 
lysosomal fraction is kept on ice while their respective protein content is 
determined using a BCA protein assay. The different fractions obtained 
from the lysosomal purification assay that are not used straight away are 
kept at -20°C. 
 
2.4 BCA protein assay 
 
BCA Protein Assay was performed as per the manufacturer’s instructions 
(SIGMA ALDRICH). Absorbance was read using a TECAN absorbance 
microplate reader at 570nm wavelength. 
 
2.5 Preparation of Coverslips for Microscopy 
 
Cellular suspensions were counted then seeded onto 15mm cover slips 
(VWR) in 24 well plates (GREINER) at ~10,000 cells per coverslip for 
CHO-H1 and CHO M12, Cln3 wild type and mutant cerebellar cells and 
human fibroblasts. 
 
2.6 Cellular imaging via fluorescent microscopy 
 
All images were obtained and captured with a Zeiss Axioimager inverted 
microscope with a Colibri LED light source, and a Zeiss Axiocam MrM 
! 47!
CCD camera using Axiovision software. Microscopy images were edited 
using Adobe Photoshop software. This software was also used to 
quantify the level of fluorescence present in cells after they had been 
stained (via thresholding). Edited cell images were arranged using Adobe 
Photoshop and Microsoft Powerpoint software. n number denotes the 
number of times the experiment has been repeated on separate days. 
 
2.7 Statistical analysis 
 
Statistical testing and graph preparation was performed using GraphPad 
Prism 5 (GraphPad Software, Inc). A P-Value of <0.05 was considered 
significant. A relative degree of significance is defined in each figure 
legend. Mutant CLN3 or SPION/FeO treated cells are determined to be 
significant against wild type/untreated controls. 
 
2.8 Live staining 
 
2.8.1 Dihydroethidine (DHE) 
 
DHE (SIGMA ALDRICH) detects the presence of Super Oxide by being 
oxidized by it. Cell medium was removed from the cells grown on cover 
slips and washed with 500µl DPBS to remove excess medium, DPBS 
was then removed. Cells were then loaded with 50µM of DHE in DPBS 
and then left in the dark at ~16oC for 30 minutes. DHE solution is then 
removed before the cells are washed twice in 1ml DPBS.  The cells are 
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then imaged live. Excitation 470nm, Emission 610. 
 
2.8.2 Diphenyl-1-Pyrenylphosphine (DPPP) 
 
DPPP (POLYSCIENCES INC) detects the presence of lipid peroxidation 
as it becomes fluorescent when it is oxidized by lipid hyperoxides. Cells 
were grown on cover slips as described in 2.5 and media was removed 
followed by 500µl DPBS wash, DPBS was then removed. Cells were 
loaded with 10µM of DPPP in DPBS and incubated at 37°C for 15 
minutes. DPPP solution was removed and the cells were washed twice 
with 1ml DPBS and imaged live. Excitation 352nm, Emission 380nm. 
 
2.8.3 Lysotracker green 
 
Lysotracker green (INVITROGEN) is a probe that fluoresces when it 
loads into acidic compartments in the cell. Cells were grown on cover 
slips as described in 2.5 and media was removed followed by 500µl 
DPBS wash, DPBS was then removed. Cells were loaded with 200nM of 
Lysotracker green probe in DPBS and incubated at 37°C for 15 minutes. 
Lysotracker green probe was then removed and the cells were washed 
twice with 1ml DPBS and imaged live. Excitation: 443nm, Emission 
505nm. 
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2.8.4 Mitotracker green 
 
Mitotracker green (INVITROGEN) is a probe that localises to the 
mitochondria and fluoresces. Cells were grown on cover slips as 
described in 2.5 and media was removed followed by 500µl DPBS  wash, 
DPBS was removed. Cells were then loaded with 200nM of Mitotracker 
green probe in DPBS and then incubated at 37°C for 15 minutes. 
Mitotracker green probe was then removed and the cells were washed 
twice with 1ml DPBS and imaged live. Excitation: 490nm, Emission 
516nm. 
 
2.8.5 Mitotracker ROS 
 
Mitotracker ROS (INVITROGEN) is a probe that localises to the 
mitochondria and becomes oxidised by mitochondria produced reactive 
oxygen species, and fluoresces. Cells were grown on cover slips as 
described in 2.5 and media was removed followed by 500µl DPBS  wash, 
DPBS was then removed. Cells were then loaded with 200nM of 
Mitotracker ROS probe in DPBS and then incubated at 37°C for 15 
minutes. Mitotracker ROS probe was then removed and the cells were 
washed twice with 1ml DPBS and imaged live. Excitation: 554nm, 
Emission 576nm. 
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2.8.6 ER tracker 
 
ER Tracker (INVITROGEN) is a probe that localises to the ER and 
fluoresces. Cells were grown on cover slips as described in 2.5 and 
media was removed followed by 500µl DPBS wash, DPBS was then 
removed. Cells were then loaded with 200nM of ER Tracker probe in 
DPBS and incubated at 37°C for 15 minutes. ER Tracker probe was then 
removed and the cells were washed twice with 1ml DPBS and imaged 
live. Excitation: 504nm, Emission 511nm. 
 
2.8.7 LipidTOX Red 
 
LipidTOX Red phospholipidosis (INVITROGEN) is a probe that detects 
phospholipidosis in the cell. Cells were grown on cover slips as described 
in 2.5 and media was removed followed by 500µl DPBS wash, DPBS was 
then removed. Cells were then loaded with 1µM of LipidTOX Red 
phospholipidosis probe in DPBS and then incubated at 37°C for 4 hours. 
LipidTOX Red phospholipidosis probe was then removed and the cells 
were washed twice with 1ml DPBS and imaged live. Excitation: 595nm, 
Emission 615nm. !
2.8.8 Magic Red cathepsin B & L  
 
Magic Red Cathepsin B & L kit (IMMUNOCHEMISTRY) was used to 
detect for the activity of the lysosomal enzymes Cathepsin B & L by using 
a substrate that releases fluorescence when it is cleaved by its respective 
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cathepsin enzyme. This was performed as per the manufacturers 
instructions. Cells were grown on cover slips as described in 2.5 and 
media was removed followed by 500µl DPBS wash, DPBS was then 
removed. Cells were then loaded with 1µM of magic red substrate in 
DPBS and incubated at 37°C for 30 minutes. Magic red substrate was 
then removed and the cells were washed twice with 1ml DPBS and 
imaged live. Excitation: 592nm, Emission 628nm. 
 
2.8.9 Fura 2 
 
Fura 2 (TEF LABS) was used to detect for the presence of Fe2+ in cells. 
Cells were grown on cover slips as described in 2.5 and media was 
removed followed by 500µl DPBS wash, DPBS was then removed. Cells 
were then loaded with 5µM of Fura 2 in complete medium containing 
0.025% Pluronic F-127 (SIGMA ALDRICH) and then incubated at 37°C 
for 1 hour. Pluronic F-127 was used as a dispersant to prevent 
aggregation of the metal ion probe. Fura 2 probe was then removed and 
the cells were washed twice with 1ml DPBS and imaged live. Excitation: 
443nm, Emission 505nm. 
 
2.8.10 Calcein 
 
Calcein probe (INVITROGEN) was used to detect for the presence of 
Fe3+ in cells. Cells were grown on cover slips as described in 2.5 and 
media was removed followed by 500µl DPBS wash, DPBS was then 
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removed. Cells were then loaded with 30µM of Calcein in DPBS 
containing and then incubated at ~16°C for 30 minutes. The Calcein 
probe was then removed and the cells were washed twice with 1ml DPBS 
and imaged live. Excitation: 485nm, Emission 530nm. 
 
2.8.11 Phen green 
 
Phen green (INVITROGEN) was used to detect for the presence of Zn2+ 
and Cu2+ in cells. Cells were grown on cover slips as described in 2.5 and 
media was removed followed by 500µl DPBS wash, DPBS was then 
removed. Cells were then loaded with 2µM of Phen green in complete 
medium containing 0.025% Pluronic F-127 and then incubated at 37°C 
for 1 hour. Pluronic F-127 was used as a dispersant to prevent 
aggregation of the metal ion probe. Phen green probe was then removed 
and the cells were washed twice with 1ml DPBS and imaged live. 
Excitation: 490nm, Emission 520nm. 
 
2.8.12 Newport green 
 
Newport green (INVITROGEN) was used to detect for the presence of 
Zn2+ and Cu2+ in cells. Cells were grown on cover slips as described in 
2.5 and media was removed followed by 500µl DPBS wash, DPBS was 
then removed. Cells were then loaded with 5µM of Newport green in 
complete medium containing 0.025% Pluronic F-127 and then incubated 
at 37°C for 1 hour. Pluronic F-127 was used as a dispersant to prevent 
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aggregation of the metal ion probe. Newport green probe was then 
removed and the cells were washed twice with 1ml DPBS and imaged 
live. Excitation: 505nm, Emission 535nm. 
 
2.8.13 N,N,N’,N’-Tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) 
 
Phen green and Newport green experiments done with the use of the 
Zn2+ chelator, TPEN (SIGMA ALDRICH), were done the same as 
described above, but with 10µM TPEN added to the metal ion probe 
solution. 
 
2.8.14 Lysosensor Yellow/Blue 
 
Lysosensor Yellow/Blue (INVITROGEN) was used to measure 
intracellular pH levels in lysosomes. Cells were grown on cover slips as 
described in 2.5 and media was removed followed by 500µl DPBS wash, 
DPBS was then removed. Cells were washed with DPBS three times then 
loaded with 1µM of Lysosensor yellow/blue in DPBS for 15 minutes at 
37oC. Cells were washed two times with 1ml DPBS and imaged live. 
Excitation: 335nm, Emission 452nm. 
 
2.8.15 Oregon green BAPTA 
 
Oregon green BAPTA probe (INVITROGEN) was used to measure 
intracellular Ca2+ levels in lysosomes. Cells were grown on cover slips as 
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described in 2.5 and media was removed followed by 500µl DPBS  wash, 
DPBS was then removed. Cells were washed with DPBS three times then 
loaded with 100µM of Oregon green BAPTA in DPBS for 6 hours at 37oC. 
Cells were washed twice with 1ml DPBS and imaged live. 10µg/ml 
TRITC-Red dextran (SIGMA ALDRICH) was used as a loading control to 
show the Oregon green BAPTA probe was in the lysosomal 
compartment. Excitation: 494nm, Emission 523nm. 
 
2.9 Western Blotting 
 
2.9.1 Denaturing protein 
 
100µl of lysosomal fraction/PNS fraction in H2O to give a protein 
concentration of 5µg was denatured in 300µl Sample buffer (10g Glycerol 
(SIGMA ALDRICH), Tris-HCL (SIGMA ALDRICH), Bromophenol Blue 
(FISHER), SDS (FISHER) in 25ml H2O) for 1 hour at 60°C.  
 
2.9.2 Gel electrophoresis 
 
The denatured proteins are loaded into wells on a 10% SDS-PAGE gel 
(FISHER) along with 10µl of a protein ladder (NEW ENGLAND BIO 
LABS). The gel is then inserted into an ATTO electrophoresis machine. 
The ATTO electrophoresis machine is then filled with Gel running buffer 
(14.4g Glycine (FISHER), 3g Tris-Base (FISHER), 1g SDS and 1 litre 
! 55!
H2O). The protein loaded gel undergoes electrophoresis at 160v for 2 
hours to separate proteins based on their respective molecular size. 
 
2.9.3 Gel transfer 
 
Immobile Transfer membrane (MILLIPORE) is washed for 1 minute in 
100% Methanol (FISHER) before being washed for a few seconds in 
Transfer buffer (3.5g Glycine, 7g Tris-Base, 1.7g SDS and 1 litre of H2O).  
The gel is then placed on top of the Immobile Transfer membrane and 
sandwiched between Whatman filter paper (GE HEALTHCARE) that has 
been soaked in transfer membrane. This is then placed in a gel transfer 
machine and 40mA per transfer membrane for 2 hours is applied to 
transfer the protein from the gel to the transfer membrane.  
 
2.9.4 Blotting of antibodies against transfer membrane 
 
The transfer membrane containing the proteins are then blocked 
overnight (to reduce non-specific binding of the antibodies) at <4°C in 
50ml of 5% Marvel milk powder solution in TBS-Tween wash buffer (6g 
Tris-Base, 8.8g NaCl, 1ml Tween 20 (SIGMA ALDRICH) made up to 
1litre with H2O). 
 
 The milk powder solution is then washed off the transfer membrane with 
repeated TBS-Tween wash steps and the transfer membrane is then 
incubated with the primary antibody overnight at <4°C (dilutions listed 
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below). Unbound primary antibody is removed via repeated TBS-Tween 
wash steps and the transfer membrane is incubated with the secondary 
antibody at ~ 16°C for 1 hour. Unbound secondary antibody is removed 
via repeated TBS-TWEEN wash steps. 
 
Primary antibody dilutions: GAPDH (GENETEX) 1:10,000 dilution from a 
1mg/ml stock, NPC2 (SIGMA ALDRICH) 1:1000 dilution from a 
0.39mg/ml stock, NPC1 (NOVUS) 1:1000 dilution from a 1.15mg/ml 
stock, Calnexin (ABCAM) 1:1000 dilution from a 1mg/ml stock, 
Cytochrome C (ABCAM) 1:5000 dilution from a 0.5mg/ml stock, Caveolin 
2 (GENETEX) 1:1000 dilution from a 0.94mg/ml. 
 
Anti mouse/Rabbit Secondary antibody dilution (THERMO SCIENTIFIC): 
1:10,000 dilution from a 0.5mg/ml. 
 
2.9.5 ECL development of antibody blotted transfer membrane 
 
 The transfer membrane is washed for 1 minute in ECL development 
solution from the ECL development kit (THERMO SCIENTIFIC). The 
membrane is then wrapped in cling film and exposed onto X-Ray film 
(Santa Cruz) inside a light-free case.  The exposed film is then developed 
using an X-ray developing machine. 
 
 
 
! 57!
2.10 Enzyme assays 
 
2.10.1 Alkaline Phosphatase  
 
This assay was used to detect the presence of the Plasma membrane 
enzyme Alkaline Phosphatase in the lysosomal fraction. This assay was 
performed in a transparent, flat well 96 well plate (GREINER). For each 
well the volumes were: 20µl lysosomal fraction, 30µl DPBS and 50µl of 
PNP substrate mixture (SIGMA ALDRICH). Following addition of the PNP 
substrate mixture the plate was incubated for 1 hour at 37°C. After 1 hour 
100µl of sodium hydroxide was added to stop the reaction. Absorbance 
was measured using a TECAN absorbance microplate reader at 405nm 
wavelength. 
 
2.10.2 Alpha Mannosidase 
 
This assay was used to detect the presence of the Golgi apparatus 
enzyme Alpha-Mannosidase in the lysosomal fraction. 10µl per ml of 1M 
HEPES (pH 7.2) was added to the PNP-α!D-mannosidase (SIGMA 
ALDRICH) to buffer the pH. For each well the volumes were: 20µl 
lysosomal fraction, 30µl DPBS and 50µl of PNP!α!D!mannosidase 
substrate mixture per well of a transparent, flat well Greiner 96 well plate 
and left for 1 hour at 37°C. 100µl of sodium hydroxide was then added to 
stop the reaction. Absorbance was measured using a TECAN 
absorbance microplate reader at 405nm wavelength. 
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2.10.3 MTS assay 
 
This assay was used to detect the presence of mitochondrial activity in 
the lysosomal fraction. This assay was performed in a transparent, flat 
well 96 well plate (Greiner). This assay was performed as per the 
manufacturer’s instructions (PROMEGA). 100µl of MTS substrate was 
added per well followed by 10µl of lysosomal fraction. The Plate was then 
left for left for 1 hour at 37°C. Absorbance was measured using a TECAN 
absorbance microplate reader at 405nm wavelength. 
 
2.10.4 β!Glucuronidase Assay 
 
This assay was used to detect the presence of the ER enzyme Beta!
Glucuronidase in the lysosomal fraction. Fluorescein di!β!D!glucuronide 
(SIGMA ALDRICH) was used as the substrate at 0.1mM in pH 7 DPBS 
+1mM MgCl2 and 1mM CaCl2. 20µl of this was added to 20µl of the 
fraction sample and 60µl DPBS. This was then left for 1 hour at 37°C. 
Fluorescence was then examined in each well at an excitation of 355nm 
and an emission of 460nm. 
 
2.10.5 Beta-Hexosaminidase assay  
 
This assay (SIGMA ALDRICH) was used to detect the presence of the 
lysosomal enzyme Beta!Hexosaminidase. This assay was performed on 
the various assays as described in (Jeyakumar et al., 2002). 
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Fluorescence was then examined in each well at an excitation of 355nm 
and an emission of 460nm. 
 
2.11 Functional assays on purified lysosomes 
 
2.11.1 ACMA pH assay 
 
9-Amino-6-Chloro-2-Methoxyacridine (ACMA) probe (MOLECULAR 
PROBES) was used on purified lysosomes to show their re-acidification 
post purification via their v-ATPase activity. The assay was performed as 
described in (Lichko and Okorokov, 1984). 
 
2.11.2 Functional Ca2+ uptake assay 
 
The Calcium sensitive Fluo-4 probe (INVITROGEN) was used to detect 
the uptake and release of Ca2+ from purified lysosomes. This assay was 
done using 25µg of protein taken from the lysosomal fraction from both 
CHO-H1 and CHO M12 cell lines. The Assay was performed as 
described in (Lloyd-Evans et al., 2003). !!
2.12 Fixed staining 
 
 
2.12.1 Fixing cells with 4% Paraformaldyhyde (PFA) 
 
Cells were grown on cover slips as described in 2.5 and media was 
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removed. Cells to be fixed are washed in 1ml DPBS followed by the 
addition of 300µl of 4% PFA (FISHER) in DPBS for 10 minutes at ~16°C 
to fix the cells. The PFA is removed and the cells undergo three 1ml 10 
minute DPBS washes. The fixed cells are either stained immediately or 
they are stored at 4°C for later use. 
 
2.12.2 Filipin staining 
 
Filipin is a polyene antibiotic that fluoresces when it is bound to 
cholesterol. Filipin (SIGMA ALDRICH) staining was performed as 
described in (Lloyd-Evans et al., 2008). Cells that have been seeded and 
fixed on coverslips were incubated in 500µl of complete medium 
containing 50µg/ml of Filipin for 30 minutes in the dark at 16°C. The 
medium is removed and the cells are washed three times with 1ml of 
DPBS. The cells can then be imaged. Excitation: 380nm, emission: 
405nm. 
 
2.12.3 Lysenin staining 
 
Lysenin toxin was used to detect the presence of sphingomyelin. Lysenin 
toxin (PEPTIDES INTERNATIONAL), staining was done as described in 
(Lloyd-Evans et al., 2008). PFA Fixed cells are incubated in Lysenin toxin 
at 1:1000 dilution of a 0.5µg/ml stock solution overnight at 4°C in DPBS 
containing 1% bovine serum albumim and 0.1% Saponin (SIGMA 
ALDRICH). The toxin is removed and the cells are washed three times 
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with 1ml DPBS. The cells are then incubated overnight at 4°C in 1:1000 
dilution of the Lysenin primary antibody (PEPTIDES INTERNATIONAL) in 
DPBS. The primary antibody is then removed and the cells are washed 
three times with 1ml DPBS. The cells are then incubated with the 
secondary antibody Dylight 488 conjugated goat anti-mouse IgG 
secondary antibody (DI-2488) (VECTOR LABS) 7.5µg/ml in DPBS 
containing 1% bovine serum albumin and 0.1% Saponin, for 30 minutes 
at 16°C. This is then removed and the cells are washed three times in 
1ml of DPBS. The cells are then imaged. Excitation: 493nm, emission: 
518nm. 
 
2.12.4 Bis (monoacyl) glycerophosphate/lyso-bisphosphatidic acid 
(p-LBPA) staining 
 
LBPA antibody binds specifically to LBPA. PFA fixed cells were incubated 
overnight at 4oC in a 1 in 1000 dilution of a 0.5mg/ml stock mouse anti- 
pLBPA antibody (ECHELON) in blocking buffer (DPBS containing 1% 
BSA, 0.1% Saponin). Cells were washed three times for 5 minutes in 
DPBS, then incubated with Dylight 488 conjugated goat anti-mouse IgG 
secondary antibody (DI-2488) 7.5µg/ml in Blocking buffer for 30 minutes 
at room temperature. Cells were washed 3 times with 1ml DPBS and 
mounted and imaged. Excitation: 493nm, emission: 518nm. 
 
 
 
! 62!
2.12.5 Sarcoplasmic Endoplasmic Reticulum ATPase 2 (SERCA2) 
staining 
 
SERCA2 antibody was used to detect the levels of the ER calcium influx 
pump SERCA2. PFA fixed cells were incubated overnight at 4oC in a 1 in 
200 dilution of a 1mg/ml stock mouse anti-Serca-2 antibody (ABCAM) in 
blocking buffer. Cells were washed three times for 5 minutes in DPBS, 
then incubated with Dylight 488 conjugated goat anti-mouse IgG 
secondary antibody (DI-2488) 7.5µg/ml in Blocking buffer for 30 minutes 
at ~16 oC. Cells were washed again 3 times with 1ml DPBS and mounted 
and imaged. Excitation: 493nm, emission: 518nm. 
 
2.12.6 Early Endosomal Antigen (EEA1) staining  
 
EEA1 antibody was used to detect the levels of Early Endosomes in the 
cell. PFA fixed cells were incubated overnight at 4oC in a 1 in 200 dilution 
of 0.65mg/ml stock mouse anti-EEA1 antibody (NOVUS) in blocking 
buffer. Cells were washed three times for 5 minutes in DPBS, then 
incubated with Dylight 488 conjugated goat anti-mouse IgG secondary 
antibody (DI-2488) 7.5µg/ml in Blocking buffer for 30 minutes at room 
temperature. Cells were washed 3 times with 1ml DPBS and mounted 
and imaged. Excitation: 493nm, emission: 518nm. 
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2.12.7 GM130 staining  
 
Gm130 antibody was used to detect the structure of the Golgi apparatus 
in the cell. PFA fixed cells were incubated overnight at 4oC in a 1 in 200 
dilution of a 0.098mg/ml stock mouse anti-GM130 antibody (ABCAM) in 
blocking buffer. Cells were washed three times for 5 minutes in DPBS, 
then incubated with Dylight 488 conjugated goat anti-mouse IgG 
secondary antibody (DI-2488) 7.5µg/ml in Blocking buffer for 30 minutes 
at ~16 oC. Cells were washed again 3 times with 1ml DPBS and mounted 
and imaged. Excitation: 493nm, emission: 518nm. 
 
2.12.8 CtxB transport assay 
 
This assay is used to follow the endocytic transport and recycling of 
ganglioside GM1 using cholera toxin B subunit. 1µg/ml FITC-CtxB 
(SIGMA ALDRICH) working solution is made up in medium. Cells are first 
washed in 1ml of cold medium before 250µl of the CtxB working solution 
is added per well. The cells are then incubated for either a 30 minutes or 
1 hour at <16°C in the dark (pulse step). After the incubation is complete 
the CtxB solution is removed and 1ml of pre-warmed medium is added to 
the cells for 1-2 hour at 37°C (chase step). After, the chase step the 
medium is removed and the cells are washed 3 times (5min per wash) in 
1% BSA and 0.05mg/ml Heparin (TOCRIS) in cold medium (this is to 
remove any non-internalised plasma membrane bound CtxB). The cells 
are washed twice in 1ml PBS and then fixed using the PFA method as 
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described previously. The fixed cells are then mounted on a slide and 
imaged. 
 
2.13 Ca2+ analysis 
 
2.13.1 Intracellular Ca2+ measurements 
 
All intracellular Ca2+ measurements were obtained and captured with a 
Zeiss Axioimager inverted microscope, which has a Colibri LED Light 
source. This Microscope also possesses a Zeiss Axiocam MrM CCD 
camera and uses the Axiovision physiology acquisition package software 
for Ca2+ analysis. Obtained Ca2+ measurement data were quantified and 
statistical tests were performed using Prism software.  
 
2.13.2 Preparation of cells for Ca2+ analysis 
 
Cellular suspensions were counted then seeded onto 8 well chamber 
slides (IBIDI) with ~20,000 cells per chamber well for both wild type and 
Cln3∆ex7/8 cells. These were then allowed to adhere overnight under 
normal cell culture conditions. 
 
2.13.3 Complete Hank’s Balanced Salt solution (HBSS) 
 
HBSS is used to keep cells viable over long experiments and is used as a 
substitute to cell medium as it is not fluorescent. Complete HBSS is 
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composed of: 1mM CaCl2, 1mM MgCl2, 1mM HEPES pH7.2 buffer, 1x 
HBSS solution (LONZA) and dH2O. 
 
2.13.4 Loading of Fura 2-AM Ca2+ probe 
 
Cells were first washed in chilled 1% BSA complete medium. The cells 
were then incubated in 200µl of a 5µM Fura 2-AM (TEF LABS) working 
solution with 0.025% pluronic acid in complete medium for 1hr at <16°C. 
The cells are then washed once in Complete HBSS. The HBSS is 
removed. 100µl of complete HBSS is then added to the cells prior to 
imaging. 
 
2.13.5 Thapsigargin mediated ER Ca2+ release 
 
Thapsigargin (SIGMA ALDRICH) is a drug that blocks Ca2+ uptake into 
the ER by inhibiting its SERCA pumps. 0.1µM, 1µM or 2µM of 
Thapsigargin was added to Fura 2-AM loaded cells and store operated 
Ca2+ release from the ER was measured live. 2µM of Ionomycin 
(INVITROGEN), an Ionophore that induces Ca2+ release from intracellular 
stores with the exception of the lysososome, was added to confirm the 
cells were still alive. 
 
2.13.6 GPN mediated lysosomal Ca2+ release 
 
Fura 2-AM loaded cells were first treated with 2µM Thapsigargin to clamp 
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the ER Ca2+ store. 200µM of the lysosomotrophic peptide GPN (ALFA-
AESAR) was then added to induce lysosomal Ca2+ release in the cells. 
2µM of Ionomycin was then added to confirm the cells were still alive. 
 
2.13.7 Rotenone mediated mitochondrial Ca2+ release 
 
Rotenone (SIGMA ALDRICH) is a drug that induces Ca2+ release from 
the mitochondria by de-polarising its membrane. 100µl of Rotenone in 
complete HBSS was added to Fura 2-AM loaded cells to give a working 
solution of 10µM Rotenone. 100µl of Ionomycin in complete HBSS was 
then added to cells to give a 2µM working solution of Ionomycin. This was 
used to confirm the cells were viable.  
 
2.13.8 NAADP-AM mediated lysosomal Ca2+ release 
 
100µl of NAADP-AM in complete HBSS was added to Fura 2-AM loaded 
cells to give a working solution of 500nM NAADP-AM. NAADP-AM was 
used to induce Ca2+ release from lysosomes via their TPC2 channels. 
 
2.13.9 Treatment with Ned19 to inhibit NAADP-AM mediated 
lysosomal Ca2+ release 
 
Fura 2-AM loaded cells are first incubated with 5µM NED-19 (ENZO LIFE 
SCIENCES), a drug that blocks NAADP mediated Ca2+ release, in 
complete HBSS for 5 minutes at ~ 16°C. 100µl of NAADP-AM in 
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complete HBSS was then added to give a working solution of 500nM 
NAADP-AM to induce lysosomal Ca2+ release.  
 
This protocol was also followed for the C-terminal peptide (CTP) 
experiment, where following Fura 2-AM staining, 100µl of CTP in 
complete HBSS was added to give a working solution of 50µM CTP to 
determine if it rescued the elevated lysosomal Ca2+  
 
2.13.10 Treatment with Nifedipine to inhibit NAADP-AM mediated 
lysosomal Ca2+ release 
 
Fura 2-AM AM loaded cells are first incubated with 10µM Nifedipine 
(SIGMA ALDRICH), an L-type Ca2+ Channel drug inhibitor, in complete 
HBSS for 5 minutes at ~ 16°C. 100µl of NAADP-AM in complete HBSS 
was then added to give a working solution of 500nM NAADP-AM to 
induce lysosomal Ca2+ release.  
 
2.13.11 Glutamate mediated Ca2+ release 
 
Fura 2-AM loaded cells had 100µl of Glutamate (TOCRIS) in complete 
HBSS added to give a working solution of 10µM Glutamate to induce 
Ca2+ release. 
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2.13.12 Store operated Ca2+ entry into cells 
 
Fura 2-AM loaded cells are contained in 100µl of low Ca2+ containing 
complete HBSS solution (20µM CaCl2 instead of 1mM). 100µl of 
Thapsigargan in complete HBSS is added to the cells to give a working 
solution of 1µM Thapsigargin to empty the ER Ca2+ store. 1mM CaCl2 is 
then added to induce store operated Ca2+ entry into the cell. 
 
2.13.13 Design of the CLN3 C-terminal peptide 
 
C-terminal peptides were designed by Dr Kim Wager (Cardiff University). 
 
2.13.14 Intra-lysosomal Ca2+ measurements 
 
Intra-lysosomal Ca2+ levels were measured using Oregon green BAPTA. 
Cells were treated with 100µM Oregon green BAPTA for 6 hours followed 
by 3 washes in 1ml PBS. 10µg/ml TRITC-dextran (SIGMA ALDRICH) 
was used as a loading control to show Ca2+ measurements were taken of 
the lysosome. 100µl of CTP in complete HBSS was added to the cells to 
give a working solution of 50µM CTP. This was to detect if there was 
reduced intra-lysosomal Ca2+ following CTP addition. 
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2.13.15 Measuring Ca2+ release via C-terminal peptides in purified 
lysosomes 
 
Lysosomes from wild type and mutant cerebellar cells were purified as 
described previously. Purified lysosomes were incubated in 2µM Fluo-4 
probe to measure Ca2+ release from lysosomes following 50µM addition 
of C-terminal peptides. !!!!!!!!
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Chapter 3: Effects of superparamagnetic iron oxide 
nanoparticles on cellular and lysosomal function 
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3.1 General introduction  
 
Lysosomal research is important to further our understanding of 
lysosomal proteins and how their loss of function results in the onset of 
lysosomal storage disease. Established techniques have attempted to 
purify lysosomes to aid in lysosomal research, however there are caveats 
to many of these techniques used (discussed further in Chapter 4). In the 
last 20 years the use of magnetic based iron particles has been used to 
some success to purify lysosomes from cells. While the methodology 
behind this was good, unfortunately the iron particles used proved to be 
unstable and toxic to cells. As technology progressed the development of 
a new type of highly magnetic iron particle, called superparamagnetic iron 
oxide nanoparticles (SPIONs), could potentially be used to purify 
lysosomes. But before we are able to use these particles for any kind of 
magnetic based lysosomal purification we must first understand if they 
are non-toxic to cells. 
 
3.2 Superparamagnetic nanoparticles: An introduction 
 
The use of magnetic nanoparticles has been garnering much interest in 
recent years due to their potential in revolutionizing nanomedicine and 
their implementation into the biomedical field (Singh et al., 2012). 
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) are small 
synthetic γ-Fe2O3 (maghemite) or Fe3O4 (magnetite) particles that 
possess a core range that is usually <100nm in diameter (Wahajuddin 
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and Arora, 2012). While other metal oxides such as copper, nickel and 
manganese are known to exhibit superparamagnetic properties; it is 
either magnetite or maghemite that is the most commonly used for 
biomedical purposes. This is due to them being more biocompatible, as 
well as being more easily degradable when compared with copper, nickel 
and manganese. SPIONs are often coated in an organic or inorganic 
coating (e.g. an organic coating consisting of dextran), and the coating of 
these nanoparticles in a suitable polymer confers important 
characteristics that are needed for use in the biomedical field. By coating 
a SPION with an organic or inorganic polymer it helps to reduce 
aggregation among different SPIONs or non-specific protein binding that 
is often seen in uncoated particles, thus helping cellular dispersion. 
Another important reason for the coating is that it helps to protect the 
surface of the nanoparticle from oxidation.  Once the SPION has been 
coated it has become functionalized.  The important characteristic for 
these SPIONs is that they become magnetized when they are exposed to 
an external magnetic field (Petri-Fink et al., 2005). This is known as 
superparamagnetism. The level at which the SPIONs react and become 
magnetized is dependent on the size of the nanoparticle itself. A 
nanoparticle ranging between 10-20nm would possess a single magnetic 
domain independent of other nanoparticles in the vicinity of the same size 
and would become magnetized at a much stronger and quicker rate than 
that of nanoparticles of a larger size that generally become magnetized 
together at a slower rate due their multiple domains (Vargas et al., 2012).   
! 73!
Many different areas of research into using SPIONs for biomedical 
purposes are currently underway as researchers have found a use for 
them in both diagnostic and therapeutic purposes. SPIONs have been 
used to help improve contrast in MRI images helping to diagnose 
progressive diseases at a much earlier stage of development (Amstad et 
al., 2009). The use for SPIONs for drug delivery by using drugs 
conjugated to a SPION particle to improve delivery to a cancer cell for 
example has been an ongoing area of research to improve 
chemotherapeutics and radiotherapeutics (Ruoslahti et al., 2010).  
Another use they are recently being used for is hyperthermia treatment by 
heating up the SPIONs to induce cell death in tumor cells to induce cell 
death and to try and ablate the tumor.  
  
3.3 Potential SPION induced cellular toxicity 
 
Toxicity is an important factor to consider when treating cells with 
magnetic nanoparticles, especially Lysosomal storage disease cell lines.  
Oxidative stress has been reported to be elevated in many different 
lysosomal storage diseases, including NPC (Vazquez et al., 2012). As 
oxidative stress is one of the more common mediators of apoptosis 
(Mukherjee et al., 2005), it is important that the SPIONs used to 
potentially purify lysosomes do not contribute to an increase in cellular 
oxidative stress.  
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Work has been carried out to evaluate whether there are any adverse 
effects SPIONs might have, and their interactions at the cellular and 
subcellular level (Wu et al., 2010).   
 
It is important to take into account the characteristics of the nanoparticles 
when it comes to discussing SPION induced toxicity in cells. The most 
common forms of SPIONs used for magnetic based techniques are either 
Magnetite (Fe3O4) or Maghemite (γ-Fe2O3) (Singh et al., 2012). As 
magnetite contains both Fe2+ and Fe3+ ions it can be rapidly oxidised to 
maghemite in the presence of air, light and also moisture (Laurent et al., 
2008). Therefore the more oxidised the magnetite particle becomes the 
greater the ratio of maghemite to magnetite of the core is present. It is 
also worth noting that uncoated magnetite and maghemite particles have 
different toxic effects depending on the cell type, with greater levels of 
DNA lesions present in magnetite treated lung epithelial cells compared 
with maghemite treatment (Hanini et al., 2011).  
 
One way in that the administration of magnetic nanoparticles to cells can 
have adverse effects is that they may act as a potential source of 
Reactive Oxygen Species (ROS) (Lin et al., 2010). SPIONs that are 
trafficked to the lysosome are then exposed to the acidic pH levels. If the 
SPIONs have been functionalised with a dextran coat then this will help 
protect the magnetite core. However once the magnetite core is exposed 
to the acidic conditions of the lysosomes, this provides favourable 
conditions for intralysosomal Fenton reactions (H2O2 + Fe2+ ! Fe3+ + OH. 
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+ OH-), releasing H2O2 as a result. The production of these highly 
damaging free hydroxyl radicals has been shown to induce lipid 
peroxidation, and as the lysosomal membrane is lipid rich it may disrupt 
lysosomal membrane integrity (Zdolsek and Svensson, 1993).  
 
3.4 The effects of coated and uncoated Magnetite and Maghemite 
particles on cell viability 
 
A recent study examined four different SPIONs produced by the company 
Liquids Research Ltd: two magnetite SPIONs (one coated with a 40kDa 
dextran, the other one not) and two maghemite SPIONs (one coated with 
a 40kDa dextran, the other one not) (Singh et al., 2012). The study aimed 
to look at the effect these four SPIONs had on the iron redox state (the 
Fenton reaction mentioned previously) and whether the presence of 
these SPIONs resulted in an increase in genotoxicity. MCL5 (human 
lymphoblastoid TK+/-) viability following treatment with four different 
SPIONs was analysed. However there was little to no change in the 
levels of MCL5 viability even in SPION concentrations reaching 100mg/ml 
indicating no cytotoxic potential from these SPIONs. The study then 
looked for an increase in the number of oxidative based lesions in 5 
different genes.  While it appears that there is an increase in the levels of 
oxidative DNA lesions when the cells are treated with maghemite, there 
appeared to be a great degree of variation in the levels of lesions 
detected (Singh et al., 2012). The study also set out to measure the 
amount of Fe3+ ions that were generated when the coated maghemite 
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particles were kept in 3 different pH conditions in vitro. There appears to 
be a huge increase in the levels of Fe3+ production after 48 hours when 
the maghemite was stored at pH 4.5 when compared with the maghemite 
stored at pH 5.5 and 7. As the lysosome has a pH of ~4.5 this could 
result in the production of large amounts of Fe3+ being produced inside 
the lysosome, possibly resulting in cytotoxic effects. However one thing 
that the researchers of this study did not take into account is the ionic 
composition of the lysosome. The large amount of protein, lipids and 
other macromolecules already present in the lysosome would provide a 
buffering effect, due to some protein/lipid ability to bind free ions 
(including protons) (Kobayashi et al., 1999), on the acidic conditions 
which could mean that the production of Fe3+ from ingested magnetic 
nanoparticles would not necessarily reach the levels observed in this 
study (Singh et al., 2012). An improved in vitro study in living cells is 
clearly required to better understand the potential degradation of SPIONs 
within lysosomes, and their potential toxic effects. 
 
3.5 Nanoparticle loaded lysosomal structure and function 
 
Other studies have looked at the effect of accumulation of various 
nanoparticles, including glass, within the lysosome and their potential 
effects on lysosomal morphology and function. The effects of 
accumulation of nanoparticles (derived from glass wool) inside the 
lysosome have been speculated to have an impact on the lysosomal pH, 
which as a result would lead to a change in the efficacy of certain types of 
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lysosomal enzymes (Frese et al., 2008, Garnett and Kallinteri, 2006). This 
in theory could mean that the accumulation of these nanoparticles could 
induce a lysosomal storage disease phenotype inside the cell. While it is 
highly unlikely that the accumulation of nanoparticles in the lysosome 
would induce a phenotype as severe as an LSD, it is important to take the 
possibility into consideration as it may have wider consequences in the 
medical arena where nanoparticles are currently used as a contrasting 
agents for MRI studies for example. One such study determined the 
effect of Carboxyl Polystyrene Particles (CPS) of different sizes (20-
500nm) on lysosomes from endothelial cells over varying exposure times 
(24-96 hours) (Frohlich et al., 2012a). CPS was used as a model for the 
effects on nanoparticle accumulation as they are not biodegradable and 
the particles could be obtained in reproducible quality (Frohlich et al., 
2012b). The study aimed to measure the effects on lysosomal 
morphology, pH and enzyme function after different exposure times to 
CPS (Frohlich et al., 2012a). The findings of the study showed that any 
damage from longer exposure to CPS was not higher than from a shorter 
exposure. It was speculated that this was because CPS have a high 
potential to bind to proteins. This could result in the formation of CPS-
protein aggregates, potentially reducing the levels of the potentially toxic 
CPS in the cell (Mayer et al., 2009, Xia et al., 2006). These findings 
suggested that the exposure of CPS did not have an adverse effect on 
lysosomal morphology or pH. Enzyme assays were performed for the 
lysosomal enzymes, cathepsin B and lysosomal sulfatase to detect if 
there were a change in the levels of their activity when exposed to CPS 
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for 24 and 72 hours (Frohlich et al., 2012a). There was a small decrease 
in the levels of the two lysosomal enzymes detected after 24 hours of 
exposure with the CPS. But the levels of enzyme activity did not decrease 
further following 72 hours exposure to CPS. This would suggest that long 
term exposure from synthetic molecules does not induce an LSD 
phenotype, decrease lysosomal enzyme function or membrane integrity 
(Frohlich et al., 2012a). 
 
3.6 Overview 
 
By comparing commercially available dextran functionalised SPIONs, one 
produced by Liquids Research Ltd (LRL) and another produced by 
Chemicell (Chem) we aim to determine which brand of SPIONs is most 
stable in the cell, with the least amount of toxic effects. These two 
SPIONs possess a 40nm magnetic magnetite core that has been 
functionalised with a 40kDa dextran coat. Another type of iron based 
particle (sold by Sigma) called iron dextran will also be tested, as this 
particle is similar in properties used in past studies to magnetically purify 
lysosomes. This particle is composed of a dextran core encompassed 
with an iron oxide coat. !!!!!!!!
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3.7 Results: Potential SPION induced toxicity 
 
Unless stated otherwise, the SPIONs used for this study were the 40kDa 
dextran coated magnetite nanoparticles provided by LRL (these SPIONS 
will be referred to as LRL SPIONs from here on). Comparison of other 
iron based nanoparticles used are the iron oxide coated dextran particles 
(Sigma Iron dextran FeO) and the dextran coated magnetite SPIONs 
provided by Chemicell (Chem SPIONs). 
 
3.7.1 Lysosomal levels after treatment with SPIONs and FeO 
particles 
 
Lysotracker green is a probe used to detect lysosomes as it fluoresces 
when it loads into a highly protonated environment. CHO-H1 cells were 
stained with a lysotracker green probe to show for the presence of 
lysosomes in the cell, and reveal any possible lysosomal expansion 
(figure 3.1). 
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Figure 3.1: (A) Representative images of cells stained with the Lysotracker green probe (white). Each panel is a general representation of the 
total population of cells observed following 24hr pulse with the different brands of SPIONs and FeO followed by a 24 hour and 48 hour chase 
compared to untreated cells. (B) Quantified data of (A). n=4 Values represent mean ± SD. n=3. >80 cells analysed, S denotes significance 
****p< 0.0001. Scale bar =10µm. 
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Untreated CHO-H1 cells stained with the lysotracker green probe showed 
that the majority of cells displayed normal levels of lysotracker staining 
(indicated by punctate fluorescence). A few untreated cells displayed 
higher levels of staining indicating lysosomal expansion was observed, 
but this was in the minority. LRL SPION treated cells after a 24 hour 
chase displayed similar levels of fluorescence as in untreated cells. After 
a 48 hour chase, there was still similar levels of punctate staining in the 
LRL SPIONs treated cells indicating that the lysosomes were still intact. 
After a 24 hour chase with Chem SPIONs there were similar levels of 
lysotracker staining as in the untreated cells, a small percentage of cells 
displayed a slightly elevated levels of lysotracker staining observed, 
possibly due to an expansion in the lysosomal system. Following a 48 
hour chase however the levels of lysosomes detected in the cell were still 
similar, although some enlarged punctate staining was observed, 
suggesting that these lysosomes were either increasing in size or their pH 
had been affected due to the particles. A 24 hour chase with the FeO 
particles displayed a significant decrease in the levels of lysosomes 
detected, after a 48 hour chase little lysotracker staining was seen. This 
suggests that the presence of FeO particles in lysosomes is having an 
effect on the lysosomes ability to maintain its pH. 
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3.7.2 Effects on Cathepsin B activity after treatment with SPIONs or 
FeO particles 
 
CHO-H1 cells were stained with the Magic Red cathepsin B probe to 
detect the levels of the lysosomal enzyme cathepsin B in cells following 
SPION or FeO treatment (figure 3.2). A reduction in staining could 
possibly indicate a problem with lysosomal pH, which is required for the 
enzyme to function. The probe works by loading a substrate into the 
lysosome which is then cleaved by cathepsin B causing a release of 
fluorescence. The greater the stain intensity then the more active 
cathepsin B is in the cells.
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Figure 3.2: (A) Representative images of cells stained with the Magic Red Cathepsin B probe, following treatment with the different brands of 
SPIONs and how this affects the activity of the lysosomal cathepsin B enzyme (white) after a 24 hour and 48 hour chase compared to 
untreated cells. (B) Quantified data of (A). n=3 Values represent mean ± SD. n=3. >60 cells analysed, S denotes significance *p<0.05, 
**p<0.01, ****p< 0.0001. Scale bar =10µm. 
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LRL SPIONs treated cells following a 24 hour chase exhibited similar 
levels of cathepsin B activity as there was in the untreated cells. 
Following a 48 hour chase the cathepsin B stain was higher in the LRL 
SPIONs than in the untreated cells suggesting that the activity of these 
enzymes has increased. Interestingly, cathepsin B activity was localized 
more to the peri-nuclear region of the cell after this chase time, possibly 
suggesting the lysosomes have redistributed to this area of the cell. 
Elevated levels of cathepsin B activity was detected in the Chem SPIONs 
treated cells, implying that cathepsin B activity was elevated following the 
treatment of Chem SPIONs. Treatment with the FeO nanoparticles after a 
24 hour chase resulted in a lower cytoplasmic cathepsin B stain in the 
cell. This could suggest that the lysosomes are leaking due to the 
unstable properties of the FeO particle and the lysosomal enzymes are 
now present in the cytosol. If the lysosomes are leaking out then the 
cytosol of the cell will now be more acidic allowing for the leaked out 
cathepsin B to cleave its substrates elsewhere in the cell. Following a 48 
hour chase with FeO particles there was little cathepsin B activity present 
suggesting that lysosomal enzyme activity or integrity has dropped 
considerably with this treatment. 
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3.7.3 Effects on Cathepsin L activity following treatment with 
SPIONs and FeO particles 
 
CHO-H1 cells were stained with the Magic Red cathepsin L probe to 
detect the levels of the lysosomal enzyme cathepsin L in cells following 
SPION or FeO treatment (figure 3.3). A reduction in staining could 
possibly indicate a problem with lysosomal pH, which is required for the 
enzyme to function. The probe works by loading a substrate into the 
lysosome which is then cleaved by cathepsin L causing a release of 
fluorescence. The greater the stain intensity then the more active  
cathepsin L in the cells is. 
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Figure 3.3: (A) Images of cells stained with the Magic Red Cathepsin L probe. Each panel is a general representation of the total population of 
cells observed following treatment with the different brands of SPIONs and how this affects the activity of the lysosomal cathepsin L enzyme 
after a 24 hour and 48 hour chase compared to untreated cells. (B) Quantified data of (A). n=3 Values represent mean ± SD. n=3. >60 cells  
analysed, S denotes significance ****p< 0.0001. Scale bar =10mm.
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CHO-H1 cells were stained with the Magic Red Cathepsin L probe to 
measure the activity of cathepsin L (indicated by punctate staining). LRL 
SPION treated cells after a 24 hour chase displayed similar levels of 
cathepsin L activity as that seen in the untreated cells (figure 3.3). After a 
48 hour chase there was slightly reduced levels of cathepsin L activity 
observed suggesting that after a longer chase time the LRL SPIONs only 
slightly effect the pH optima necessary for cathepsin L to work properly. 
After a 24 hour chase with Chem SPIONs there was a small increase in 
the levels of cathepsin L activity detected. The cathepsin L activity 
appears to be present in the per-nuclear region of the cell. After a 48 hour 
chase the cathepsin L activity decreased slightly in the Chem SPION 
treated cells but the staining observed was less punctate as seen 
previously and was now more cytoplasmic. Treatment with FeO particles 
resulted in greatly reduced levels of cathepsin L activity over both chase 
times suggesting that the presence of this particle has affected the ability 
of this enzyme to function correctly. 
 
3.7.4 Determining levels of phospholipidosis in SPION and FeO 
particle treated cells 
 
CHO-H1 cells were treated with the LipidTOX Red probe to measure the 
levels of phospholipidosis (figure 3.4) in SPION and FeO treated cells. 
This was done to detect if the presence of these nanoparticles in 
lysosomes resulted in an increase in phospholipidosis in the cell.
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Figure 3.4: (A) Images of cells stained with the LipidTOX Red phospholipidosis probe. Each panel is a general representation of the total 
population of cells observed following treatment with the SPIONs and FeO and how the levels of phospholipidosis are affected after a 24 hour 
and 48 hour chase compared to untreated cells. (B) Quantified data of (A). n=3 Values represent mean ± SD. n=3. >60 cells analysed, S 
denotes significance ****p< 0.0001. Scale bar =10µm.
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24 hour chase of LRL treated cells displayed lower levels of 
phospholipidosis present when compared to that of the untreated cells, 
while slightly reduced levels of phospholipidosis were detected after a 48 
hour chase in the LRL SPION treated cells. Phospholipidosis levels 
detected in the Chem SPION treated cells were increased following a 24 
hour chase. An increased size of puncta was seen which would suggest 
that greater levels of phospholipidosis were present in large endocytic 
vesicles such as the late endosome. Following a 48 hour chase with the 
Chem SPIONs fewer enlarged puncta were observed, but similar 
phospholipidosis levels were detected when compared with untreated 
cells. A 24 hour chase with FeO particles showed elevated levels of 
phospholipidosis in many of the cells observed. Many cells that displayed 
this elevated level of phospholipidosis had staining present throughout 
the cell. Interestingly the phospholipidosis levels decreased in the cells 
that underwent a 48 hour chase with the FeO particles, but this was still 
greater than untreated cells. 
 
3.7.5 Effect on mitochondria numbers following SPION and FeO 
treatment 
 
CHO-H1 cells were stained with the Mitotracker green probe to measure 
the number/distribution of Mitochondria in the cell (figure 3.5).  
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Figure 3.5: (A) Images of cells stained with the Mitotracker green probe (mitochondria). Each panel is a general representation of the total 
population of cells observed following treatment with the different brands of SPIONs and how this affects the levels of mitochondria present 
after a 24 hour and 48 hour chase compared to untreated cells. (B) Quantified data of (A). n=3 Values represent mean ± SD. n=3. >60 cells 
analysed, S denotes significance *p<0.05, ****p< 0.0001. Scale bar =10µm. 
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After a 24 and 48hr chase with LRL there were still similar levels of 
mitochondria detected to that in the untreated cells. After a 24hr chase in 
the Chem SPION treated cells there was a large drop in the levels of 
mitochondria detected. The levels detected did improve after a 48 hour 
chase but this was still slightly below the levels of mitochondria seen in 
the untreated cells. In the FeO treated cells there was an interesting 
phenotype observed after a 24 hour chase. Rather than a diffuse type of 
staining seen in the other cells, the staining was more punctate, but by a 
48 hour chase the cells presented with a more diffuse staining similar to 
that seen in wild type. 
LRL SPION treated CHO-H1 cells were stained with the mitochondrial 
matrix protein antibody LRP130. Using this antibody the levels of 
mitochondria were monitored along with those in the untreated cells. The 
results indicated that using another marker for mitochondria their levels 
do not change in LRL SPION treated cells after a 24 hour chase. 
 
3.7.6 Levels of mitochondrial produced Reactive Oxygen Species 
 
CHO-H1 cells were stained with the MitoROS probe to measure the 
levels of mitochondria ROS in the cell (figure 3.6). Elevated staining might 
indicate that the mitochondria are more stressed and therefore producing 
higher levels of ROS than normal, while lower levels of ROS would 
suggest that the mitochondria are not functioning at as high a capacity as 
mitochondrial ROS is naturally produced from correct mitochondrial 
function in healthy cells. 
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Figure 3.6: (A) Images of cells stained with the MitoROS probe (Mitochondria produced ROS). Each panel is a general representation of the 
total population of cells observed following treatment with the SPION and FeO particles and how this affects the levels of mitochondria 
produced ROS present after a 24 hour and 48 hour chase compared to untreated cells. (B) Quantified data of (A). n=3 Values represent mean  
± SD. n=3. >60 cells analysed, S denotes significance ****p< 0.0001. Scale bar =10µm.
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MitoROS staining following a 24 hour chase with LRL SPION treated cells 
was similar to that of the untreated cells. After a 48 hour chase with LRL 
SPIONs there was only a small increase (but not significantly) in the 
levels of MitoROS detected, indicating that the mitochondria are still 
working properly. After a 24 hour chase with the Chem SPION there is an 
elevation in the levels of MitoROS detected, suggesting that the 
mitochondria are producing more ROS than normal possibly due to toxic 
effects of increasing levels of free Fe2+/Fe3+. This elevated level of 
MitoROS staining was also observed following a 48 hour chase with 
Chem SPIONs. Treatment with FeO particles followed by a 24 hour 
chase resulted in high levels of MitoROS staining in the majority of cells 
observed. This indicates that the mitochondria are producing more ROS 
than normal due to an increase in stress, and following a 48 hour chase 
with FeO particles there is a large drop in ROS levels detected which 
could be a result of the mitochondrial function now being impaired 
(resulting in less ROS being produced). 
 
3.7.7 Detecting levels of lipid Peroxidation following treatment with 
SPIONs and FeO particles 
 
CHO-H1 cells were stained with the DPPP probe to detect the presence 
of lipid peroxidation in the cell. As little lipid peroxidation should be 
present in a healthy cell its presence may indicate cellular toxicity 
following SPION or FeO treatment. 
 
! 94!
Figure 3.7: (A) Images of cells stained with the lipid peroxidation probe DPPP. Each panel is a general representation of the total population of 
cells observed following treatment with SPIONs and FeO particles and how much lipid peroxidation is produced after a 24 hour and 48 hour 
chase compared with untreated cells. (B) Quantified data of (A). n=3 Values represent mean ± SD. N=3. >60 cells analysed, S denotes  
significance ***p<0.001, ****p< 0.0001. Scale bar =10µm.
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The DPPP probe produce a diffuse cellular stain when no lipid 
peroxidation is present, however punctate staining indicates lipid 
peroxidation. The majority of untreated cells displayed no lipid 
peroxidation when stained with DPPP, however some cells did present 
with small amounts of lipid peroxidation. Cells treated with LRL SPIONs 
after a 24 and 48 hour chase showed little to no levels of lipid 
peroxidation (figure 3.7). The same was seen in the Chem SPION treated 
cells after a 24 hour chase. But after a 48 hour chase lipid peroxidation 
was starting to be detected. In both the 24 hour and 48 hour chase, FeO 
treated cells there were high levels of lipid peroxidation detected in all the 
cells, evident by the distinct punctate staining around the peri-nuclear 
area of the cells. 
 
3.7.8 Detecting levels of superoxide in LRL SPION and FeO particle 
treated cells 
 
CHO-H1 cells were treated with the DHE probe to measure the levels of 
superoxide (Indicated by the punctate staining) present in the cell 
following a 24 and 48 hour chase with LRL SPIONs and FeO particles 
(figure 3.8). 
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Figure 3.8: Images of cells stained with the superoxide probe DHE. Each panel 
is a general representation of the total population of cells observed following 
treatment with the different brands of SPIONs and how much superoxide is 
produced after a 24 hour and 48 hour chase. n=3. Scale bar =10µm. 
 
Cells treated with LRL SPIONs after a 24 and 48 hour chase showed 
similar levels of super oxide present as that seen in untreated cells, 
suggesting that the long term presence of LRL SPIONs in lysosomes 
does not increase the levels of ROS in the cells. In the FeO treated cells 
following a 24 hour chase most cells displayed concentrated levels of 
super oxide around the peri-nuclear region of the cell. After a 48 hour 
chase a lot of the cells still displayed super oxide staining, however the 
diffuse stain observed in these cells appeared brighter than the untreated 
and LRL SPION treated cells. This could suggest that high levels of 
superoxide are now present throughout the cell. 
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3.7.9 Determining the levels of free Fe2+ in SPION and FeO treated 
cells 
 
CHO-H1 cells were treated with the Fura 2 to measure the levels of free 
iron present in the cell. Fura 2 is a probe that is sensitive to free Fe2+at 
360nm wavelength and its fluorescence is quenched when in the 
presence of free Fe2+. 
Cells treated with LRL SPIONs for a 48 hour chase displayed slightly 
lower staining in the cell when compared with untreated cells, suggesting 
more free iron may be now present in the LRL SPION treated cells (figure 
3.9). In the Chem SPION treated cells following a 48 hour chase the Fura 
2 staining is even more quenched than what was seen in the LRL SPION 
treated cells, indicating that more free Fe2+ is present throughout the cell. 
After treatment with FeO followed by a 48 hour chase there was little Fura 
2 staining present in the cell, suggesting that high amounts of free 
Fe2+was present throughout the cell. 
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Figure 3.9: Images of cells stained with the Fura 2 probe to detect for the presence of free iron. Each panel is a general representation of the 
total population of cells observed following treatment with the different brands of SPIONs and how much free iron is detected in the cell  
following a 48 hour chase compared with untreated cells. (B) quantified data of (A).  n=3. >50 cells analysed, S denotes significance. *p<0.05, 
****p<0.0001. Scale bar =10µm.
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3.7.10 Determining the levels of free Fe3+ in SPION and FeO treated 
cells 
 
CHO-H1 cells were stained with calcein, a probe thats fluorescence is 
quenched in the presence of free Fe3+, to determine the levels of free 
Fe3+ after a 24 hour pulse and 48 hour chase with SPIONs/FeO (figure 
3.10). LRL SPION treated cells showed similar levels of calcein staining 
as that seen in the untreated cells, suggesting that the levels of free Fe3+ 
present in these cells are similar. Also with the levels of Fe2+ similar in the 
LRL SPION treated cells compared with untreated cells, it suggests that 
the dextran coat of the SPIONs is protecting the particle from the acidic 
environment of the lysosome. The levels of calcein stain dropped 
however in the Chem SPION treated cells, suggesting that the levels of 
Fe3+ are elevated in Chem SPION treated cells. The large drop in 
fluorescence seen in the FeO treated cells strongly suggests that there 
are high levels of free Fe3+ present in the FeO treated cells. 
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Figure 3.10: (A) Images of cells stained with the Calcein probe to detect for the presence of free Fe3+. Each panel is a general representation of 
the total population of cells observed following treatment with the different brands of SPIONs and how much free Fe3+ is detected in the cell  
following a 48 hour chase compared with untreated cells (B) quantified data of (A).  n=2. >40 cells analysed, S denotes significance. 
****p<0.0001. Scale bar =10µm.
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3.7.11 Lysosomal and phospholipidosis level comparison after 
treatment with 10kDa LRL SPIONs vs 40kDa LRL SPIONs 
 
CHO-H1 cells were treated with another commercially available LRL 
SPION which possesses a 10kDa dextran coat as opposed to the 40kDa 
dextran coat that is commonly used to purify lysosomes, and lysotracker 
green and LipidTOX red staining was compared (figure 3.11). 
 
Figure 3.11. (A) Images of cells stained with the lysotracker green and LipidTOX 
red probes. Each panel is a general representation of the total population of 
cells observed following treatment with the 40kDa and 10kDa LRL SPIONs after 
a 24 hour chase compared with untreated. (B) Quantified data of lysotracker 
data. (C) Quantified data of LipidTox red data. n=3 Values represent mean ± 
SD. n=3. >80 cells analysed, S denotes significance *p<0.05. Scale bar =10µm. 
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Cells treated with the 10kDa LRL nanoparticle displayed similar 
lysotracker stain but elevated levels of LipidTOX red stain when 
compared to that seen in the untreated and 40kDa LRL SPION treated 
cells, suggesting an increase in phospholipidosis. This would suggest that 
the 10kDa LRL SPION is not as stable as the 40kDa LRL SPION when in 
the acidic environment of the lysosome, causing a small increase in 
toxicity present.  
 
3.7.12 Mitochondria and their respective ROS levels after treatment 
with 10kDa LRL SPIONs vs 40kDa LRL SPIONs 
 
Comparison of the mitotracker green and MitoROS stains in CHO-H1 
cells treated with the other commercially available LRL SPION that 
possesses a 10kDa dextran coat as opposed to a 40kDa dextran coat, as 
well as untreated cells (figure 3.12). Cells treated with the 10kDa LRL 
SPION displayed mitotracker green staining similar to that seen in the 
40kDa LRL SPION treated and the untreated cells. However MitoROS 
staining was noticeably lower in the 10kDa treated cells when compared 
with the untreated and 40kDa treated cells. This could indicate that 
10kDa LRL SPIONs are affecting the function of the mitochondria at a 
much faster rate than that seen in 40kDa LRL SPION cells. 
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Figure 3.12: (A) Images of cells stained with the mitotracker green and MitoROS 
probes. Each panel is a general representation of the total population of cells 
observed following treatment with the 40kDa and 10kDa LRL SPIONs after a 
24hr chase compared with untreated cells. (B) Quantified data of Mitotracker 
data. (C) Quantified data of MitoROS data. n=3 Values represent mean ± SD. 
n=3. >60 cells analysed. Scale bar =10µm. 
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3.7.13 Lipid peroxidation and superoxide levels in cells treated with 
10kDa and 40kDa LRL SPIONs 
 
Comparison of the DPPP and DHE stains in CHO-H1 cells treated with 
the other commercially available LRL SPION that possesses a 10kDa 
dextran coat as opposed to a 40kDa dextran coat, as well as untreated 
cells (figure 3.13). 
 
Figure 3.13: (A) Images of cells stained with the DPPP probe and DHE. Each 
panel is a general representation of the total population of cells observed 
following treatment with the 40kDa and 10kDa LRL nanoparticles after a 24hr 
chase compared with untreated. (B) Quantified data of DPPP data. n=3 Values 
represent mean ± SD. n=3. >70 cells analysed. Scale bar =10µm. 
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Cells treated with the 10kDa LRL SPIONs showed little to no levels of 
DPPP staining, indicative of lipid peroxidation, which was also seen in the 
untreated and 40kDa LRL nanoparticle treated cells. The DHE stain for 
super oxide also revealed that the majority of cells displayed little to no 
superoxide present which was also seen in the untreated and 40kDa LRL 
SPION treated cells. 
 
3.7.14 Effect on lysosomes and their enzymes activity in CHO M12 
cells following LRL SPION treatment 
 
Lysotracker green probe and the magic kit cathepsin B and L assays 
were used to see if there was any lysosomal dysfunction that occurs in 
NPC1 null CHO M12 cells after they were treated with LRL SPIONs for a 
24 hour pulse, followed by a 48 hour chase (figure 3.14). 
Lysotracker green probe and the magic kit cathepsin B and L assays 
were used to see if there was any lysosomal dysfunction that occurs in 
CHO M12 cells after they were treated with LRL SPIONs for 24 hour 
followed by a 48 hour chase (figure 3.14). The levels of lysosomes 
detected via the use of lysotracker green did not change in the LRL 
SPION when compared with untreated CHO M12 cells. Cathepsin B 
activity did not change. Cathepsin L activity was marginally elevated in 
the SPION treated CHO M12 cells, however the important thing is that 
the enzyme activity doesn’t drop as that would indicate a major pH 
change. 
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Figure 3.14: (A) Images of cells stained with Lysotracker green, magic kit 
Cathepsin B and L. Each panel is a general representation of the total 
population of cells observed following treatment with LRL SPIONs following a 
24hr pulse and 48hr chase. (B) Quantified data of Lysotracker data. (C) 
Quantified data of cathepsin B data. (D) Quantified data of cathepsin L data. n=3 
Values represent mean ± SD. n=3. >40 cells analysed. Scale bar =10µm. !!!
!!!!!!!!!!
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3.8 Discussion 
 
With the increasing use of SPIONs in the field of biomedicine, there is a 
growing interest in the toxic effects these SPIONs have once they are in 
the cell. Some studies have utilized the toxic effects of SPIONs to induce 
cells to undergo apoptosis; commonly this is used in studies for treating 
cancer cells (Petri-Fink et al., 2005). However for the purpose of utilizing 
SPIONs for the magnetic purification of lysosomes it is important to 
determine that the SPIONs that are loaded into the endocytic system do 
not induce toxicity, specifically in lysosomes. The lysosome has an acidic 
pH which is maintained by the V-ATPase pumps found on the lysosomal 
membrane. The heavily protonated intra-lysosomal lumen is tightly 
regulated and the acidic pH is maintained as it is necessary for many 
lysosomal enzymes to function (Mindell, 2012). Magnetite and maghemite 
based SPIONs that have been functionalized with a dextran coat have 
been shown to release free Fe2+/Fe3+ when exposed for long periods in 
an acidic environment (Singh et al., 2012). This is a result of the dextran 
coat of the SPIONs being degraded inside the acidic environment of the 
lysosome, resulting in the magnetite core being exposed to the acidic 
environment. This results in degradation of the magnetite particle causing 
the release of free Fe2+/Fe3+ (Singh et al., 2012). This free Fe2+/Fe3+ then 
can catalyze the formation of highly reactive hydroxyl radicals which have 
been shown to induce an increase in cellular stress levels (Uchiyama et 
al., 2008).  This increase in cellular stress has been found to primarily 
damage the mitochondrial membrane, resulting in the mitochondria losing 
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their membrane potential and becoming depolarised (Kim et al., 2003, 
Nieminen et al., 1997). This loss of mitochondrial function results in the 
release of pro-apoptotic proteins such as cytochrome c (Uchiyama et al., 
2008).  
The lysosome itself can be damaged due to the presence of free iron. 
The production of hydroxyl radicals has been shown to induce lipid 
peroxidation (Zdolsek and Svensson, 1993). As the lysosome has a lipid 
rich membrane the peroxidation of these lipids has been found to disrupt 
lysosomal membrane integrity causing the release of lysosomal enzymes 
and protons out of the lysosomes into the cell (Zdolsek and Svensson, 
1993). 
As mentioned before it is important that for the utilization of SPIONs to 
purify lysosomes they must not be toxic to the cells otherwise it would not 
be an effective means of purifying a good yield of lysosomes. Also it is 
important to determine that the particles do not alter the pH of the 
lysosome as this would induce lysosomal dysfunction and affect the 
function of many key lysosomal enzymes.  
Cells were treated with two different types of magnetite based SPIONs 
(LRL SPIONs and Chemicell SPIONs) to determine any toxic effects they 
might induce in cells after long term exposure to the acidic environment of 
the lysosome. An Iron oxide coated dextran particle (FeO) was also 
tested, as this has similar properties to iron based nanoparticles that have 
been used previously to magnetically purify lysosomes (Chen et al., 2005, 
Diettrich et al., 1998, Duvvuri and Krise, 2005).  
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3.8.1 Nanoparticle effects on the lysosome and lysosomal enzymes 
 
As the nanoparticles are taken up into the cell they are trafficked along 
the endocytic pathway until they reach its end point, the lysosome. As the 
SPIONs are primarily located inside the lysosome this is most likely 
where any initial toxicity would occur. Lysotracker green probe loads into 
high acidic compartments and fluoresces, meaning that the pH of the 
lysosome has an acidic pH-optima for the probe to work in it (figure 3.1). 
The Magic red cathepsin kits for cathepsin B and L was also used to 
measure the activity of these two lysosomal enzymes (figure 3.2 and 3.3). 
Drastic changes in the pH of the lysosome would affect the function of 
these two enzymes. The levels of lysosomes detected using the 
lysotracker green probe revealed that there was no change in the levels 
of lysosomes detected in the LRL SPIONs treated cells, while there 
appeared to be an increase in lysotracker staining in some cells treated 
with Chem SPIONs. No change in lysotracker staining was observed 
following LRL SPION treatment indicates that the long term presence of 
these particles in an acidic compartment appears to have no effect on 
lysosomal pH otherwise there would be a drastic change in lysotracker 
fluorescence. However the increase lysotracker staining displayed in the 
Chem SPION treated cells, which increased as the particles remained in 
the lysosome for a longer time, suggests that these particles are 
becoming unstable at a much faster rate than that of the LRL SPIONs. 
Interestingly there was a drastic reduction in lysotracker staining over the 
two time points monitored with cells treated with FeO particles. This 
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strongly suggests that these particles are highly unstable once they reach 
the lysosomes and are causing a reduction in the lysosomal pH, possibly 
by damaging the lysosomal membrane causing protons to leak out of the 
lysosome. The cathepsin B and L activity assays also seem to suggest 
this. It is only after a 48 hour chase that there is a change in cathepsin B 
activity in the LRL SPION treated cells, suggesting that only now they are 
starting to become less stable. There is a general increase in the activity 
of the two cathepsin enzymes observed in the Chem SPIONs treated 
cells at an earlier time point suggesting again that these particles are 
becoming unstable at a faster rate than the LRL SPIONs. Cathepsin B 
has been found to be a key mediator in apoptosis, so higher levels of it 
may be resulting in greater toxicity being present in the Chem SPION 
treated cells (Sandes et al., 2007). The FeO treated cells appeared to 
display cathepsin staining throughout the cell, not in lysosomal vesicle 
compartments. This may explain why lysotracker stains in FeO treated 
cells is so low as the lysosomal membrane has become damaged 
causing the leaking of protons as well as lysosomal enzymes into the 
cytosol. The cathepsin B enzymes are now potentially active inside the 
cytosol of the cell, cleaving off target proteins and other important 
macromolecules. After a longer chase time the level of cathepsin B 
activity did decrease in FeO treated cells most likely due to the cell 
undergoing apoptosis. Interestingly there was little change in the levels of 
cathepsin L activity in the SPION treated cells (figure 3.3), which 
suggests that any changes in the pH inside the lysosomes is still within 
the pH range for cathepsin L to function. Cathepsin L levels drop 
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drastically after FeO particle treatment though which could possibly be 
because it has already initiated apoptosis, and now has become inactive.  
 
3.8.2 SPION induced Phospholipidosis  
 
Research has been done into the fate of drugs once they enter the cell, 
with many drugs being cationic amphiphilic drugs (CADs) due to their 
respective chemical structures. It has been found that the accumulation of 
these CADs inside lysosomes has an effect on phospholipid metabolism 
resulting in the accumulation of phospholipids inside lysosomes 
(Anderson and Borlak, 2006). It was important to determine if the 
presence of SPIONs and FeO particles inside lysosomes had a similar 
effect as CADs do on phospholipid accumulation. LRL SPION treated 
cells did not exhibit an increase in the levels of phospholipidosis, which 
suggests that they are not exhibiting CAD like effects on phospholipid 
metabolism and membrane properties when they are present inside 
lysosomes (figure 3.4). However this was not the case with Chem SPION 
treated cells which did exhibit an increase in phospholipidosis which 
could be a result of these SPIONs not being as stable as LRL SPIONs 
and the free iron that is being released is having an effect on 
phospholipid metabolism. This also appeared to be the case with the FeO 
treated cells which from previous data shows they are highly unstable 
and greatly effect lysosomal pH and cathepsin activity, which is likely why 
there is an increase in phospholipidosis occurring in these cells. 
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3.8.3 Determining the effects on mitochondrial function 
 
One of the areas that is most studied when It comes to the toxic effects of 
nanoparticles is their effect on mitochondrial viability, as mitochondria are 
highly susceptible to hydroxyl radicals (Zdolsek and Svensson, 1993).  
The mitochondria levels do not vary greatly between the treatments with 
the different SPION/FeO particles (figure 3.5). There does appear to be 
changes in the levels of mitochondrial produced reactive oxygen species 
(ROS) present (figure 3.6). Mitochondria naturally produce reactive 
oxygen species, and changes in these levels could indicate a problem in 
their function. LRL SPION treated cells appear to show little to no change 
in the levels of mitochondrial produced ROS suggesting that there is 
currently no effect on mitochondria function. However there does appear 
to be elevated levels in the FeO and Chem SPION treated cells where 
greater levels of mitochondria ROS is being produced. This would 
indicate that the mitochondria are becoming stressed and beginning to 
function incorrectly, causing an increase in the levels of ROS as a result. 
While the elevated levels are the same over the two time points 
measured in the Chem SPION treated cells, the levels of mitochondrial 
produced ROS drop dramatically between the 24 hour and 48 hour chase 
times in the FeO treated cells. This could be because after a 48 hour 
chase with FeO particles the mitochondria have become damaged to the 
point where they no longer function as efficiently as normal mitochondria 
do, releasing less mitochondria ROS as a result. 
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3.8.4 Lipid peroxidation and super oxide production 
 
The DPPP probe was used to detect for the presence of lipid peroxidation 
occurring inside the lysosome. As the membrane of lysosome is 
composed heavily of lipids it is important that no lipid peroxidation was to 
occur when the lysosomes take up the LRL nanoparticles (figure 3.7).  
Any lipid peroxidation that occurs could have an effect on lysosomal 
membrane stability (Zdolsek and Svensson, 1993). Even after a 48 hour 
chase there were no signs of lipid peroxidation found in the LRL SPION 
treated cells. This is likely because while only a small amount of free iron 
may have been released from the magnetite core, it is not enough to 
induce lipid peroxidation. After a shorter chase time with Chem SPIONs 
no peroxidation was found in the cells, suggesting that at this time point 
the lysosomal membrane is not compromised. However this appeared to 
change following a 48 hour chase as lipid peroxidation was starting to 
appear suggesting that by this time point the lysosomal membrane is 
starting to become damaged. High levels of lipid peroxidation were seen 
in the FeO treated cells at both chase times, further highlighting the 
particles lack of stability as the large amount of free iron released has 
damaged the lysosomal membrane at a much faster rate than the two 
SPION particles. 
The DHE stain for superoxide showed that the presence of the LRL 
SPIONs did not cause the levels of superoxide to increase in the cell, 
even after a longer chase, which like the results of the lipid peroxidation 
probe show how stable this nanoparticle is even after a long time in the 
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lysosomes acidic environment (figure 3.8). The FeO treated cells seemed 
to have an initial increase in the levels of super oxide which is most likely 
due to the FeO being converted to free iron and the release of further 
super oxide particles from the peroxidation of lipids. Following a longer 
chase time the staining for super oxides was high throughout the cell, 
implying that the super oxides produced from the free iron inside the 
lysosome has leaked out and is now present in other parts of the cell. 
 
3.8.5 Imaging the levels of free Fe2+ and Fe3+ being released 
 
Fura 2 is a probe that is sensitive to Fe2+ at 360nm wavelength, where its 
fluorescence is quenched when bound to free iron.  The probe was used 
to analyse the rate of the release of iron in cells treated with the SPIONs 
and FeO (figure 3.9). Unsurprisingly the LRL SPION treated cells 
appeared to have the least amount of free Fe2+ release when compared 
with the other particles. There was a large drop in fluorescence with the 
probe after a longer chase time with Chem SPION treated cells which 
would indicate that the particles are only really stable for around a 24 
hour chase. The FeO treated cells displayed large amounts of free Fe2+ 
present which explains the high levels of lipid peroxidation, lysosomal 
dysfunction and super oxide presence seen previously. The levels of free 
Fe3+ were also analysed and the LRL SPIONs again appeared to be the 
most stable as little free Fe2+ and Fe3+ was observed. The FeO particles 
released high levels of both forms of Fe, giving a strong indication of 
where the toxicity is coming from. 
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3.8.6 Importance of structure of dextran coat of SPIONs 
 
As mentioned previously it is important to coat the magnetite SPION with 
a functionalized, biological coat to protect it from the acidic environment 
of the lysosome. Work done to determine if an LRL produced SPION with 
a 10kDa coat as opposed to a 40kDa coat resulted in a marginal increase 
in the levels of cellular toxicity (figures 3.11, 3.12, 3.13). With cells treated 
with the 10kDa SPIONs there was a slight increase in the levels of 
lysotracker and phospholipidosis detected, as well as a decrease in the 
levels of mitochondria ROS produced in the cells. However interestingly 
there was no major increase in the levels of super oxide or lipid 
peroxidation. This is most likely because the 10kDa SPIONs are reaching 
the lysosomes and becoming unstable at a faster rate than that seen with 
40kDa SPIONs, due to the smaller dextran coat degrading faster than a 
40kDa dextran coat would. This highlights the need for an adequate sized 
dextran coat to be functionalized to the magnetite particle, to offer 
suitable protection of the SPION core from the acidic environment of the 
lysosome. 
 
3.8.7 Lysosomal toxicity in NPC1 null cells treated with SPIONs 
 
CHO M12 cells are null for the protein NPC1, which results in the 
accumulation of lipids inside the lysosome (Lloyd-Evans and Platt, 2010). 
Previous work done to magnetically purify lysosomes from healthy and 
diseased cell resulted in toxicity in both sets of cells, but especially in the 
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diseased cells (Diettrich et al., 1998). As NPC1 deficiency results in the 
accumulation of many lipids in the lysosome, this has an effect on other 
important factors in the cell such as lysosomal Ca2+ levels as well as 
endocytic trafficking defects (Lloyd-Evans and Platt, 2011, te Vruchte et 
al., 2004). It was important to determine that while LRL SPIONs were 
stable in the lysosomes of healthy cells, they would also be stable in a 
diseased lysosome, as this would affect the ability of the SPIONs to be 
able to magnetically purify diseased lysosomes. The levels of lysotracker 
staining and the activity of cathepsin B and L were observed in CHO M12 
cells which were treated for a long chase time of 48 hours, so that the 
SPIONs have time to reach the lysosome. There was however no 
changes in lysosomal levels or the activity of the two cathepsins which 
would indicate that these diseased lysosomes are not damaged, or their 
enzyme functions altered by the presence of LRL SPIONs present in 
them.  
 
3.8.8 Summary 
 
With the potential use of using highly magnetic SPIONs to purify 
lysosomes, it was important to determine what brand of SPIONs was the 
most stable inside cells. LRL produced SPIONs showed little to no toxic 
effects in the lysosomes following a long chase time, especially when 
compared with the Chem SPION and the FeO particle. Also importantly it 
was important that the LRL SPION did not produce any dysfunction in the 
lysosomes of CHO M12 cells. This means that it is a suitable nanoparticle 
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to utilize for the purification of lysosomes from both healthy and diseased 
cell lines. !!!!!!!!!!!!!!!!!!!!!!
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!!
Chapter 4: Developing an improved technique for 
magnetically purifying lysosomes !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!
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4.1 Density gradient centrifugation 
 
As previously stated (chapter 1 general introduction), de Duve first 
discovered lysosomes using a technique called density gradient 
centrifugation. He set out to “explore the cell with a centrifuge” and was 
able to isolate lysosomes as well as other organelles of similar density 
such as peroxisomes and mitochondria (Cox and Cachon-Gonzalez, 
2012).  Thanks to this, de Duve and others were able to characterize the 
enzyme content of the isolated organelles gaining insight in the 
organelles function, long before they were studied under a microscope. 
DGC is still commonly used today in research for isolating different cell 
types such as cancer stem cells from a total cell population (Liu et al., 
2012). The method behind using DGC for organelle isolation works by 
homogenising a cell to release its cellular contents. These organelles are 
then centrifuged at high RCF over a sucrose gradient. This results in the 
separation of individual organelles based on their respective density (Liu 
et al., 2011).  
 
This was how de Duve isolated lysosomes for the first time and in doing 
so he also purified out mitochondria and peroxisomes, due to their similar 
densities. The main problem with DGC for organelle isolation arises when 
it is used to try and extract lysosomes from lysosomal storage disease 
cells. Lysosomes isolated from storage disease cells typically accumulate 
lipids either as a primary or secondary storage material (Cox and 
Cachon-Gonzalez, 2012). All this excess stored material leads to a 
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change in the buoyant density of the lysosome, due to the stored lipids 
making the lysosomes buoyancy lighter. When they are separated over a 
sucrose gradient their variable densities result in deposition of lysosomes 
across the gradient with predominant bands in different locations to 
lysosomes isolated from control cells that are often contaminated by other 
organelles of similar densities (Graham, 2001). This has been noted 
before when researchers tried extracting lysosomes from the lysosomal 
storage disease infantile free sialic acid storage disease (ISSD) cell lines 
(Mendla et al., 1988). This is a major problem that has largely stifled 
research into lysosomal protein function and LSDs since de Duve’s 
groundbreaking work. 
 
4.2 Density Gradient Electrophoresis 
 
Density gradient electrophoresis (DGE) is a technique that not only 
utilizes an organelles density but also exploits its surface charge to 
isolate it. The idea behind this technique is that many organelles possess 
a similar density (e.g. lysosomes and peroxisomes) but may have a 
different surface charge, allowing for a second level of separation that 
DGC cannot provide (Tulp et al., 1993). The DGE is a specialised 
apparatus that isolates subcellular organelles by using a ficoll gradient 
that then has a current applied to it. At either end of the DGE apparatus is 
an anode and a cathode (top and bottom respectively) that allows the 
upward electrophoresis of organelles, resulting in the more negatively 
charged (and small) organelles being collected first (Tulp et al., 1996, 
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Tulp et al., 1999). A previous study attempted to purify out lysosomes 
from both wild type and NPC cells using DGE (work unpublished).  
Subcellular organelles underwent DGE and the fractions produced were 
collected and characterized by western blots. Each fraction contained a 
peak for a particular organelle indicating enrichment of this particular 
organelle in that fraction. While there are peaks of specific organelles in 
different fractions, there is a continuous high level of ER contamination 
detected in every fraction. This is due to the structural nature of the ER, 
when it is damaged (by homogenisation) it forms so called microsomes of 
multiple sizes and densities, resulting in high ER contamination when it 
comes to purification methods that utilize an organelles density. Another 
problem that was observed in this study was that a large amount of 
starting material (~20 million cells) was required to perform a single DGE 
purification, ultimately yielding very low quantities of pooled membranes 
(50-100µg). However the yield obtained from each individual fraction was 
only enough to perform a single western blot, which only ended up 
confirming that the fraction possessed ER contaminants. Thus, the 
technique cannot realistically be used for obtaining pure fractions of 
lysosomes or for performing functional assays. 
 
4.3 The use of iron particles for purifying lysosomes 
 
Novel techniques have been developed that utilise density gradient 
centrifugation to purify lysosomes by manipulating their buoyant density 
during the purification process. This has been done by loading the 
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lysosome, via the endocytic pathway, with heavy molecules such as 
dextrans, gold and more commonly colloidal iron (Arai et al., 1991, 
Arborgh et al., 1973, Henning and Plattner, 1974). The methodology 
behind this is that by making the lysosome as dense and heavy as 
possible it should be possible to isolate them from a homogenate by 
making it much heavier than other organelles so they would pellet under 
less centrifugal force when compared with other organelles (Chen and 
Arriaga, 2006). However this method requires multiple time-consuming 
centrifugation steps as well as sample clean up steps to produce a small 
yield of lysosomes that are often damaged by the purification process 
(pelleting at high speed). Another problem with this technique is that the 
loading of these large molecules into lysosomes can produce toxic side 
effects. An example of this would be the iron particle loaded into 
lysosomes would likely react with the high proton content inside the 
intralysosomal lumen, causing free iron to leach off the particle. It has 
been established that free iron interacts strongly with lipids to produce 
free radicals, which with the lysosomal membrane being lipid rich would 
most likely have an effect on lysosomal membrane integrity (Zdolsek and 
Svensson, 1993) which can have a knock on effect of causing either the 
dissipation of lysosomal protons (altering lysosomal pH) and Ca2+ content 
out of the lysosome (Chen and Arriaga, 2006). This could potentially lead 
to phospholipidosis like phenotypes or ultimately membrane damage, 
which is likely to induce significant cellular stress and alterations in 
function. To compensate for this cells would be treated for shorter 
amounts of time with these particles, so they are not exposed to the 
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acidic environment of the lysosome for to long. This was done to avoid 
potential toxicity issues. However this would result in less iron being 
loaded into the lysosome, thereby reducing the capabilities of purifying 
lysosomes using this method. While this method has only had limited 
success in purifying lysosomes from healthy cells, purifying lysosomes 
from lysosomal storage disease cells would be greatly more difficult. It 
has been well established that most lysosomal storage disease 
lysosomes store lipids in either a primary or secondary manner (Cox and 
Cachon-Gonzalez, 2012). This storage would result in the buoyancy of 
the lysosomes to become lighter than that of non-storing lysosomes. This 
would result in a greater quantity of iron/gold particles needed to be 
loaded into lysosomes for there to be a great enough change in their 
density so they are capable of being purified in this manner. Other 
caveats for this would also include that in many lysosomal storage 
diseased cells endocytic trafficking is retarded so that not enough of 
these particles would potentially reach the lysosome to induce a great 
enough change in their density (te Vruchte et al., 2004).  
 
4.4 The initial use of magnetic nanoparticles for lysosomal 
purification 
 
The first major attempt at purifying lysosomes using magnetic 
nanoparticles was done during the early 1990s, where dextran particles 
were coated in an iron oxide coat (FeO) were fed to Dictyostelium 
discoideum (Rodriguez-Paris et al., 1993). The lysosomes from the 
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Dictostelium discoideum were then purified with the use of a 0.8 tesla 
magnet. The results of this study found that ~76% of the ingested iron 
dextran particles were found in the lysosomal fraction they obtained, 
which indicated that these particles remained within the endocytic system 
as they are trafficked to the lysosome. This important study showed that 
while the iron-dextran particles may not have necessarily been the most 
stable particles, the use of magnetic separation to purify lysosomes was a 
possible alternative to purifying lysosomes from other more established 
techniques.  
 
4.5 Lysosomal purification using magnetic nanoparticles 
 
At the time in 1998 (and still in some cases today) not all defective 
lysosomal proteins that result in the development of a lysosomal storage 
disease had been characterized, or even identified. Diettrich et al realized 
the importance of proteomic research to help improve understanding of 
the pathogenic mechanisms that result in a lysosomal storage disease 
phenotype (Diettrich et al., 1998). The group knew that to effectively 
research and characterize these lysosomal proteins there needed to be a 
way to purify out the lysosome from cultured LSD cells. This problem had 
been ongoing since de Duve’s pioneering work in efforts to isolate pure 
lysosomal fractions with low contamination of other organelles.  
Professor Bryan Winchester’s group had previously attempted to use 
DGC to isolate lysosomes from patients suffering from ISSD (Diettrich et 
al., 1998). ISSD is a rare autosomal recessive disorder where a mutation 
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on a gene located on chromosome 6 results in a deficiency in lysosomal 
sialidase, resulting in gangliosides not being broken down within the 
lysosome causing storage of sialic acid (Aula et al., 2002). Diettrich et al 
observed that due to the accumulation of sialic acid in the diseased cell 
inside the lysosomal compartment, the density is affected to the extent 
there is a greater level of contaminants. This obstacle led a growing need 
to develop a new method to purify out lysosomes, one which allowed for 
the purification of the compartment that is not dependent on morphology 
or buoyant density (as both are likely to be altered in LSDs). Diettrich et al 
took inspiration from the Rodriguez-Paris et al study (as described earlier) 
and adpated this method to exploit the endocytic trafficking of 
macromolecules to potentially purify lysosomes from ISSD cells. Colloidal 
iron dextran (FeO) was prepared as previously used by (Rodriguez-Paris 
et al., 1993) and then loaded into both wild type fibroblasts and ISSD 
fibroblasts. After an overnight chase the cells were homogenized and the 
released organelles were passed through a magnetic field contained in a 
Miltenyi MiniMACS column.  The lysosomes that were now bound to the 
column due to the magnetic field were then eluted off using either 
hypotonic solution or buffers containing low concentrations of non-ionic 
detergents.  Enzyme assays were then performed on the isolated 
lysosome fractions to determine the level of lysosomal enrichment 
achieved between the wild type and ISSD fibroblast cell lines.  
 
An enrichment of ~50% was observed, suggesting that lysosomes were 
being purified. However there was still high lysosomal activity in the post 
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nucleic supernatant (PNS) (flow through that passed over the column). 
This would suggest a large amount of lysosomes are still just passing 
through the magnetic field. Also only a small yield of purified lysosomes 
was obtained, possibly due to the FeO particles possessing poor 
magnetic properties. An increase in cellular toxicity observed in the cells 
treated with the FeO particles resulted in a shorter treatment time, which 
would only reduce the yields further as less particles are being 
endocytosed into the cell due to the shorter treatment time (Diettrich et 
al., 1998). 
 
A few years later a study utilized the magnetic separation method whilst 
researching the inter-relationship between the lysosomal proteins NPC1 
and NPC2 that cause Niemann-Pick type C1 and C2 disease respectively 
(Chen et al., 2005). The livers of mice treated with iron dextran were 
harvested over a 0.5,1,2,4 hour time course following the injection of the 
FeO into the mouse. By doing this, they were able to isolate different 
fractions that contained organelles from the different parts of the 
endocytic pathway. This was confirmed by the use of western blotting 
techniques using marker proteins specific for each compartment.  
By not using detergents to elute the lysosomes off the magnetic column 
they only obtained a low yield of protein in the lysosomal fraction (<50µg 
of protein). However, the benefit of not using detergents meant that the 
lysosomes were still structurally intact. A re-acidification assay using 
acridine orange was performed to show that the lysosomes were still 
! 127!
functional and could be re-acidified after magnetic separation, however 
an entire fraction was required per assay. 
 
To fully understand the fate of drugs once they are in the cell and how 
they are distributed and sequestered would help researchers to design 
and modify the drugs so they could optimize their intracellular distribution. 
Duvvuri et al set out to improve a way to accurately measure the 
lysosomal accumulation of drugs as their previous attempt had taken a 
more indirect approach (Duvvuri and Krise, 2005). They used an 
adaptation of the magnetic separation method used by Diettrich et al to 
purify out lysosomes from HL-60 cells using home made FeO particles 
(Duvvuri and Krise, 2005). The addition of hypotonic and isotonic buffers 
as well as detergents used during the magnetic lysosomal purification 
resulted in a greater protein yield in the lysosomal elution than what was 
seen using this technique in previous studies (Duvvuri and Krise, 2005). 
However, the use of detergents means the purified lysosomes are no 
longer structurally intact. While the use of detergents is detrimental to the 
development of an assay intended to produce a lysosomal fraction that 
has a high yield and that functional assays can still be performed, the 
protocol itself is an effective way of purifying out lysosomes while using 
crudely made, poorly magnetic, unstable FeO particles.  
 
One of the major developments Duvvuri and Krise made during their 
attempts at purifying lysosomes was the introduction of certain types of 
osmotic changing buffers to aid in their attempts at purifying lysosomes 
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(Duvvuri and Krise, 2005). The buffers they used were originally adapted 
from a study showing how hypotonic buffers were useful in cell 
homogenisation as this caused swelling and bursting of the cellular 
membrane, while the addition of an isotonic buffer after homogenisation 
helped maintain organelle structural integrity post homogenisation 
(Graham, 2002). The addition of these buffers to the lysosomal 
purification technique Duvvuri et al used helped increase the yield of 
lysosomes they obtained as more lysosomes would be passed over the 
magnetic field rather than be spun out with the unbroken cells during the 
centrifugation step of the assay (Duvvuri and Krise, 2005).   
 
 An important study was done where early endosomes were purified to 
study their protein content (Glebov et al., 2006).  This study was 
important in the development of our own magnetic purification assay, as 
they were able to show that they could effectively purify out early 
endosomes. This is difficult as the pulse and chase times have to be very 
precise (a 10 minute pulse and a 10 minute chase), or else the magnetic 
nanoparticles would have already been processed out of the early 
endosome. While in previous studies using magnetic separation to purify 
out endocytic organelles has show that a reduced pulse time gives a poor 
yield (Diettrich et al., 1998), due to there being only a short amount of 
time for the cells to take up the FeO particles. However, this study was 
able to purify out early endosomes with a decent yield, despite there only 
being a 10 minute pulse time for the cells to endocytose the particles. 
This was due to the highly magnetic SPIONs they used, provided by 
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Liquids Research Ltd (LRL). The main issue to consider is that only a 
small amount of the LRL SPIONs would be present in the early 
endosome after such a short pulse time, the strong magnetic properties 
from the SPIONs resulted in a good amount of early endosomes to be 
magnetically purified out of the cell. This would indicate that LRL SPIONs 
had a much higher magnetic potential than the colloidal iron dextran 
conjugates used in the previous studies. 
 
The pioneering work done by Professor Winchester, Professor Ioannou 
and Dr Krise during the last 20 years has helped pave the way for a new 
technique to purify lysosomes by loading them with magnetic 
nanoparticles via the endocytic pathway followed by their subsequent 
purification via a magnetic field which has resulted in a new, novel and 
vastly improved method for purifying lysosomes without the need for 
established methods such as density gradient centrifugation. 
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Figure 4.1: Simplified schematic on the methodology on how the dextran 
functionalised SPIONs are loaded into the lysosome. The SPIONs are taken up 
into the cell via fluid phase endocytosis, where they reach the early endosome 
(EE) after ~10 minutes. They are next trafficked to the late endosome (LE) after 
~30 minutes. After 30 minutes of being in a healthy cell, the SPIONs should be 
in the late endosomal-lysososmal compartments. Some SPIONs might be 
recycled back out of the cell via the recycling endosome (RE). 
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4.6 Results  
 
It is important to determine that the magnetic nanoparticles used to purify 
lysosomes are first capable of reaching lysosomes, so no other organelle 
is being purified. Another important factor to take to take into 
consideration is that endocytic uptake and the trafficking of the SPIONs 
will vary across different cell lines. 
 
4.6.1 Using fluorescent LRL SPIONs to determine their subcellular 
localization after different chase times 
 
LRL produced SPIONs coated with a 40kDa Dextran that contains TRITC 
dextran were treated to CHO-H1 and CHO M12 to measure the endocytic 
trafficking of these nanoparticles as they are trafficked through the 
endocytic system across two different chase times. These fluorescent 
LRL SPIONs are produced in the same way as the normal LRL SPIONs 
used in the lysosomal purification assay, however 1:10 of the 40kDa 
dextran coat is composed of TRITC dextran. The particles still possess a 
magnetic SPION magnetite core and 40kDa dextran coat so they should 
still be trafficked through the endocytic system as normal LRL SPIONs. 
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Figure 4.2: LRL SPIONs coated with TRITC dextran were treated to CHO-H1 
and CHO M12 cells for a 24 hour pulse followed by a 24 or 48 hour chase. The 
cellular localization of the TRITC (Tetramethylrhodamine) coated SPION was 
then determined by the use of lysotracker green and AlexaFluo-488 dextran. A 5 
minute pulse with AlexaFluo-488 was used as an early endosomal marker while 
a 20 minute pulse with AlexaFluo-488 will have loaded into late endosomes and 
can be used as a marker for them, lysotracker green was used as a lysosomal 
marker. The localization of the TRITC-SPIONs was then determined by 
measuring the levels of co-localistion with the different endocytic organelles 
after the two different chase times. Images displayed are representative. n=3. 
Scale bar =10µM. 
 
A pulse of 5 minute and 20 minute with AlexaFluo-488 dextran was used 
as a marker for early and late endosomes respectively, while lysotracker 
green was used as a lysosomal marker. After a 24 hour pulse followed by 
a 24 hour chase with the LRL TRITC-SPIONs there was high co-
localisation between LRL TRTIC SPIONs and AlexaFluo-488 in the late 
endosomal compartment, which indicates that a 24 hour pulse and 24 
hour chase is enough time for LRL SPIONs to reach the late endosome-
lysosomal compartments. After a 48 hour chase in the CHO-H1 cells 
there was high co-localisation present in the lysosomes, showing that the 
particles are still present in the lysosomes after an additional 24 hours. 
CHO M12 cells treated with a 24 hour pulse with LRL TRITC SPIONs 
showed no co-localisation in the early endosome or late endosome 
compartments (figure 4.2). This suggests that a 24 hour chase is not 
enough time for the nanoparticles to be trafficked to the later endocytic 
vesicles in CHO M12 cells, most likely due to the retarded endocytic 
trafficking present in NPC1 null cells (te Vruchte et al., 2004). After a 48 
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hour chase there is high co-localisation with lysotracker green, which 
shows that the SPIONs are now in the lysosomal compartment. This data 
shows that a longer chase time is required for the SPIONs to reach the 
lysosomes in CHO M12 cells so that they can then be magnetically 
purified. 
 
4.6.2 Comparison of different chase times from LRL SPION treated 
CHO-H1 cells  
 
The first step in developing the magnetic purification method was to 
determine what chase time produced the greatest amount of protein yield 
from the eluted lysosomal fraction after a 24 hour pulse. 
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Figure 4.3: Protein levels detected in the lysosomal fraction across different 
chase times following a 24 hour pulse. n=3 Values represent mean ± SD, n=3. 
*P <0.001; **P <0.001; ***P >0.05; ****P <0.05, S denotes significant, n.s. 
denotes not significant. 
 
CHO-H1 cells grown to confluency in a T75 flask were treated with a 24hr 
pulse of LRL SPIONs followed by either a 6, 12, 24, 36 or 48 hour chase. 
The lysosomes were then extracted using magnetic separation. BCA 
protein assays were performed on the lysosomal fractions obtained from 
each individual chase time to determine the protein content present in 
each fraction. The data shows that following a 24 hour pulse and a 24 
hour chase is the optimum chase time to get the highest yield of 
! 136!
lysosomes from LRL SPION treated CHO-H1 cells (figure 4.3). Shorter 
chase times produce a lower yield protein in the lysosomal fraction, most 
likely because all the SPIONs have not been trafficked to the lysosome 
yet. Longer chase times result in a small decline in the protein detected in 
the lysosomal fraction, possibly due to the SPIONs becoming unstable 
and losing their magnetic capability. 
 
4.6.3 Comparison of different Iron based nanoparticles used to 
purify lysosomes 
 
Magnetic purification was performed on CHO-H1 cells that had been 
treated with a 24 hour pulse with FeO particles and Chem SPIONs 
followed by a 24 and 48 hour chase time. BCA protein assays were 
performed on the lysosomal fractions obtained following treating with the 
different iron based nanoparticles at the two different chase times and 
compared with the protein detected in the lysosomal fraction from the use 
of LRL SPIONs (figure 4.4). 
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Figure 4.4: Protein levels detected in the lysosomal fraction after purification 
using the three different iron based nanoparticle providers after a 24 hour pulse 
and a 24 and 48 hour chase. Values represent mean ± SD, n=3. S denotes 
significance, *P <0.001; **P <0.001; ***P <0.001;****P <0.001; *****P >0.05; 
******P <0.01, s denotes Significant, n.s. denotes not significant. 
 
After a 24 hour chase there was significantly higher amount of protein 
detected in the lysosomal fraction with the use of LRL SPIONs when 
compared with the use of FeO and Chem SPIONs. The FeO lysosomal 
fraction yield following a 24 hour chase was significantly lower than both 
the LRL and Chem SPIONs indicating poor magnetic capabilities. After a 
48hr chase, the yields detected in the lysosomal fraction dropped after 
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the use of FeO, LRL and Chem SPIONs. After a 48 hour chase the LRL 
SPIONs still resulted in the highest detected in the lysosomal fraction. 
Interestingly there was a greater drop in yield in the lysosomal fraction 
from a 24 hour chase to 48 hour chase with the use of Chem SPIONs 
compared with LRL SPIONs, suggesting that the Chem SPIONs are less 
stable over longer time periods when in lysosomes compared with LRL 
SPIONs. FeO lysosomal fraction yield does drop after a 48 hour chase 
but the drop is not significant.  
 
4.6.4 Utilising Maghemite based SPIONs 
 
LRL SPIONs composed of a maghemite core rather than a magnetite 
core was pulsed to CHO-H1 cells for 24 hour followed by a 24 hour 
chase.  Maghemite SPIONs possess the same properties as the LRL 
magnetite SPIONs with the exception of the core being composed 
primarily of maghemite. The LRL maghemite SPIONs still have a 40kDa 
dextran coat so they should still be trafficked to the lysosome in the same 
manner as the LRL magnetite SPIONs do. 
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Figure 4.5: Protein levels detected in the lysosomal fraction following purification 
from CHO-H1 cells with LRL Maghemite based SPIONs and a LRL Magnetite 
based SPIONs following a 24 hour pulse and 24  hour chase. n=3. Values 
represent mean ± SD. S denotes significance *P <0.001. 
 
The lysosomes were then purified and the yield in the lysosomal fraction 
was determined. There was a significantly lower yield in the lysosomal 
fraction when using maghemite SPIONs (figure 4.5). This is most likely 
due to maghemite having a lower magnetic potential than magnetite. 
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4.6.5 Comparison of different pulse times yields from LRL SPION 
purified lysosomes 
 
CHO-H1 cells underwent a longer pulse time with LRL SPIONs to 
determine if giving the cells more time to take up the nanoparticles 
increases the yield in the lysosomal fraction. 
 
Figure 4.6: Protein levels detected in the lysosomal fraction following 
purification from CHO-H1 cells from two different pulse times followed by 
a 24 hour chase. n=3. Values represent mean ± SD, n=3 S. denotes 
significant. *P<0.05. 
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Graph displays the yields obtained following lysosomal purification in the 
lysosomal fraction from a confluent flask of T75 CHO-H1 cells that 
underwent a 24 or 36 hour pulse (figure 4.6), followed by a 24 hour chase 
using LRL SPIONs. There was a significant drop in the protein levels 
detected in the lysosomal fraction following a 36 hour pulse when 
compared with a 24hr pulse. This suggests that a 24 hour pulse is optimal 
for enough SPIONs to be endocytosed by the cell for the best lysosomal 
fraction yield. 
 
4.6.6 Comparison of 10kDa LRL SPIONs vs 40kDa LRL SPIONs to 
purify lysosomes 
 
Two types of Magnetite SPIONs are produced by Liquids Research Ltd. 
The Magnetite core in both are similar however they possess either a 
40kDa dextran coat or a 10kDa dextran coat. The size of the dextran coat 
may affect the trafficking and stability of the SPIONs which may result in 
a lower yield in the lysosomal fraction.  
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Figure 4.7: Protein levels detected in the lysosomal fraction following purification 
from CHO-H1 cells using the 10kDa dextran coated LRL SPIONs compared with 
the normally used 40kDa dextran LRL SPIONs. Values represent mean ± SD, 
n=3. S denotes significant. *P<0.05. 
 
Figure 4.7 displays the yields obtained following lysosomal purification in 
the lysosomal fraction from a confluent tank of T75 CHO-H1 cells that 
were treated with the two different dextran sized LRL SPIONs, followed 
by a 24 hour pulse and a 24 hour chase. There was on average a 
significantly higher yield obtained using the 40kDa dextran coated LRL 
SPIONs when compared with the 10kDa LRL SPIONs suggesting that 
these particles are either not as magnetic or are more unstable (figure 
4.7). 
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4.6.7 Comparison of utilising different centrifugation speeds during 
the lysosomal purification assay 
 
Each step during the lysosomal purification assay may impact the yield 
obtained in the eluted lysosomal fraction. It is important to determine the 
optimum centrifugation speed as the lysosomes that contain the 
endocytosed SPIONs are now denser and may be pelleted out under 
faster centrifugation speeds. 
 
Figure 4.8: Protein levels detected in the lysosomal fraction following 
purification from CHO-H1 cells following that involved two different 
centrifugation speeds during the assay. Values represent mean ± SD, 
n=3. S denotes significance *P <0.001. 
 
Figure 4.8 displays the yields obtained following lysosomal purification in 
the lysosomal fraction from a confluent tank of T75 CHO-H1 cells that 
underwent a 24 hour pulse followed by a 24 hour chase using LRL 
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SPIONs where the centrifugation speed was changed during the assay. 
During the lysosomal purification assay where unbroken cells and nuclei 
are pelleted via centrifugation, a greater centrifugation speed was 
administered to determine the effects on yield. There was on average a 
higher yield obtained when only applying 1500 rpm of centrifugal force 
when compared with 2000 rpm, which resulted in a significantly lower 
yield being obtained. This lower yield may be due to lysosomes being 
pelleted out during the centrifugation step, as they are now denser due to 
the accumulation of the SPIONs inside them. 
 
4.6.8 Effect of varying homogenisation techniques on lysosomal 
purification from CHO-H1 cells 
 
For optimum yields in the lysosomal fraction, effective homogenisation of 
cells during the lysosomal purification assay is essential. By utilising 
correct homogenisation techniques during the lysosomal purification 
assay should result in a greater lysosomal fraction yield. 
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Fig. 4.9: Graph displaying the importance on the use of suitable homogenisation 
techniques during the lysosomal purification assay. Values represent mean ± 
SD, n=3. S denotes significance *P <0.001.  
 
One confluent T75 tank of CHO-H1 cells were scraped into the hypotonic 
buffer A and subsequently homogenised. The broken cell suspension 
was either homogenised once (Single Homog), centrifuged and the 
supernatant passed over the column or the nuclear pellet from the 
previous step was resuspended, homogenized once more (Double 
Homog) centrifuged again and the second supernatant also passed over 
the column. Further to the Dounce homogenisation, some samples were 
also passed through either a 21 gauge (G) needle or a 23 G needle as 
indicated. Addition of the needle homogenisation step dramatically 
improves the yield in the lysosomal fraction by 100% (data not shown), 
the greatest yield is obtained following re-homogenisation of the nuclear 
pellet as well as constricted passage through a 23G needle (200% 
increase when compared to no needle) (figure 4.9). 
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4.6.9 The potential to re-use LS columns 
 
The LS columns are only produced by Miltenyi and are one of the most 
expensive components of the lysosomal purification assay. LS columns 
were re-used to determine if this had an affect on the protein yield 
obtained in the lysosomal fraction.  
 
Figure 4.10: Protein levels detected in the lysosomal fraction following 
purification from CHO-H1 cells with the use of a new LS column (first use) and a 
column that has been washed using detergents and then re-used. Values 
represent mean ± SD, n=3. S denotes significance *P <0.001. 
 
Graph displays the yields obtained following lysosomal purification in the 
lysosomal fraction from a confluent tank of T75 CHO-H1 cells that 
underwent a 24 hour pulse followed by a 24 hour chase using LRL 
SPIONs. As part of the assay the organelles that are not pelleted down in 
the centrifugation step are passed over an LS column that is attached to 
a two-tesla magnet. Magnetised lysosomes will stick to the column while 
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other organelles will pass straight through. There was a significantly 
higher yield in the lysosomal fraction when using a new column than what 
was obtained re-using an LS column that had been washed using 
detergents (figure 4.10). This would suggest that the LS columns are not 
meant to be re-used as they lose their magnetic capabilities. 
 
4.6.10 Utilising the lysosomal purification assay in different cell 
types 
 
The lysosomal purification assay was utilised on different cell lines to 
observe the yields obtained in the lysosomal fraction. 
Figure 4.11: Protein levels detected in the lysosomal fraction following 
purification using the lysosomal purification method in different cell lines. An 
approximately similar number of cells were treated with LRL SPIONs for a 24 
hour pulse followed by a 24 hour chase before being magnetically purified. 
Values represent mean ± SD. 
 
Graph displays the yields obtained in the lysosomal fraction using 
different cell types following lysosomal purification on approximately the 
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same number of cells using LRL nanoparticles (figure 4.11). The cells 
were treated with a 24 hour pulse of LRL SPIONs followed by a 24 hour 
chase. The highest yield of protein obtained in the lysosomal fraction is 
from CHO-H1 cells. This would suggest that the homogenization method 
used during the lysosomal purification assay is tailored towards 
homogenizing CHO-H1 cells. A Balch homogeniser would potentially 
improve the lysosomal fraction yield in the other cell types as it is a much 
more effective means of homogenising cells. 
 
4.6.11 Addition of sucrose to the lysosomal purification assay 
 
The addition of sucrose to the isotonic buffer B used in the lysosomal 
purification assay as well as to the DPBS used to elute the material off 
the LS column was checked to see if this improves the protein yield 
obtained in the lysosomal fraction.  
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Figure 4.12: Protein levels detected in the lysosomal fraction following 
purification from CHO-H1 cells when 100µM of sucrose was added to the 
lysosomal purification method. Values represent mean ± SD, n=3. S 
denotes significance *P <0.001. 
 
Graph displays the yields obtained following lysosomal purification in the 
lysosomal fraction from a confluent tank of T75 CHO-H1 cells that 
underwent a 24 hour pulse and a 24 hour chase using LRL SPIONs in the 
presence or absence of sucrose added to the isotonic buffer B used 
during the assay. 100µM of sucrose was added to Buffer B used in the 
lysosomal purification assay, as well as the lysosomes now being eluted 
in 100µM of sucrose in PBS. The results from adding sucrose to the 
method have resulted in a significant increase in the protein levels 
detected in the lysosomal fraction (figure 4.12), suggesting that sucrose 
may aid in helping maintain lysosomal integrity when they are 
magnetically attached to the column during the assay. 
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4.6.12 β-Hexosaminidase activity measured in each fraction 
obtained from the lysosomal purification assay 
 
The activity of the lysosomal enzyme β-Hexosaminidase was tested in 
each of the fractions obtained during the different steps in the lysosomal 
purification assay. This was done to determine that the lysosomes were 
primarily retained on the LS column during the entire assay until they are 
eluted off. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.13: β-hexosaminidase assay was used to detect for the presence of the 
lysosomal enzyme β-hexosaminidase from the different fractions obtained from 
the different steps in the lysosomal purification assay. n=1. 
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β-Hexosaminidase (β-Hex) enzyme activity in a 10µl aliquot taken from 
each fraction was measured using the 4-Methylumbelliferyl-N-acetyl-beta-
D-glucosaminide substrate in a pH 5 sodium acetate buffer. As can be 
seen, some activity remains in the homogenate (this varies depending on 
the quality of the homogenization). The residual activity in the post-
nuclear supernatant (PNS1) is reduced following re-homogenisation, 
centrifugation and application of the supernatant over the column 
(collected fraction is PNS2), indicating that some of the lysosomes do not 
bind to the column on first application, probably as a result of bulk flow. 
Lysosomes are not being sheared by the magnetic field induced by 
proximity to the 2 Tesla magnet as only a similar background level of β-
Hexosaminidase activity can be seen in the PNS2 flow-through, the 
DNase wash flow through and the PBS wash flow through. If the 
lysosomes were succumbing to the shear forces of the magnetization 
protocol we would expect to see much higher β-Hexosaminidase activity 
in these fractions, instead we observe that most of the activity is eluted 
once removed from the magnet, in the lysosomal fraction (figure 4.13). 
 
4.6.13 β−Hexosaminidase as an enzyme marker used to detect the 
presence of lysosomes 
 
β-!Hexosaminidase was used as an enzyme marker to determine if there 
is an enrichment of lysosomes in the PNS and lysosome fraction. 
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Figure 4.14: β-Hexosaminidase enrichment (Fluorescence/mg ) in the lysosomal 
fraction compared with the PNS fraction for use as a lysosome marker. Values 
represent mean ± SD, n=3. S denotes significance *P <0.001.  
 
The data shows that there is a significantly greater amount of beta-
hexosaminidase activity present in the lysosomal fraction when compared 
with the PNS fraction (figure 4.14). This shows that there is a much 
greater enrichment of the lysosomal enzyme beta-hexosaminidase in the 
lysosomal fraction. 
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4.6.14 α-Mannosidase as a marker for the Golgi apparatus 
 
An α- Mannosidase enzyme assay was used as a marker for the 
presence of the Golgi apparatus in the PNS and lysosome fraction of 
cells that were treated with LRL SPIONs. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15: Enzyme activity of α-Mannosidase (Abs change/min/µg) in the PNS 
fraction compared with the lysosomal fraction. Values represent mean ± SD, 
n=3. S denotes Significant *P <0.001. 
 
As shown in figure 4.15, α-Mannosidase activity is significantly higher in 
the PNS fraction compared with little to no activity detected in the 
lysosome fraction (figure 4.14). This would suggest that the purified 
lysosomal fraction was free of contamination of the Golgi apparatus. 
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4.6.15 Alkaline phosphatase as a marker for the presence of the 
plasma membrane 
 
The Alkaline Phosphatase enzyme was used as a marker for the 
presence of the Plasma membrane in both the PNS and lysosome 
fractions of cells treated with LRL SPIONs. 
Figure 4.16: Enzyme activity of Alkaline phosphatase (Abs change/min/µg) in 
the PNS fraction compared with the lysosomal fraction. Values represent mean 
± SD, n=3. *P <0.001, S denotes Significant. 
 
As shown in figure 4.16, alkaline phosphatase enzyme activity was 
significantly greater in the PNS fraction and only a negligible level of 
activity was observed in the lysosomal fraction (figure 4.15). This would 
indicate that the lysosomal fraction is free from plasma membrane 
contamination. 
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4.6.16 β-Glucuronidase as a marker for the presence of the ER 
 
β-Glucuronidase was used as a marker for the presence of the 
endoplasmic reticulum (ER) in the PNS and lysosomal fraction of cells 
treated with LRL SPIONs.  
 
Figure. 4.17: Enzyme activity of β-Glucuronidase (Flu released/min/µg) in the 
PNS fraction compared with the lysosomal fraction. Values represent mean ± 
SD, n=3. S denotes Significant. *P <0.001. 
 
There was a significantly greater amount of β-Glucuronidase activity in 
the PNS but no activity was detected in the lysosomal fraction (figure 
4.17).  This suggests that the lysosomal fraction is free from ER 
contamination. 
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4.6.17 MTS assay used to detect the presence of mitochondria 
 
A MTS assay was used as a marker for the presence of mitochondria in 
cells that were treated with LRL SPIONs. 
 
Figure 4.18: Enzyme activity of PMS (Abs change/min/µg) in the PNS fraction 
compared with the lysosomal fraction for use as a mitochondria marker. Values 
represent mean ± SD, n=3. S denotes Significant. *P <0.001. 
 
As shown in figure 4.18, a significantly greater level (~20X greater) of 
MTS enzyme activity was detected in the PNS fraction than what was 
detected in the lysosomal fraction. This data suggests that there is only a 
small amount of mitochondrial contamination present in the lysosomal 
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fraction. This may be due to the mitochondria often undergoing 
autophagy inside the lysosome. 
 
4.6.18 Western blots performed on the lysosomal fraction to 
determine purity 
 
Lysosomal purity was determined by checking for the presence of other 
organelles via western blotting techniques. 
 
 
Figure 4.19: Presence of different organelles in the lysosomal fraction 
determined via western blotting. Different antibodies were used to 
determine for the presence of different organelles found in the cell. n=3. 
 
GAPDH (CYTOSOL) 
NPC2 (LYSOSOMES) 
NPC1 (LATE ENDOSOMES/LYSOSOMES) 
CALNEXIN (ER) 
CYTOCHROME C (MITOCHONDRIA) 
CAVEOLIN 2 (PLASMA MEMBRANE) 
PNS LYSOSOMES 
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5µg of the lysosomal fraction (from CHO-H1 cells) protein and PNS 
fraction protein were analysed using western blotting techniques to detect 
for the presence of specific organelles using corresponding antibodies 
(figure 4.19). The magnetically purified lysosomal fraction exhibited a 
large enrichment of lysosomal proteins NPC1 and NPC2, while being 
largely free from contamination from other organelles, with the exception 
of caveolin 2. There were small levels of this marker detected in the 
lysosomal fraction, possibly due to its presence in the late endosome 
during caveolin-mediated endocytosis. 
 
4.6.19 Comparison of the lysosomal fraction yield obtained from 
CHO-H1 and CHO M12 cells 
 !The lysosomal purification was utilised on NPC1 null CHO M12 cells 
treated with LRL SPIONs to determine it can be used in NPC1 null cells 
to potentially purify lysosomes. 
CHO-H1 and CHO M12 cells were pulsed with LRL SPIONs for 24 hours 
followed by a 24 hour chase. After the lysosomes were magnetically 
purified and the lysosomal yield determined (figure 4.20). There is a 
significantly greater amount of lysosomal yield obtained from CHO-H1 
cells when compared with CHO M12 cells. This is likely due to the 
retarded trafficking present in NPC cells so the LRL SPIONs have not 
reached the lysosome yet. 
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Figure 4.20: Protein levels detected in the lysosomal fraction purified from CHO-
H1 and CHO M12 treated with LRL SPIONs following a 24hr pulse and a 24hr 
chase. n=3. S denotes significant, *P<0.001. 
 
4.6.20 Comparison of the lysosomal fraction yield obtained from 
CHO M12 cells over two different chase times 
 
Two different chase times were tested in CHO M12 cells to determine the 
optimum chase time for this cell type. As studies have shown before that 
NPC1 null cells have retarded endocytic trafficking so a longer chase time 
would result in a greater protein yield in the lysosomal fraction. 
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Figure 4.21: Protein content of purified CHO M12 lysosomes treated with LRL 
SPIONs following a 24 hour pulse and either a 24 hour or 48 hour chase. n=3. S 
denotes significant, *P<0.05. 
 
Data shows that a yield of ~120µg per ml of lysosomes was obtained 
from CHO M12 cells following a 24 hour pulse and 24 hour chase. The 
yield of lysosomes obtained significantly increased however following a 
longer chase time to about ~140µg per ml (figure 4.21). This is most likely 
due to the SPIONs having more time to reach the lysosome after a longer 
chase time due to the retarded endocytic trafficking that is present in NPC 
null CHO M12 cells. However the yield obtained from a 48 hour chase in 
CHO M12 cells is still lower than what is obtained from CHO-H1 cells that 
had a shorter pulse. This possibly suggests that there is an uptake 
problem present in the CHO M12 cells where not as much of the LRL 
SPIONs is taken into the cell, or that a lot that is taken up is recycled 
back out of the cell.  
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4.6.21 Functional assays performed with purified CHO-H1 and CHO 
M12 lysosomes to measure the levels of Ca2+ uptake and pH re-
acidification 
 
Lysosomes were purified from CHO-H1 and CHO M12 cells (as 
described in chapter 2 material and methods). Fluo-4 was used as a 
probe to detect the levels of Ca2+ uptake into the purified lysosomes. This 
was done to show that the lysosomes in the lysosomal fraction were still 
intact following magnetic purification and could uptake and maintain its 
Ca2+ content. The ACMA assay was also use to show that the lysosomes 
could re-acidify following purification. 
 
Once the ATP-regenerating system was added there was a higher level 
of Ca2+ uptake observed in the CHO-H1 lysosomes when compared with 
the CHO M12 lysosomes (figure 4.22 (A)). NAADP was added to induce 
Ca2+ release from the purified lysosomes via the TPC channels. A greater 
NAADP release was observed in the CHO-H1 lysosomes when 
compared with CHO M12 lysosomes. This strongly suggests that NAADP 
acts on a Ca2+ release channel, TPC2, on the lysosomal membrane. The 
further addition of the lysosomotrophic agent GPN caused further Ca2+ 
release from CHO-H1 lysosomes, but not CHO M12 lysosomes. This 
suggests that CHO-H1 lysosomes possess a higher Ca2+ content than 
CHO M12 lysosomes. It has been shown that NPC1 null cells possess 
lower lysosomal Ca2+ levels. The addition of C2-ceramide caused pores 
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to form in the lysosomal membrane, releasing the remaining Ca2+ 
content. 
The rate of lysosomal re-acidification was determined (figure 4.22 (B)) 
using the pH sensitive ACMA probe. After the addition of the ATP 
regenerating system the rate of re-acidification was the same in both sets 
of lysosomes, indiciating there is no pH defect in CHO M12 cells. Figure 
4.22 (C) shows that there was no significant difference in the rate of re-
acidification in CHO-H1 and CHO M12 lysosomes.  
 
Figure 4.22 (A) The rate of Ca2+ uptake was measured in both CHO-H1 and 
CHO M12 lysosomes to detect any Ca2+ uptake defects. (B) rate of re-
acidification on purified lysosomes was observed. (C) quantified levels of re-
acidification in CHO-H1 and CHO M12 lysosomes shows no significant 
difference in the rate of re-acidification. n=3 
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4.7 Discussion 
 
One of the main aims of this PhD was to develop a fast and effective way 
to purify lysosomes from cells where there is little contamination from 
other organelles as well as the lysosome still being functional. The benefit 
of this assay is that it is faster than more established techniques (e.g. 
Density gradient centrifugation) and produces a higher yield of 
lysosomes.  
One of the key materials needed for the lysosomal purification assay is 
the highly magnetic superparamagnetic nanoparticles (SPIONs) that are 
provided by Liquids Research Ltd (LRL). The LRL SPIONs possess a 
greater magnetic potential than that of other magnetic nanoparticles used 
in previous studies that attempted to purify lysosomes via the use of 
magnetic purification (Chen et al., 2005, Diettrich et al., 1998, Duvvuri 
and Krise, 2005). 
 
4.7.1 Importance of determining appropriate pulse/chase times 
 
There are important factors to consider with the use of SPIONs to purify 
lysosomes. As mentioned before (chapter 1 introduction) the endocytic 
system is composed of different endocytic vesicles, with the cargoes in 
these vesicles present for a determinate amount of time before they are 
trafficked to their correct cellular location. However it is important to note 
that trafficking of endocytosed materials as well as the rate at which cells 
endocytose material from the extracellular medium, do vary between 
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different cell types. As a result of this it is imperative that an appropriate 
pulse/chase time needs to be determined when utilizing magnetic 
lysosomal purification in different cell types. As shown in (figure 4.2), the 
utilisation of magnetic fluorescent SPIONs, provided by Liquids Research 
Ltd, to monitor the uptake and their subsequent trafficking through the 
endocytic system to the lysosome. In healthy cells such as CHO-H1 we 
found that a 24 hour pulse and 24 hour chase was an optimal time for the 
SPIONs to reach the late endosomal/lysosomal vesicles (figure 4.2). This 
was also supported in the lysosomal fraction yields acquired as shorter 
chase times than 24 hour (following a 24 hour pulse) resulted in a lower 
lysosomal fraction yield obtained while longer chase times than 24 hour 
resulted in a steady decrease in yield (possibly due to the particles 
staring to become unstable). A longer pulse of 36 hour (followed by a 24 
hour chase) also did not improve the yield and in fact resulted in a lower 
lysosomal fraction yield obtained (figure 4.6), which suggests that a 24 
hour pulse is adequate time for CHO-H1 cells to take up a sufficient 
amount of SPIONs so the lysosomes can be purified. However when a 24 
hour pulse and 24 hour chase is applied to NPC1 null CHO M12 cells 
treated with fluorescent LRL SPIONs there was little presence of these 
SPIONs in the late-endosome/lysosome vesicles, however the SPIONs 
were detected in the lysosomes following a longer chase time (figure 4.1). 
This explains why there is a lower lysosomal fraction yield obtained from 
SPION treated CHO M12 cells when there is a shorter chase time, 
however the yield does increase following a longer chase time (figure 
4.21). The need for an increase in chase times is indicative of slower 
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endocytic trafficking which has been characterized before in NPC1 
deficient cells. Also it has been published before that there is an 
endocytic uptake problem in NPC1 deficient cells, as defects in 
AnnexinA2 localisation result in many endocytosed molecules to be 
trafficked back out the cell (te Vruchte et al., 2004). This could explain 
why despite a longer chase time the lysosomal fraction yield obtained 
from CHO M12 cells is still lower than that obtained from CHO-H1 cells 
(figure 4.20). A longer pulse time with the SPIONs might be necessary 
when trying to purify lysosomes from CHO M12 cells, so as to give 
additional time for these cells to take up a greater amount of SPIONs.   
 
4.7.2 Sourcing the correct magnetic nanoparticles to use for the 
lysosomal magnetic purification assay 
 
Determining the correct type of iron as the SPION core is important, as it 
has been shown before that maghemite has lower magnetic capabilities 
when compared with magnetite (Chourpa et al., 2005). This was evident 
when lysosomes purified with maghemite based SPIONs resulted in a 
lower lysosomal fraction yield when compared with the lysosomal fraction 
yield from magnetite SPIONs (figure 4.4). Magnetite based SPIONs 
produced by Chemicell and LRL were utilised to purify lysosomes to 
highlight that even though different magnetite based SPIONs hold 
magnetic capabilities, they do not necessary produce similar yields. The 
lysosomal fraction yield over two different time points using magnetite 
based SPIONs resulted in a higher yield of lysosomes from the LRL 
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produced SPIONs when compared with the Chemicell produced ones 
(figure 4.4). This highlights the need to determine the most magnetic 
SPIONs to obtain the highest lysosomal fraction yield possible. Dextrans 
coated with an Iron oxide coat (FeO), which are similar in properties to 
what was used in previous studies to purify lysosomes (Diettrich et al., 
1998), were also used to attempt to purify lysosomes. However this 
resulted in a poor yield in the lysosomal fraction, most likely due to the 
poor magnetic properties of these particles and the toxic effect it induces 
in the cells caused by their instability (as shown in results chapter 3). In 
the case with the Chemicell SPIONs it is most likely a combination of a 
less magnetic magnetite core and that the SPIONs become increasingly 
less stable the longer they are present in the lysosome that results in a 
lower lysosomal fraction yield obtained when compared with the LRL 
magnetite based SPIONs. 
As mentioned previously (Results in chapter 3) the LRL SPIONs that 
were coated with a 10kDa dextran as opposed to a 40kDa dextran 
appeared to result in a marginal increase in cellular toxicity after a 24 
hour pulse and 24 hour chase. This is most likely the reason why a lower 
lysosomal fraction yield is obtained when using the 10kDa LRL SPIONs 
as opposed to the 40kDa LRL SPIONs (figure 4.7), as the particles are 
still highly magnetic but they are potentially damaging the lysosomes 
resulting in less lysosomes being able to remain on the column during the 
magnetic purification assay. 
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4.7.3 Importance of the magnetic properties of LRL SPIONs once 
they enter a magnetic field 
 
The hydrodynamic core of the 40kDa LRL SPION is 45nm in size, 
therefore they magnetize at a rapid rate as they possess fewer domains 
needed to reach full magnetization. However the SPIONs ability to remain 
in fluid phase is important as once they are in lysosomes and pass 
through the magnetic field during the purification assay they will be 
immobilized in the magnetic field. If the SPIONs were to go out of their 
fluid phase when they pass through a magnetic field they would solidify 
and form spicules, which would ultimately sheer the lysosome apart from 
the inside. A β-hexosaminidase assay was performed on all the fractions 
produced during the purification assay to measure for the presence of the 
lysosomal enzyme β-hexosaminidase. If the activity of this enzyme was 
high in the wash steps applied to the lysosomes attached to the column it 
would indicate that the lysosomes are structurally damaged and leaking 
enzymes out. The results showed that this was not the case as the 
majority of the enzyme activity was in the lysosomal fraction and not in 
the other fractions as it would be if the lysosomes were badly damaged 
and leaking out (figure 4.14). 
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4.7.4 Important homogenisation steps during the lysosomal 
purification assay to get the best yield 
 
One of the biggest effects there was on the lysosomal fraction yield 
obtained via magnetic purification using LRL SPIONs is from the 
efficiency of homogenization during the purification assay. Correct 
homogenization is important as it is necessary for the lysosomes 
containing the SPIONs to be released from whole cells, other wise they 
would just get spun down during the centrifugation step. The addition of 
hypotonic and isotonic buffers used in the Krise et al study on 
magnetically purifying lysosomes helped increase the yields obtained 
(Duvvuri and Krise, 2005). But other homogenization steps are required 
for a greater yield of lysosomes to be acquired. The greatest increase in 
lysosomal fraction yield was via the addition of passing the cellular 
homogenate through a 23G needle after homogenizing with a Dounce 
homogenizer. The constriction force applied to the cells helps break more 
cells open (figure 4.9). However it was interesting to note that when a 
21G needle was used instead it resulted in a lower lysosomal fraction 
yield (figure 4.9). This is possibly due to less constrictive force being 
applied to the cell homogenate to break open the cells as a 21G needle 
possesses a wider needle shaft. By re-suspending the nuclear pellet and 
unbroken cells that are pelleted down and repeating the homogenisation 
steps before again centrifuging and passing the supernatant through the 
column there is an increase in the lysosomal fraction yield (figure 4.9). 
This is due to more cells getting the chance to be broken up due to the 
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repeat homogenization steps so more lysosomes are released that can 
then be passed of the column. 
Another variable that was found to be important during the lysosomal 
purification assay was the speed at which the unbroken cells and nucleic 
material is centrifugated down during the assay. This centrifugation step 
results in the organelles from the homogenized cell to be in the 
supernatant so that they can be passed over the LS column. By 
increasing the centrifugation speed during this step it results in a lower 
yield obtained in the lysosomal fraction (figure 4.8). This would possibly 
indicate that once the lysosomes have taken up the magnetic 
nanoparticles they are more susceptible to being pelleted out as they are 
now much more dense due to the accumulation of SPIONs inside them.  
The results found from testing different homogenization steps and 
centrifugation speeds have helped highlight the need for the use of 
correct homogenization technique and centrifugation speeds to get the 
optimal lysosomal yield possible. 
 
4.7.5 LS columns 
 
The Miltenyi LS columns are one of the most expensive components of 
the lysosomal purification assay. The columns are provided exclusively 
from Miltenyi and are composed of tightly packed iron filings. While it 
states that the columns are one use only their re-usability was tested. A 
LS column that had just had lysosomes magnetically purified eluted off it 
was immediately washed multiple times with a mild detergent to remove 
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any lingering proteins that may still be on the column. The detergent was 
then removed with multiple washes with water, then left to dry following 
an ethanol wash. When the columns were then tested to see if they could 
be re-used it resulted in a significantly lower yield obtained (figure 4.10). It 
is still unclear why a lower lysosomal fraction yield is obtained due to the 
re-use of LS columns. The iron fillings may have oxidised when the 
column is washed multiple times, affecting the lysosomes ability to bind to 
it when they are passing through it during the lysosomal purification 
assay.  
 
4.7.6 Determining what is the best cell type to use 
 
As it was determined that the 40kDa LRL SPIONs were the best particles 
for magnetically purifying lysosomes in CHO-H1 and CHO M12 cells we 
wanted to show that these particles could be used for purifying lysosomes 
from other cell types. It was found that CHO-H1 cells produced the 
highest yield of lysosomes from the use of magnetic purification (figure 
4.11). While the lysosomal numbers are not necessarily lower in the cell 
types that produced a lower yield in the lysosomal fraction (e.g. 
fibroblasts) it is most likely that the homogenization technique used in the 
assay is not sufficient in certain cell types to break open cells. The yields 
however could be improved by utilizing a Balch homogenizer during the 
homogenization steps to help break open “tougher” cells. This machine 
utilizes small ball bearings that passes the cell homogenate over these 
ball bearings in a constricted chamber to further increase yields (Manunta 
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et al., 2007). This additional homogenization step may be necessary for 
gaining higher yields of purified lysosomes in certain cell types. 
 
4.7.7 Purity of purified lysosomes 
 
The purified lysosomes from CHO-H1 cells were tested for the presence 
of other cellular organelles via the use of enzyme assays (figures 4.14-
18) as well as antibodies via western blots (figure 4.19). As shown the 
lysosomes are highly pure from the presence of other organelle markers, 
and are enriched with the lysosomal protein markers NPC1 and NPC2. 
There was some caveolin 2 (the plasma membrane marker) present in 
the lysosomal elution. This however is possibly due to caveolin 2 being 
present in late endosomes when it is internalised with its cargo 
(Rodriguez et al., 2007). <5% mitochondria enzyme activity was observed 
in the lysosomal elution when a mitochondria enzyme assay was done on 
it (figure 4.18). This low level contamination most likely is due to 
mitochondria frequently being cleared to the lysosome via autophagy for 
degradation and the recycling of their components. 
 
4.7.8 Addition of sucrose to the lysosomal purification assay 
 
While the lysosomal purification assay is much faster than that of current 
established lysosomal purification techniques (~1 hour as opposed to >16 
hour) the lysosomes are still magnetically bound to the LS column for a 
short amount of time. 100µM Sucrose was added to the isotonic buffer B 
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as it has been shown before that sucrose helps maintain lysosomal 
membrane integrity. The lysosomes are also eluted into PBS containing 
100µM sucrose as this would be of benefit for functional assays to be 
performed on the purified lysosomes. The addition of 100µM sucrose to 
the lysosomal purification assay has improved the yield seen in the 
lysosomal fraction (figure 4.13). This would suggest that the addition of 
sucrose helps maintain lysosomal structure, and also stops lysosomes 
from bursting too soon before they are eluted off the column.  
 
4.7.9 Functional Ca2+ uptake and re-acidification of purified 
lysosomes from CHO-H1 and CHO M12 cells 
 
By using the magnetic lysosomal purification assay to purify lysosomes 
from CHO-H1 cells and NPC1 null CHO M12 cells we were able to 
perform functional assays on them (figure 4.22). We were able to 
determine there is a Ca2+ uptake problem in CHO M12 cells, as well as 
that they contained lower levels of lysosomal Ca2+, which has been shown 
before. We were able to determine that there was no pH defect in CHO 
M12 cells, which we could therefore suggest that Ca2+ defects are one of 
the main driving forces in NPC pathogenesis. 
This shows that the lysosomes that are purified by this method can still 
remain structurally intact and can then be functionalized post-purification. 
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Chapter 5: Characterising juvenile neuronal ceroid 
lipofuscinosis disease cellular phenotypes 
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5.1 Background  
 
CLN3 disease, also known as JNCL, is a neurological disorder that arises 
from mutations in the CLN3 gene that gives rise to a progressively severe 
pathology starting at around 4-6 years of age leading to death, typically in 
the late teens/early twenties. As mentioned before, the role and function 
of the CLN3 protein is still widely disputed and there has been a lack of 
progress in mechanistic research in this field hampering not only our 
understanding of this disease at a cellular level but also the development 
of any potential treatment for CLN3 disease patients.  
For us to truly be able to develop any form of therapy for JNCL we must 
first understand the changes in cell biology that occur following loss of 
CLN3 function. 
 
5.2 Common phenotypes observed in different CLN3 mutant cells 
 
CLN3, as well as all NCLs, are distinct in that cells present with the 
lysosomal accumulation of the auto-fluorescent material lipofuscin (Cao 
et al., 2011). This auto-fluorescent material has been found to consist of 
aggregates containing proteolipid which is an important component of 
subunit c of the mitochondria ATP synthase (Cao et al., 2011). While the 
storage of subunit c is common in many cell types that have mutations in 
CLN3, the molecular function is still unresolved as the loss of CLN3 
function has been reported to have a broad impact on diverse cellular 
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processes such as vesicular trafficking, pH regulation, lipid transport and 
autophagy (Tecedor et al., 2013).  
Many studies performed on mammalian cells have linked CLN3 with a 
role in endosomal organelles (Cotman and Staropoli, 2012). Several 
studies have shown that there are defects in lysosomal pH in different cell 
lines with CLN3 mutations, with many of these studies suggesting that the 
lysosomal pH is more alkaline (Holopainen et al., 2001). This alkalization 
of the lysosomal pH has been linked with alterations in cathepsin D 
processing as well as the accumulation of APP (Golabek et al., 2000).  
CLN3 deficiency has also been implicated to result in impaired 
endocytosis in mouse neurons, endothelial cells as well as patient 
fibroblasts (Tecedor et al., 2013). This has been speculated to be a result 
of alterations in the actin cytoskeleton, as CLN3 has been shown to be 
weakly associated with the HOOK1 protein which is important for 
recruitment of the cytoskeleton during endocytosis (Luiro et al., 2004). 
However it is still not fully understood how the absence of CLN3 impairs 
this network, and the knock on effect it has on endocytosis and 
subsequent trafficking (Schultz et al., 2014).  
Autophagy has also been found to be severely affected in CLN3 mutant 
cells. The accumulation of subunit c has been found to be localized to 
autophagic vacuoles in Cln3Δex7/8 knock-in mouse cells, which suggests 
that there is a disruption in autophagosome maturation in these cells. 
Correct autophagy function is important for cellular viability, as it is 
needed for the production of key metabolites during times of stress or 
nutritional deprivation (Cao et al., 2006). The autophagic vacuole is 
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initiated by the de novo formation of an isolation membrane that then 
engulfs organelles or cytoplasmic material for degradation. This then 
fuses with lysosomes to become increasingly more acidic through the 
uptake of protons from the fused lysosomes to become an autolysosome, 
where the engulfed material can then be degraded and its components 
recycled back into the cell (Cao et al., 2006). While autophagy has been 
found to have an important role in other neurodegenerative diseases 
such as Huntingtons and Alzheimers (Palmer et al., 1995, Seehafer and 
Pearce, 2006), the defects in autophagosome maturation are still not fully 
understood in CLN3 mutant cells.  
These common defects mentioned have been implied to relate closely to 
CLN3’s function as they have been suggested to occur before the 
accumulation of detectable lysosomal lipid storage meaning they are 
possibly upstream events in CLN3 pathogenesis (Cotman and Staropoli, 
2012).  
 
5.3 Cerebellar defects seen in JNCL 
 
The Cerebellum is a region of the brain that has an important role in 
motor control as well as possibly being involved in some degree of 
cognitive function. Within the cerebellum lies a network of different groups 
of tightly regulated neurons including the Purkinje cells, a group of 
neurons that are solely responsible for motor coordination inside the 
cerebellar cortex.  
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CLN3 has been found to be expressed in the purkinje cells of the 
cerebellum (Bohland et al., 2009), and research has shown that the loss 
of CLN3 leads to cerebellar defects. Following the loss of Cln3 in mouse 
studies there are a number of different phenotypes that present, such as 
loss of purkinje neurons and glial activation. Aberrant cell proliferation 
and maturation are also observed . Also a significant number of genes 
have been found to be altered in Cln3 knockout mice. These gene 
expression changes include alterations in neurotransmission, neuronal 
cell structure and inflammation (Brooks et al., 2003, Weimer et al., 2009). 
 
5.4 Purpose for phenotyping Cln3Δex7/8 cells 
 
The cellular role and localization of the CLN3 protein is still not fully 
understood and is often the subject of controversy in the NCL field. 
Cln3Δex7/8 knock-in mice have been genetically manipulated so that they 
have a near identical mutation to that found in the 1kb gene deletion 
found in the majority of JNCL patients (Bennett and Rakheja, 2013). This 
mutation results in the 3-10 fold knockdown of Cln3 mRNA levels found in 
the mouse tissues. While this does not completely remove all traces of 
Cln3 protein inside the cell, it is suitable to determine if the knockdown in 
Cln3 expression results in lysosomal storage seen in other lysosomal 
diseases (Cotman et al., 2002).  
As stated before one of the main clinical phenotypes in CLN3 patients is 
severe ataxia, which bears resemblance to another lysosomal storage 
disease, NPC. While a lot of work has been done characterizing the 
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pathology of the cerebellar during disease progression in NPC 
(particularly the loss of Purkinje neurons over time from disease onset), 
little work has been done to phenotype cerebellum cells that possess a 
mutated CLN3 protein. It is important to determine if these CLN3 mutant 
cerebellar cells share similarities in altered lipid content and changes in 
endocytic trafficking that are often altered in other types of lysosomal 
storage diseases. 
 
5.5 Previous studies in Cln3Δex7/8 cerebellar cells 
 
Cln3Δex7/8 knock-in mice were produced to provide a suitable neuronal cell 
system so that key biological processes could be observed in Cln3 
mutant cells (Fossale et al., 2004).  
Cln3Δex7/8 mice have been found to present with similar onset of 
symptoms seen in CLN3 disease patients. 10-14 week old mice start to 
exhibit sensory and motor coordination defects, while severe vacuolation 
was observed in older Cln3Δex7/8 mouse tissue (Staropoli et al., 2012). 
This would suggest that this mouse model is suitable for studying the 
effects of Cln3 deficiency in cells. The Cln3Δex7/8 cerebellar cells (cb) have 
been shown to accumulate subunit c of the mitochondrial ATP synthase, 
possess defects in autophagy, lower endocytic uptake, as well as 
processing defects in cathepsin D and defects in the levels of 
mitochondrial ATP (Fossale et al., 2004), which have been found to occur 
in other CLN3 mutant cell lines (Schultz et al., 2014). This would suggest 
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that the Cln3Δex7/8 cerebellar cells are a suitable Cln3 deficient model to 
determine key pathogenic phenotypes in the onset of CLN3 disease. 
 
5.6 Overview 
 
The purpose of this chapter is to attempt to characterize organelle 
dysfunction in Cln3Δex7/8 cerebellar cells to improve our understanding of 
where CLN3 might be working and what it may be doing in the cell. It is 
important to look at all organelles to potentially identify the effects Cln3 
deficiency has on their respective cellular functions and how defects in 
this could potentially culminate in CLN3 disease. An important phenotype 
that will be determined is the presence of endocytic trafficking 
abnormalities, as this will be important to take into consideration for the 
potential use of magnetically purifying lysosomes from Cln3Δex7/8 
cerebellar cells. Analysis of key phenotyping will also be done with CLN3 
patient fibroblasts to help identify key phenotypic changes that are found 
in both Cln3Δex7/8 cerebellar cells as well as in patient cells. The patient 
cells to be analysed are one fibroblast line that is homozygous for the 
common 1kb mutation and one homozygous for a missense mutation 
found in the C-terminus of the CLN3 protein that results in CLN3 disease: 
the D416G mutant. Similar phenotypes observed between these different 
genotypes and cell lines would hopefully help elucidate CLN3’s potential 
cellular function 
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5.7 Results 
 
Despite much research being done on CLN3, the underlying cellular 
mechanisms that give rise to this disease are still poorly understood. 
Before being able to understand the mechanisms that give rise to the 
CLN3 phenotype we must first understand the key phenotypes present in 
CLN3 mutant cells, and how these phenotypes may potentially give rise 
to CLN3 disease. 
 
5.7.1 Determining changes in lysosomal levels in mutant Cln3 
cerebellar and CLN3 fibroblast cells 
 
A common phenotype in many lysosomal storage diseases is an 
expansion in the lysosomal network. This has been hypothesised to be 
due to the cell up regulating the number of lysosomes to try and cope 
with the excess storage of lipids and other macromolecules in these  
diseased cells. The use of the lysotracker green probe was used to 
determine the number of acidic compartments present in the cell to check  
for any expansion of the lysosomal system.
! 181!
 
Figure 5.1: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained with lysotracker red probe (white) to detect the levels of acidic 
organelles (lysosomes). (B) Representative images of wild type human 
fibroblast (wild type HF) cells as well as human fibroblasts homozygous for the 
CLN3 1kb mutation (HF CLN3 1kb) and homozygous for the CLN3 D416G 
mutation (HF CLN3 D416G) cells stained with lysotracker red (white). Hoescht 
was used as a nuclear marker (blue). (C) & (D) quantified data of (A) & (B) 
respectively. Values represent mean ± SD. N=3. >80 cells analysed, S denotes 
significance *p< 0.05. Scale bars= 10µm. 
 
Cerebellar cells showed no change in the levels of lysosomes detected 
using the lysotracker red probe in either the cbCln3+/+ or cbCln3∆ex7/8 cells 
(figure 5.1). Similar levels of lysotracker red staining was observed 
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between wild type fibroblast and fibroblasts carrying the CLN3 1kb 
mutation, although a few cells showed marginally higher levels of 
lysotracker staining. Fibroblast cells that carry the CLN3 D416G mutation 
exhibited lower levels of lysotracker red staining when compared with 
normal and the CLN3 1kb mutation fibroblasts. 
 
5.7.2 Cathepsin B activity in mutant Cln3 cerebellar and CLN3 
fibroblast cells 
 
Magic Red Cathepsin B kit is used to detect the activity of the lysosomal 
enzyme cathepsin B. The assay works by adding a cathepsin B substrate 
to the cells, when there is cathepsin B activity it cleaves the substrate 
releasing a fluorescent product. Changes in the levels of cathepsin B 
could potentially indicate a change in the lysosomal pH required for 
cathepsin B to work. 
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Figure 5.2: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained with Magic red cathepsin B (white) to detect the activity of the the 
lysosomal enzyme cathepsin B. (B) Representative images of wild type human 
fibroblast (wild type HF) cells as well as human fibroblasts homozygous for the 
CLN3 1kb mutation (HF CLN3 1kb) and homozygous for the CLN3 D416G 
mutation (HF CLN3 D416G) cells stained with Magic red cathepsin B (white). 
Hoescht was used as a nuclear marker (blue). (C) & (D) quantified data of (A) & 
(B) respectively. Values represent mean ± SD. N=3. >80 cells analysed, S 
denotes significance *p< 0.05. Scale bars= 10µm. 
 
No change in the levels of cathepsin B activity was observed between the 
two cerebellar cell types (figure 5.2). A slightly greater amount of 
cathepsin B activity was observed in the fibroblast cells that possess the 
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two CLN3 mutations when compared with the wild type fibroblast cells. 
This possibly indicates that lysosomal enzyme activity is elevated in 
CLN3 mutant lysosomes, but as cathepsin B is dependent on acidic pH 
optimum to work, this would suggest that CLN3 1kb mutants and D416G 
mutants still possess an acidic pH in the lysosome. 
 
5.7.3 Cathepsin L activity in mutant Cln3 cerebellar and CLN3 
fibroblast cells 
 
Magic Red Cathepsin L kit is used to detect the activity of the lysosomal 
enzyme cathepsin L. The assay works by adding a cathepsin B substrate 
to the cells, when there is cathepsin L activity it cleaves the substrate 
releasing a fluorescent product. Changes in the levels of cathepsin L 
could potentially indicate a change in the lysosomal pH required for 
cathepsin L to work. 
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Figure 5.3: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained with Magic red cathepsin L (white) to detect the activity of the the 
lysosomal enzyme cathepsin L. Hoescht was used as a nuclear marker (blue). 
(B) Representative images of wild type human fibroblast (wild type HF) cells as 
well as human fibroblasts homozygous for the CLN3 1kb mutation (HF CLN3 
1kb) and homozygous for the CLN3 D416G mutation (HF CLN3 D416G) cells 
stained with Magic red cathepsin L (white). Hoescht was used as a nuclear 
marker (blue). (C) & (D) quantified data of (A) & (B) respectively. Values 
represent mean ± SD. N=3. >80 cells analysed, S denotes significance *p< 0.05. 
Scale bars= 10µm. 
 
Magic Red Cathepsin L kit is used to detect the activity of the lysosomal 
enzyme cathepsin L. The assay works by adding a cathepsin L substrate 
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to the cells, when there is cathepsin L activity it cleaves the added 
substrate releasing a fluorescent product. No difference in cathepsin L 
activity was seen between the cbCln3+/+ and cbCln3∆ex7/8 cerebellar cells 
(figure 5.3). Interestingly greater levels of cathepsin L activity were 
observed in both the CLN3 mutant fibroblast cell lines when compared 
with the wild type fibroblast cells. Greater cathepsin L activity was 
detected in the CLN3 1kb mutation when compared with the CLN3 
D416G mutants, suggesting greater activity of this enzyme in the 1kb 
mutant cells. 
 
5.7.4 Mitochondrial numbers and function 
 
By using Mitotracker green to detect mitochondrial levels in cells it 
revealed that there was no difference in the mitochondrial levels detected 
in both cbCln3+/+ and cbCln3∆ex7/8 cerebellar cells (figure 5.4). MitoROS 
probe is used to detect the levels of mitochondrial produced ROS, which 
is a natural by product of mitochondrial function (due to the formation of 
free electrons as a by-product of the electron transport chain) and any 
increase or decrease in levels can indicate mitochondrial dysfunction. 
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Figure 5.4: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained with Mitotracker green probe to detect mitochondrial levels and 
MitoROS probe to detect the levels of mitochondrial produced reactive oxygen 
species (ROS) (white). (D) Wild type human fibroblast cells as well as human 
fibroblasts homozygous for the CLN3 1kb mutation and homozygous for the 
CLN3 D416G mutation stained with MitoROS probe. Hoescht was used as a 
nuclear marker (blue). (B), (C) & (E) quantified data of (A) & (D) respectively. 
Values represent mean ± SD. N=3. >60 cells analysed, S denotes significance 
*p< 0.05. Scale bars= 10µm. 
 
No changes in the levels of mitochondrial produced ROS was detected in 
the two cerebellar cell types. By observing the stains in fibroblast cells 
there appears to be slightly lower levels of mitoROS staining present in 
both CLN3 mutant fibroblast cell lines when compared with wild type 
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fibroblasts. This reduction of MitoROS staining was significantly lower in 
the 1kb mutation cell lines. While the difference is small, it could signify 
that the mitochondria are starting to lose viability. 
 
5.7.5 Levels of ER density and the ER Ca2+ influx pump SERCA2 
 
SERCA 2 antibody was used to stain for the presence of the SERCA 2 
Ca2+ channel that is responsible for the uptake of Ca2+ into the ER. ER 
tracker probe was used to stain the ER as a whole to detect for any 
changes in ER density in the cell, which could be a sign of ER stress. 
 
 
 
 
 !
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Figure 5.5: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained SERCA2 antibody and ER tracker probe to detect the levels of the 
SERCA2 protein and ER structure respectively (white). (D) Wild type human 
fibroblast cells as well as human fibroblasts homozygous for the CLN3 1kb 
mutation and homozygous for the CLN3 D416G mutation stained with SERCA2 
antibody. Hoescht was used as a nuclear marker (blue). (B), (C) & (E) quantified 
data of (A) & (D) respectively. Values represent mean ± SD. N=3. >40 cells 
analysed, S denotes significance *p< 0.05. Scale bars= 10µm. 
 
There was no significant change in the levels of SERCA 2 found in the 
cbCln3∆ex7/8 cerebellar cells when compared with cbCln3+/+ cerebellar 
cells (figure 5.5). Staining with ER tracker revealed that there was an 
increase in the density of ER in the cbCln3∆ex7/8 cerebellar cells when 
compared with cerebella cbCln3+/+ cells (figure 5.5). This thickening of the 
ER observed in these cells would suggest that there is an increase in the 
levels of ER stress in the cbCln3∆ex7/8 cerebellar cells. Staining with 
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SERCA 2 antibody in the human fibroblast cells revealed a marginal 
increase in the levels of SERCA 2 detected in both the CLN3 mutant cell 
lines when compared with wild type fibroblasts. This could possibly 
indicate that there is an expansion of the ER membrane in both the CLN3 
mutant fibroblasts, which might be a sign of the ER stress response, but 
additional work is required to determine this. 
 
5.7.6 Determining changes in lipid content 
 
One common phenotype in lysosomal storage diseases is the storage of 
different lipids. Three common lipids that have been found to be stored 
are cholesterol, sphingomyelin and LBPA. By observing the storage of 
these lipids may indicate a problem in the trafficking or degradation of 
these molecules. 
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Figure 5.6: Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar cells 
and normal human fibroblast cells as well as human fibroblasts homozygous for 
the CLN3 1kb mutation and homozygous for the CLN3 D416G mutation stained 
with Filipin, Lysenin and P-LBPA antibody to detect for the presence of 
Cholesterol, Sphingomyelin and LBPA respectively. Hoescht was used as a 
nuclear marker (blue). n=3. Scale bars= 10µm. 
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Filipin complex is used as a stain for free cholesterol as it specifically 
binds to it and fluoresces, indicated by punctate staining. By observing 
the filipin staining in the cells we observed that there was no change in 
the levels of cholesterol present between the cbCln3+/+ and cbCln3∆ex7/8 
cerebellar cells (figure 5.6). However there was a small change in the 
cholesterol levels detected when comparing the CLN3 mutant fibroblast 
cells with normal fibroblast cells. Comparing the CLN3 1kb mutant 
fibroblast cells with the wild type fibroblasts revealed that the levels of 
cholesterol weren’t significantly different between the two cell types, the 
distribution of cholesterol was different in the CLN3 1kb mutant cells 
(more peri-nuclear in normal fibroblast cells compared with general whole 
cell distribution seen in CLN3 1kb mutant cells). The cholesterol 
localization in the CLN3 D416G mutant cells is similar to that seen in wild 
type fibroblasts (peri-nuclear), but the overall levels of cholesterol staining 
observed was higher in the CLN3 D416G mutant when compared with 
wild type fibroblasts. 
 
Lysenin toxin was used to detect for sphingomyelin levels (indicated by 
punctate staining). There was a small increase in the levels of 
sphingomyelin in the cerebellar cbCln3∆ex7/8 cells when compared to the 
cbCln3+/+ cells. The cbCln3∆ex7/8 cerebellar cells that exhibited higher 
levels of lysenin staining displayed brighter staining inside the cell, rather 
than the staining generally being present along the plasma membrane of 
the cell. Utilising lysenin toxin stain on the fibroblast cells resulted in 
staining of the plasma membrane in the wild type cells, however the 
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results seen in both CLN3 mutant fibroblast cells was more variable. In 
both the CLN3 mutant fibroblasts there was elevated levels of intracellular 
lysenin staining present in some cells, but there were also some cells that 
displayed similar levels of lysenin staining seen in wild type fibroblasts. 
However the proportion of cells that displayed intracellular lysenin 
staining were much higher in the CLN3 1kB mutant cells when compared 
with CLN3 D416G mutant cells, possibly suggesting a more severe 
phenotype.  
 
P-LBPA antibody was used to detect the levels of LBPA inside the cells, 
indicated by punctate staining (figure 5.6). The levels of LBPA were 
higher in the cbCln3∆ex7/8 cells when compared with cbCln3+/+ cerebellar 
cells, suggesting an accumulation of this lipid in endosomal vesicles in 
cbCln3∆ex7/8 cerebellar cells. The levels of LBPA staining was similar in 
CLN3 1kb mutant fibroblast cells when compared with their respective 
wild type cells, implying that storage of this lipid is not present in fibroblast 
cells that carry the same type of mutation as the cerebellar cbCln3∆ex7/8 
where LBPA storage seems to be up. Interestingly LBPA staining was 
lower in the CLN3 D416G mutant cells than what was observed in both 
the wild type and CLN3 1kb mutant cells, possibly suggesting defects in 
the synthesis of this lipid in cells that possess the CLN3 D416G mutant 
variant. 
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5.7.7 Determining changes in the Golgi apparatus 
 
It has been implied by some research groups that CLN3 is a Golgi 
protein. GM130 antibody was used to detect for any changes in 
morphology of the Golgi apparatus in wild type and CLN mutant cells. 
 
Figure 5.7: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained for the Golgi protein GM130 to determine changes in Golgi 
structure (white). (C) Representative images of wild type human fibroblast cells 
as well as human fibroblasts homozygous for the CLN3 1kb mutation and 
homozygous for the CLN3 D416G mutation stained with the GM130 antibody 
(white). Hoescht was used as a nuclear marker (blue). (B) & (D) quantified data 
of (A) & (C) respectively. Values represent mean ± SD. n=3. >50 cells analysed. 
Scale bars= 10µm. 
 
Using the GM130 antibody we observed that there were no changes in 
the morphology of the Golgi apparatus in both the two different cerebellar 
genotypes as well as the wild type and both mutant fibroblast cell lines. 
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(figure 5.7). This suggests that the CLN3 protein loss does not affect 
Golgi morphology. 
 
5.7.8 Metal ion levels in wild type and Cln3 mutant cerebellar cells 
 
Some studies have suggested that changes in metal ion content may 
lead to disease pathogenesis in lysosomal storage diseases. The use of 
metal ion probes was used to detect changes in tightly regulated metal 
ions such as Zn2+, Cu2+ and Fe2+. Loss in regulation of metal ion content 
may lead to disease pathogenesis.  
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Figure 5.8: (A) Representative images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained with the Zn2+, Fe2+ and Cu2+ ion probes Phen green and Newport 
green. Cells are also imaged using these probes in the presence of the zinc 
chelator TPEN. (B), (C), (D) & (E) Quantified data on Newport green, Newport 
green + TPEN, Phen green and Phen green + TPEN respectively. Values 
represent mean ± SD. N=3. >60 cells analysed for each stain. S denotes 
significance. *P<0.05, ***P< 0.001. Scale bars= 10µm. 
 
Zn2+ and Cu2+ probe Newport green showed that there was no difference 
in the Zn2+ and Cu2+ levels detected in the cbCln3+/+ and cbCln3∆ex7/8 cells 
(figure 5.8). The Zn2+ chelator TPEN is added to cells stained with 
newport green so that only the remaining Cu2+ is stained. This results in a 
significantly greater level of Cu2+ staining present in the cerebellar 
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cbCln3∆ex7/8 cells than what is seen in the cbCln3+/+. The phen green 
probe was also used to stain for cellular levels of Zn2+. Cellular levels of 
Zn2+ was the same in the cbCln3+/+ cerebellar and cbCln3∆ex7/8 cells, 
however following the chelation of Zn2+ with TPEN the cbCln3∆ex7/8 cells 
exhibited significantly less fluorescence. This is possibly because phen 
green is quenched when it binds to Cu2+ and Fe2+ suggesting that these 
two metal ions are possibly elevated. 
 
5.7.9 Early endosomal levels are elevated in cbCln3∆ex7/8 and CLN3 
mutant fibroblast cells 
 
EEA1 antibody was used as a marker for the presence of early 
endosomes in cerebellar and fibroblast cells. An increase in the levels of 
early endosomes could be an indication of an increase in endocytic 
uptake of molecules from outside the cell as well as an increase in the 
endocytic trafficking of these molecules (figure 5.9). 
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Figure 5.9: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells stained for the Early endosomal protein EEA1 to determine early 
endosomal levels (white). (C) Representative images of wild type human 
fibroblast cells as well as human fibroblasts homozygous for the CLN3 1kb 
mutation and homozygous for the CLN3 D416G mutation stained with the EEA1 
antibody (white). Hoescht was used as a nuclear marker (blue). (B) & (D) 
quantified data of (A) & (C) respectively. Values represent mean ± SD. n=3. >70 
cells analysed. S denotes significance. ***P< 0.001, ****P<0.0001. Scale bars= 
10µm. 
 
The levels of EEA1 staining (indicated by punctate staining) was 
significantly higher in the cbCln3∆ex7/8 cerebellar cells when compared 
with what was seen in cbCln3+/+cells. Staining of the fibroblasts also 
revealed that cells carrying either the CLN3 1kb or CLN3 D416G mutation 
possessed elevated levels of EEA1 when compared with wild type 
fibroblasts. 
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5.7.10 Determining the rate of endocytosis by monitoring the 
trafficking of ganglioside GM1 
 
CtxB transport assay was used to monitor the cellular trafficking of the 
GM1 ganglioside. CtxB supplied to live cells binds to GM1 ganglioside 
and is then internalised into the cell so that it can be used to monitor the 
transport of GM1 inside the cell. In healthy cells GM1 is trafficked to the 
Golgi (shown by bright staining round the nuclei), while in cells with 
retarded endocytic trafficking the GM1 stain presents itself as intra-
vesicular punctate staining with little to no Golgi staining present. For 
counting purposes the rate of GM1 trafficking is designated into three 
categories: Golgi (the majority of the staining observed is in the Golgi), 
intermediate (there is some Golgi staining is present but there is still high 
amounts of GM1 (staining outside the Golgi in punctate endocytic 
compartments) and punctate (there is no Golgi staining present, only 
punctate staining). The cells were treated to both a 1 hour and 30 minute 
pulse to give time for the CtxB to be internalized into the cell and bind to 
GM1. This is then followed by either a 1 or 2 hour chase to measure GM1 
trafficking. 
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Figure 5.10: (A) Representative Images of cbCln3+/+ and cbCln3∆ex7/8 cerebellar 
cells treated with FITC-CtxB to measure the uptake and trafficking speed of 
ganglioside GM1 (white). (B) Respective counts of GM1 cellular location was 
done for both cerebellar cell types after their respective pulse/chase times. (C) 
Wild type human fibroblast cells as well as human fibroblasts homozygous for 
the CLN3 1kb mutation and homozygous for the CLN3 D416G mutation treated 
with FITC-CtxB to measure trafficking. Hoescht was used as a nuclear marker 
(blue). n=3. >100 cells counted for each pulse/chase time experiments for CtxB 
localization quantification. 
 
A greater degree of Golgi staining was observed in the cbCln3∆ex7/8 
cerebellar cells when compared to cbCln3+/+cerebellar cells (figure 5.10), 
this would suggest that there is faster endocytic trafficking occurring in 
the cbCln3∆ex7/8 cerebellar cells. By observing the cellular staining present 
in the fibroblast cells following a 30 minute pulse and 2 hour chase of the 
CtxB toxin there was a greater degree of Golgi staining evident in both 
the CLN3 1kb and D416G mutant genotypes when compared with the 
wild type fibroblast cells. This would suggest that in the CLN3 mutant cell 
lines there is faster endocytic trafficking occurring as was seen in the 
cbCln3∆ex7/8 cerebellar cells. 
 
5.7.11 Dextran fusion assay to determine endocytic trafficking 
speed. 
 
A dextran fusion assay was performed to detect any increase in the rate 
of endocytic trafficking in the cerebellar cell, to confirm the phenotype we 
observed using the CtxB transport assay. This assay works by observing 
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the trafficking of fluorescent dextrans as they pass through the endocytic 
system. 
 
 
Figure 5.11: Representative images of cbCln3+/+and cbCln3∆ex7/8 cerebellar cells 
pulsed with TRITC-dextran (red) for 24 hour and chased for 12 hour and AF488-
Dextran (green) for 10 minutes so they are present in lysosomes and early 
endosomes respectively. (A) The treated cells are imaged for the localization of 
the two endocytic vesicle markers for signs of co-localisation (yellow). Lines 
were drawn around the cell to highlight their location (B) % of cells that exhibited 
overlap. Lines were drawn around the cells to highlight their location. (N=2). 
 
A 24 hour pulse and 12 hour chase of TRITC-dextran allows it to be 
trafficked to the lysosomes where it can be visualized at 570nm 
wavelength (Red). A pulse of 10 minutes of Alexa Fluo-488 dextran 
(AF488-Dex) is a suitable time for this dextran to be uptaken into the cell 
and the majority of the dextran to reside in the early endosomes in cells 
with normal trafficking rates. The early endosomes can then be visualized 
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at 480nm wavelength (green). Any elevated endocytic trafficking will 
result in a greater degree of co-localisation between the TRITC-dextran 
and AF488-dextrans as the AF488-dextran would have been trafficked 
along the endocytic pathway to the lysosome at a faster rate than normal 
(co-localisation visualized in yellow). A greater degree of co-localisation 
between the two different fluorescent dextrans was observed in the 
cbCln3∆ex7/8 cerebellar cells when compared with the cbCln3+/+cells 
(~70% versus 20%) (figure 5.11). This data suggests that there is faster 
endocytic trafficking present in cbCln3∆ex7/8 cerebellar cells compared with 
cbCln3+/+cerebellar cells. This result supports the CtxB transport assay 
data which also suggested that cbCln3∆ex7/8 cerebellar cells have faster 
endocytic trafficking (figure 5.10). 
 
5.7.12 Intra-lysosomal measurements of pH and Ca2+ 
 
Ca2+ and pH probes were loaded into the lysosome to detect for any 
changes in the Cln3 mutant cerebellar cells when compared with the wild 
type cells. Changes in intra-lysosomal Ca2+ content or pH may possibly 
may be the reason for the elevated endocytic trafficking observed in the 
mutant Cln3 cells. 
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Figure 5.12: Quantified data for lysosomal Ca2+and pH levels detected in 
cbCln3+/+ and cbCln3∆ex7/8 cerebellar cells. (N=2). (t-test) P<0.02, n.s. denotes 
not significant. 
 
Oregon green BAPTA was used as an intra-lysosomal Ca2+ probe. 
Quantification of the levels of lysosomal Ca2+ detected in cbCln3+/+and 
cbCln3∆ex7/8 cerebellar cells displayed that there was a significant 
increase in the levels of lysosomal Ca2+ detected in the cbCln3∆ex7/8 than 
what was seen in the cbCln3+/+cells (p<0.02) (figure 5.12). Lysosensor 
yellow/blue probe was used to detect differences in lysosomal pH. While 
there was a small reduction in lysosomal pH detected in the cbCln3∆ex7/8 
compared to cbCln3+/+, this was not a significant decrease (p>0.05). 
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5.8 Discussion 
 
 
A majority of JNCL patients carry the 1kb deletion in the CLN3 gene, 
which is predicted to result in the formation of a truncated protein product 
which is either rapidly degraded or non-functional (Kwon et al., 2005). 
Two mouse models have been produced (Cln3∆ex7/8 and Cln3∆ex7/8insneo) 
which lack exons 7-8 in the Cln3 mouse gene to replicate the 1kb 
mutation commonly seen in humans, as well as a third model which has 
exons 1-6 missing and is considered a knockout Cln3 mouse model 
(Cln3∆ex1-6) (Cao et al., 2006, Weimer et al., 2009). While similar 
phenotypes have been shown across the three different mouse models 
there are still some phenotypic differences exhibited between the different 
mouse models (e.g. seizures etc). A result of the differences in 
phenotypes observed between the three mouse models has led some 
people to suggest that the Cln3 protein in these mouse models is still 
maintaining some functionality. The Cln3∆ex7/8 mouse model is described 
as a knock-in of the common 1kb mutation (Cotman et al., 2002) which 
encodes a mutant CLN3 with a native C-terminus (Mao et al., 2003).  
One of the most prevalent phenotypes associated with JNCL is the loss 
of motor coordination that can potentially be attributed to defects in the 
cerebellum as a result of CLN3 mutation. While cerbella cells derived 
from the Cln3∆ex7/8 mouse model have been produced, little work has 
been done to characterise key phenotypic changes that occur in these 
cells due to Cln3 mutation. Phenotyping the Cln3∆ex7/8 was done to detect 
any key changes such as lipid levels, metal ion content and lysosomal pH 
and enzyme activities allowing us to determine the key defects resulting 
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in pathogenesis in the Cln3 mutant cerebellar cells. Some work was also 
done on phenotyping human fibroblasts that possessed the 1kb CLN3 
mutation as well as fibroblast cells that possess the rare D416G mutation. 
This missense mutation is the only mutation that induces JNCL disease 
that is found in the C-terminus region of the CLN3 protein. 
 
5.8.1 Lysosomal pH in CLN3 mutant cells 
 
It has been suggested by many groups that the pH of lysosomes is 
altered in CLN3 mutant cells. However there are conflicting reports on 
whether the pH in lysosomes of CLN3 mutant cells is higher or lower, with 
this change in pH often attributed to defects in lysosomal enzyme activity 
in this disease (Golabek et al., 2000). By using the lysotracker green 
probe (figure 5.1) we first wanted to see if the levels of lysosomes present 
were increased in the different cerebellar and fibroblast genotypes. As 
lysotracker green requires a low pH to fluoresce it would give an 
indication if there was a major change in the pH of the mutant lysosomes. 
No difference in lysosomal levels was detected with the use of lysotracker 
green between cbCln3+/+ or cbCln3∆ex7/8 cells which appears to suggest 
that there is no lysosomal expansion occurring in the two different 
genotypes and that the pH is similar otherwise the probe would be 
dimmer. It was a little surprising that there was no change in lysotracker 
staining present between the two different cerebellar genotypes as it had 
previously been reported using these cells that lysotracker fluorescence 
decreases in the cbCln3∆ex7/8 cells, suggesting a elevated pH problem 
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(Cao et al., 2011). However a key difference in this phenotype observed 
between this study and the previous one was that they performed 
lysotracker on fixed cells. When a cell is fixed it results in pores forming in 
all the organelle membranes including lysosomes, causing them to no 
longer be able to maintain their pH gradient. This loss of pH in the fixed 
cells would explain why they observed decreased lysotracker staining in 
the same cell type compared to our findings. 
Lysotracker staining was elevated in the CLN3 fibroblast cells possessing 
the 1kb mutation which would seem to suggest that there is an expansion 
in the lysosomal system in this genotype (perhaps complementary to 
elevated lipids), commonly observed in other lysosomal storage disease 
due to the accumulation of primary and secondary storage products. 
Interestingly the levels of lysosomes detected in the CLN3 D416G 
mutants were similar to that seen in wild type fibroblast cells, which would 
appear to indicate that there is no expansion in the lysosomal system in 
this genotype. Our findings on the levels of cathepsin B and L activity 
showed that there was no difference in the activity of either of these 
enzymes in the cbCln3+/+ or cbCln3∆ex7/8 cells suggesting that there is no 
drastic change in the pH levels of the lysosomes in the Cln3 mutant 
cerebellar cells (figure 5.2). There was however an increase in the activity 
of these two cathepsin enzymes found in the CLN3 1kb and D416G 
mutant cells. As there is an increase in activity of these cathepsin 
enzymes it would suggest that the enzymes in these cells are more 
active, otherwise we would expect to see a drop in the enzymes activity. 
The use of intracellular pH probes (figure 5.12) also showed there was no 
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significant change in the pH levels in Cln3 mutant lysosomes which 
correlates with lack of change in cathepsin activity observed in the two 
cerebellar cell types. 
 
5.8.2 Mitochondrial function 
 
One of the most predominate phenotypes observed across the majority of 
different cell types that possess a mutant CLN3 protein is the 
accumulation of subunit c of mitochondrial ATP synthase in lysosomes, 
which has led people to speculate that there is a problem with 
mitochondrial function in these mutant cells. When analysing the two 
cerebellar cell types there appeared to be no difference in the levels of 
both mitochondrial levels or the amount of mitochondrial produced ROS 
in the cells (figure 5.4). This was surprising as it had previously been 
reported using these same cells that there was an increase in the levels 
of subunit c in these cells, which would suggest a potential mitochondrial 
problem (Cao et al., 2011). The levels of mitochondria produced ROS 
were lower however in both the CLN3 1kb and D416G fibroblast cells. 
The difference observed in the CLN3 mutant fibroblast cells might be due 
to autophagic clearance defects, which do not seem to be present in the 
mutant cerebellar cells.  
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5.8.3 CLN3 mutations increase ER stress 
 
Recent work performed on SH-SY5Y cells has suggested that an 
increase in the levels of CLN3 expression in cells helped reduce the 
levels of ER stress when cells were treated with the ER stress inducing 
agent tunicamycin (Wu et al., 2014). A knockdown in the expression of 
CLN3 resulted in an increase in the levels of ER stress, with elevated 
levels of the pro-apoptotic  CCAAT/-enhancer-binding protein 
homologous protein (CHOP) (Wu et al., 2014).  While there was only a 
marginal increase in the levels of the ER Ca2+ influx channel pump 
SERCA2 in the cbCln3∆ex7/8 cells there did appear to greater ER staining 
present in these cells compared with the cbCln3+/+ cells (figure 5.5). The 
increase in ER staining may be indicative of and increase in ER stress 
(Lindholm et al., 2006). There was an increase in the levels of SERCA2 
present in the CLN3 1kb and D416G mutant cells, which could also be 
indicative of an increase in ER stress. Further work needs to be done to 
determine if down stream activators of ER stress such as CHOP are 
elevated in the CLN3 mutant cells. 
 
5.8.4 Storage of lipids in CLN3 mutant cells 
 
It has already been shown in some studies that there was lipid storage 
occurring in CLN3 mutated lymphoblast cells, suggesting that the 
absence of CLN3 results in disruptions in lipid trafficking and metabolism 
(Rusyn et al., 2008). There was an increase in the levels of LPBA and 
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sphingomyelin in the cbCln3∆ex7/8 when compared with the cbCln3+/+ cells 
(figure 5.6). It has been found that sphingomyelin increases in CLN3 
mutated lymphoblasts possibly due to the accumulation of ceramide, 
reducing sphingomyelin degradation (Kang et al., 2013). This increase in 
sphingomyelin was present also in the CLN3 1kb and D416G mutant 
fibroblast cells, which would suggest that this increase in sphingomyelin 
is present in different mutated CLN3 cell lines. The increase in the 
phospholipid LBPA has not been characterised before in mutant CLN3 
cells, however it has been reported that there are lower levels of LBPA in 
CLN3 disease cells (Hobert and Dawson, 2007). LPBA has been found to 
be localised primarily in the late endosomes and has been speculated to 
be involved in regulating endosomal cholesterol content. Levels of 
endosomal cholesterol were found to decrease when LBPA was 
decreased due to the reduced storage capacity in the endosomal 
compartments (Chevallier et al., 2008). Therefore if LBPA were increased 
we would expect to see an increase of cholesterol in the cell. This was 
not the case with the cbCln3∆ex7/8 cells that had higher LBPA levels as the 
cholesterol levels detected in these cells was the same as that in the 
cbCln3+/+ cells. Interestingly however the levels of LBPA appeared to 
decrease in the CLN3 1kb and D416G mutant fibroblast cells, however 
the cholesterol present in these cells was elevated, particularly in the 
D416G mutant which had the lowest LBPA levels present. This would 
seem to suggest that LBPAs role in controlling the endosomal levels of 
cholesterol are still not fully understood.  
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5.8.5 CLN3 as a Golgi protein? 
 
The localization of the CLN3 protein is still subject to debate in the NCL 
field. Many studies have implicated the presence of CLN3 in the late 
endosomal/lysosomal part of the cell as many studies into JNCL have 
found defects in lysosomal pH, deficiencies in bulk endocytosis as well as 
a defect in autophagosome maturation which requires fusion with 
lysosomes (Cotman and Staropoli, 2012). However some have 
speculated that the CLN3 protein is localized to the Golgi. Work that has 
implicated CLN3s role in the Golgi has primarily been done in S.pombe 
yeast. Recent studies using this yeast model have found that Btn1p 
deletion (Battennin the yeast orthologue of CLN3) results in disruption of 
the Golgi morphology as well as problems in the correct sorting of Golgi 
associated proteins such as the mannose-6-phosphate receptor (Codlin 
and Mole, 2009). Staining with a Golgi marker on the two cerebellar Cln3 
genotypes as well as in the CLN3 1kb and D416G mutant fibroblasts 
revealed that there appeared to be no changes in the morphology of the 
Golgi in these cells (figure 5.7). This would suggest that in these cell 
types the CLN3 protein is not acting on the Golgi. However it would be 
interesting to see if mannose-6-phosphate is mislocalised in these cells, 
to determine if there is a defect in the trafficking of some lysosomal 
enzymes. 
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5.8.6 Changes in metal ion content in cbCln3∆ex7/8 cells 
 
Metal ions have many important roles in the cell such as acting as 
important co-factors for enzymes, however elevated levels have been 
found to induce cellular toxicity (Grubman et al., 2014). Levels of Cu2+ 
and Fe2+ were found to be elevated in cbCln3∆ex7/8 (figure 5.8), which 
supports previous work done that has found elevated levels of these 
metal ions in the brains of Cln3 mutant mice (Grubman et al., 2014). This 
dysregulation in metal ion homeostasis could be due to CLN3s proposed 
role in metal ion transport as it has been found to be similar to the Major 
facilitator superfamily group of transmembrane metal ion transporters. 
 
5.8.7 Elevated rate of endocytic trafficking 
 
Correct endocytic trafficking is important for cells to process, deliver and 
recycle molecules to their correct cellular location. Defects in lysosomal 
function due to the accumulation of lipids or transport problems can result 
in the retardation of endocytic trafficking and the recycling of lipids.  
As the early endosome is the first endocytic organelle found in the 
endocytic pathway we investigated structural components to determine if 
early endosome localisation or levels were different in the CLN3  and 
Cln3 mutant cells (figure 5.9). What was observed was an expansion of 
the early endosomal system in these CLN3 mutant cells which might be 
an indication that these organelles are capable of trafficking a greater 
volume of extracellular molecules along the initial part of the endocytic 
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pathway, or that there is a defect in transport (upregulation). Both a CtxB 
trafficking assay and dextran fusion assay were utilised to determine the 
rate of endocytic trafficking in the CLN3 and Cln3 mutant cells (figures 
5.10 and 5.11). In the cbCln3∆ex7/8 cells there was faster endocytic 
trafficking exhibited. This contradicts some studies which have suggested 
that the loss of CLN3 would result in retarded endocytic trafficking due to 
its proposed close interaction with the Hook1 protein which is important 
for microtubule coordination and interactions with different Rab proteins 
to mediate correct endocytic trafficking (Luiro et al., 2004). Endocytic 
trafficking levels has previously been analysed in the cbCln3∆ex7/8 before 
where slower endocytic trafficking was observed in these cells (Cao et al., 
2011). However the group used FITC-dextran to measure trafficking 
rates, and this dextran is pH sensitive. This pH sensitivity could mean that 
the FITC-dextran was trafficked to lysosomes much faster in the 
cbCln3∆ex7/8 where its fluorescence quenched due to the pH, making it 
appear that there was less endocytic uptake of the fluorescent dextran. 
Despite this there is accelerated endocytic trafficking present in the 
cbCln3∆ex7/8 cells and this has been shown using two different methods. 
There was elevated endocytic trafficking observed in the two CLN3 
mutant cells as well, which implies that the effect of CLN3 mutant is 
conserved in this sense between cerebellar and fibroblast cells. 
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5.8.8 Lysosomal Ca2+ levels in cbCln3∆ex7/8 
 
Ca2+ is an important ion in the cell, and it has an important role to play in 
regulating endocytic trafficking. An example of this would be in the 
lysosomal storage disease NPC1 where low levels of lysosomal Ca2+ 
have been measured which results in defects of late endosomal-
lysosomal fusion. This defect arises due to large amounts of Ca2+ being 
required to mediate the fusion process (Lloyd-Evans and Platt, 2011). 
This loss of efficient fusion causes defects in the endocytic pathway 
leading to slower endocytic trafficking. While Ca2+ has been measured in 
NPC1 lysosomes, no work has been done to quantify the levels of Ca2+ in 
Cln3 mutant cells. Using an intracellular Ca2+ probe to measure 
lysosomal Ca2+ levels there was a significant increase in the lysosomal 
Ca2+ store in cbCln3∆ex7/8 cells. This elevated Ca2+ could potentially be 
responsible for the accelerated trafficking being observed in these cell 
types.  
 
5.8.9 Overview 
 
Our results from this chapter show differences in the phenotypes 
observed between mutant CLN3 in cerebellar and fibroblast cells. This 
highlights the need to study different cell lines of the same disease to 
help further our understanding of the pathogenesis occurring in cells that 
are found in different parts of the body. While some lipids appeared to be 
elevated in in the cerebellar cells, their excess storage may still be 
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downstream of the initial mechanisms that result from Cln3 mutations in 
cerebellar cells. The ER stress observed in the cerebellar cells could 
indicate that this might be a result of Ca2+ homeostasis problem as it is 
the largest Ca2+ store inside the cell and its close interactions with the 
lysosome may go some way as to explaining the increase in lysosomal 
Ca2+ levels. The work done on the fibroblast cells which possess the two 
different CLN3 mutations display more elevation in lipid storage when 
compared with what was seen in cerebellar cells. However, further work 
must be done on the two CLN3 mutants to accurately measure changes 
in lysosomal pH and Ca2+. It should also be noted that the fibroblasts had 
more heterogenous differences, this could possibly be due to them being 
patient fibroblasts, which other gene variations might be present. From 
the initial analysis done on the two CLN3 fibroblasts it would appear that 
the CLN3 1kb mutation produces a more severe phenotype than that 
seen in that seen in the D416G cells. This could possibly be because the 
D416G mutant protein is still getting to its correct cellular location, but its 
function has been impaired by the point mutation in the C-terminus of the 
CLN3 protein.  
Very little has been done in the CLN3 field on cellular Ca2+ level changes. 
With the evidence that suggests that intra-lysosomal Ca2+ is elevated in 
cbCln3∆ex7/8 it was important next to determine if this has a knock on 
effect on other Ca2+ stores found in the cell. Also it is important to 
determine the main cause as to why there is elevated Ca2+ inside 
lysosomes. 
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Chapter 6: Altered homeostasis in intracellular Ca2+ 
stores 
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Noticeable phenotypes observed in the Cln3Δex7/8 cerebellar cells were 
faster endocytic trafficking, thickening of the ER as well as elevated Ca2+ 
levels in the lysosome (Chapter 5 results). The elevated lysosomal Ca2+ 
might explain the other two key phenotypes observed, as there may be 
dysfunction in cellular Ca2+ homeostasis in Cln3Δex7/8 cerebellar cells.   
 
6.1 Ca2+ homeostasis in CLN3 mutant cells 
 
The large levels of lysosomal Ca2+ found in Cln3Δex7/8 cerebellar cells 
would strongly suggest that CLN3 is involved in the regulation of Ca2+ in 
this store. As Ca2+ is a potent cellular messenger that is involved in 
numerous cellular roles including apoptosis (Galione et al., 2014), it is 
important to determine if there are any changes in major Ca2+ stores in 
CLN3 cells.  
Very few studies have looked at cellular changes in Ca2+ levels in CLN3 
mutant cells.  
Work done in human SH-SY5Y cells (precursor neuroblastoma cells) 
utilized siRNA to knock down expression of CLN3 to measure changes in 
total intracellular Ca2+ levels (An Haack et al., 2011). The use of siRNA 
appeared to only partially reduce the expression of the CLN3 protein 
however, suggesting that the siRNA used was not particularly effective. 
The result of siRNA induced CLN3 knock down resulted in an increase in 
intracellular Ca2+ levels observed. However the Ca2+ response after KCl 
induced depolarization was no different than that seen in the wild type 
cells analysed. The study then looked into the use of Ca2+ channel 
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modulators to see if these could correct the elevated intracellular Ca2+ 
levels due to CLN3 depletion. L-type Ca2+ channel inhibitors were chosen 
from the Ca2+ modulators screened, which were amlodipine, flunarizine, 
R(+) Bay K8644, nimodipine, nicardipine and nifedipine. The study 
proceeded to combine all these modulators together and incubated the 
CLN3 depleted cells to determine if this reduces intracellular Ca2+ levels. 
The treatment with multiple different L-type Ca2+ channel inhibitors did 
result in a decrease in the intracellular Ca2+ levels in the CLN3 depleted 
cells. The same group did a follow up study using siRNA to knockdown 
CLN3 levels in primary neurons (Warnock et al., 2013), in an effort to 
replicate an accurate model of the human disease. Knockdown of CLN3 
by siRNA resulted in an elevation in intracellular Ca2+. Cellular membrane 
depolarization with KCL resulted in a significant increase in intracellular 
Ca2+ levels, however this elevation was abolished with the addition of 
amlodipine.  
This study highlights the potential use of L-type Ca2+ inhibitors to treat 
intracellular Ca2+ abnormalities that may occur in Cln3Δex7/8 cerebellar 
cells. But this also illustrates the difference in cell type with no KCl effect 
in SH-SY5Y cells, showing the importance for using suitable cells. 
Another study has previously suggested that the CLN3 protein interacts 
with the pro-apoptotic protein calsenilin, a neuronal Ca2+ binding protein 
(Chang et al., 2007). Calsenilin binds to the C-terminus of presenilin 1 
and 2 proteins and acts as a transcription repressor in the ER (Carrion et 
al., 1999). Calsenilin is believed to regulate diverse Ca2+ mediated 
signals, where it is involved in sensitizing neuronal cells to Ca2+ induced 
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apoptosis (Lilliehook et al., 2002). CLN3 protein was found to interact with 
calsenilin via a yeast two-hybrid yeast system, and it was speculated that 
CLN3 plays an anti-apoptotic role in the cell as a decrease in CLN3 levels 
and an increase in calsenilin levels resulted in increased apoptosis 
(Chang et al., 2007). While the mechanisms on how CLN3 interaction 
with calsenilin is involved in the regulation of apoptosis remains unknown, 
it has been suggested that mutations in CLN3 result in the mutant CLN3 
protein accumulating in the ER. The accumulation of the mis-trafficked 
protein may then induce ER stress, leading to dysregulation of the ER 
Ca2+ store and an increase in Ca2+ induced apoptosis (Chang et al., 
2007).  
The suggestion that CLN3 mutant proteins accumulate in the ER, 
inducing an increase in ER stress was further explored in a study that 
utilizes the ER stress inducing agent, tunicamycin (Wu et al., 2014). The 
ER stress response is a highly conserved function, which results in pro-
apoptotic signals being released from the ER due to the unfolded protein 
response (Smith et al., 2011). ER stress response mediated apoptosis 
has previously been reported in CLN3 mutant cells (Galizzi et al., 2011). 
Short hairpin RNAs were treated to SH-SY5Y cells to knockdown CLN3 
expression. ER stress was then induced with tunicamycin, and this 
resulted in an increase in apoptotic cells. Overexpression of CLN3 
resulted in a greater resistance to tunicamycin induced ER stress 
response, suggesting a role in suppressing Ca2+ induced apoptosis via 
the ER stress response pathway (Wu et al., 2014).  
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6.2 The role of CLN3: A lysosomal Ca2+ leak channel? 
 
CLN3 has been found to have similarity with the major facilitator 
superfamily group of ion transporters (Pao et al., 1998). Because of this 
similarity and several studies implicating lysosomal pH irregularities in 
CLN3 mutant cells it is possible that CLN3 is pH regulated or H+ 
permeant. Although our data suggests that there is no difference in pH in 
Cln3Δex7/8 cerebellar cells when compared with wild type cells (results 
chapter 5). 
The accelerated endocytic trafficking observed and the elevated 
lysosomal Ca2+ is similar to phenotypes seen in another lysosomal 
storage disease, mucolipidosis type IV (MLI V). TRPML1 (transient 
receptor potential cation channel 1) is the protein affected in MLIV and it 
is believed to be a Ca2+ leak channel located on the late endosome 
membrane, with the protein also believed to be pH sensitive so that it is 
only active in the late endosome (LaPlante et al., 2002). Other Ca2+ leak 
channels have been implicated in indirectly affecting lysosomal function, 
such as presenilin 1 (associated in familial Alzheimer’s disease) (Lee et 
al., 2010).  
CLN3 is strongly linked in being protective against apoptosis, similar to 
the function of another anti-apoptotic protein known as Bax inhibitor 1 (Bi-
1).  
Bi1 itself is a member of the highly conserved Transmembrane Bax 
Inhibitor-1 containing motif proteins (TMBIM) (Bultynck et al., 2012). BI-1 
has recently been found to be an important factor in controlling ER 
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induced apoptosis via lowering the Ca2+ content of the ER. The Bi-1 
protein has been found to possess a pH sensitive domain within its last 9 
amino-acids, which supports the evidence that this protein acts as a 
H+/Ca2+ antiporter where protons from the cytosol are pumped into the 
ER lumen in exchange for the release of ER Ca2+ to alleviate ER stress. 
The Ca2+ releasing domain was found to be on the C-terminus of the Bi-1, 
and the key residue was discovered to be an aspartic acid, which when 
changed to a glycine didn’t release Ca2+ (Bultynck et al., 2012). 
The topology of Bi-1 and CLN3 are very similar, as they both have 6 
transmembrane domains, with the C-terminus of both proteins facing out 
into the cytosol (Bultynck et al., 2012, Mao et al., 2003). The C-terminus 
has also been suggested to transiently be in one of either two 
configurations where it is either embedded in the membrane or out into 
the cytosol (Mao et al., 2003). These two potential configurations may 
suggest that the orientation of the C-terminus of either protein changes 
when the protein becomes active. The similarities in the topology of Bi-1 
and CLN3 as well as their suggested roles in protection against apoptosis 
warrants further investigation into a potential overlap of function. Recent 
work has found that Bi1 shares homology with a bacterial membrane 
transporter found in the bacteria Bacillus Subtillis called YetJ which has 
been found to be pH regulated and involved in Ca2+ transport across 
membranes (Chang et al., 2014). The YetJ protein does appear to have 
similarities with that of major facilitator superfamily, which could indicate, 
conserved functions present in YetJ, Bi-1 and the CLN3 protein. 
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As mentioned earlier, Bi-1 belongs to the TMBIM family of proteins which 
also include a Golgi protein called GAAP (Golgi anti-apoptotic protein). 
This may have some similarities with the CLN3 yeast orthologue Battenin. 
 
6.3 Overview 
 
The role of Ca2+ has not been characterized in CLN3 disease 
pathogenesis. The elevated Ca2+ seen in Cln3Δex7/8 lysosomes could 
suggest that CLN3 is involved in regulating Ca2+ in the lysosome, 
possibly by leak. The similarities between CLN3 and Bi1 structure could 
possibly reveal CLN3’s true role in the cell, and these possible similarities 
will be explored. CLN3’s role in conferring resistance to the ER stress 
response will also be explored as it is possible that the mutant Cln3 
protein in the cerebellar cells are stuck in the ER contributing to an 
increase in ER stress. 
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6.4 Results 
 
Our previous work measuring intra-lysosomal Ca2+ levels showed 
elevated lysosomal Ca2+ in the Cln3∆ex7/8 cerebellar cells. Ca2+ 
dysregulartion may result in pathogenic mechanisms that give rise to 
CLN3 phenitypes so it is important to determine the regulation and 
storage of Ca2+ in these cells. 
 
6.4.1 Baseline cytosolic Ca2+ levels 
 
Resting baseline levels of Ca2+ was measured to determine if there is an 
elevated resting Ca2+ level in the Cln3∆ex7/8 cerebellar cells. 
Figure 6.1: This was analysed in both cbCln3+/+ and cbCln3∆ex7/8 cells. No 
difference was found in the resting cytosolic Ca2+ levels between cbCln3+/+ and 
cbCln3∆ex7/8 cells. Values represent mean ± SD, n=10, P >0.05, >200 cells 
analysed. 
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Baseline, unstimulated, Ca2+ levels of the cytosol were analysed and the  
observed in the cytosolic Ca2+ levels between cbCln3+/+ and cbCln3∆ex7/8 
cells over multiple different experiments. This would indicate that any 
changes observed in intracellular Ca2+ observed in cbCln3∆ex7/8 cells are 
likely to arise in defects from the major Ca2+ stores in the cell. 
 
6.4.2 Ca2+ responses in cbCln3+/+ and cbCln3∆ex7/8 cells treated with 
sub-inhibitory 0.1µM Thapsigargin 
 
As there was no difference in the resting Ca2+ levels in the cells, there 
may be a difference in the Ca2+ content of the different organelles. The 
ER is the largest Ca2+ store in the cell, so its Ca2+ content was measured 
using the drug Thapsigargin. Thapsigargin is a SERCA pump inhibitor 
that causing the release of ER Ca2+ by preventing Ca2+ uptake into the 
ER, thus causing a Ca2+ gradient difference across the ER membrane. 
0.1µM thapsigargin is a sub-inhibitory concentration of thapsigargin so it 
should not induce a large ER Ca2+ release. 
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Figure 6.2: (A) Significantly higher levels of ER Ca2+ release was observed in 
the cbCln3∆ex7/8 cells when compared with cbCln3+/+ cells. (B) Significantly more 
cells responded to the low levels of thapsigargin in the cbCln3∆ex7/8 when 
compared to the cbCln3+/+ cells. (C) cbCln3∆ex7/8 cells have significantly more ER 
Ca2+ release events when compared to cbCln3+/+ cells. (D) Averaged traces 
from one representative experiment from which the data from (A), (B) and (C) 
were analysed. 2µM Ionomycin was added at the end of the experiment to show 
the cells were still alive. Values represent mean ± SD n=4, >60 cells analysed. 
*s denotes Significant (A) P<0.05 (B) P<0.01 (C) P<0.05. 
 
Significantly elevated levels of Thapsigargin induced ER Ca2+ release 
were observed in cbCln3∆ex7/8 cells when compared with cbCln3+/+ cells 
(figure 6.2 (A)). Despite the cells being treated with sub-inhibitory levels 
of thapsigargin, there was ~50% greater release seen from the ER Ca2+ 
store in the mutant compared to the cbCln3+/+ cells (figure 6.2 (A)). Also 
! 226!
~80% of cbCln3∆ex7/8 cells responded to thapsigargin addition compared 
to ~10% of cbCln3+/+ cells indicating that they are more sensitive to 
thapsigargin at a low levels (figure 6.2 (B). The cbCln3∆ex7/8 cells that did 
release Ca2+ also seemed to undergo a greater number of Ca2+ release 
events from the ER (~3 events on average) when compared with the few 
cbCln3+/+ cells that did respond only having a single Ca2+ release event 
(figure 6.2 (C)). 
 
6.4.3 Ca2+ responses in cbCln3+/+ and cbCln3∆ex7/8 cells treated with 
1µM Thapsigargin 
 
A higher concentration of thapsigargin was added to cells to detect ER 
Ca2+ release when the concentration of thapsigargin has a greater 
inhibitory effect. 
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Figure 6.3: (A) Significantly higher levels of ER Ca2+ release were observed in 
the cbCln3∆ex7/8 cells when compared with cbCln3+/+ cells. (B) The same amount 
of cbCln3+/+ and cbCln3∆ex7/8 cells responded to thapsigargin treatment. (C) 
Averaged data from one experiment to illustrate a reduction in the difference in 
level of Ca2+ released between cbCln3+/+ and cbCln3∆ex7/8 cells and that there is 
now only a single Ca2+ event observed following 1µM thapsigargin treatment in 
both cell types. 2µM Ionomycin was added at the end of the experiment to show 
the cells were still alive. Values represent mean ± SD, n=3, >50 cells analysed. 
*s denotes Significant (A) P<0.01 (B) P>0.05. 
 
Treating both cell types with 1µM thapsigargin results in ~25% more Ca2+ 
being released from the ER in the cbCln3∆ex7/8 when compared with the 
cbCln3+/+ cells (figure 6.3). The difference in the amount of Ca2+ being 
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released from the two cell types is lower than with 0.1µM thapsigargin 
(figure 6.2). Again, unlike the previous experiment, the same percentage 
of cells responded to 1µM thapsigargin in the two cell types showing that 
this concentration of thapsigargin is ample for eliciting a Ca2+ response in 
most cbCln3+/+ cells. Also only one Ca2+ release event was observed in 
both cell types, indicating that this concentration causes significant Ca2+ 
release from the ER Ca2+ store in the two cell types to the extent that no 
further spontaneous events are observed. 
 
6.4.4 Ca2+ response in cbCln3+/+ and cbCln3∆ex7/8 cells treated with 
2µM Thapsigargin 
 
An optimum inhibitory concentration of thapsigargin was added to cells to 
detect ER Ca2+ release. 
 
Figure 6.4: (A) Similar levels of ER Ca2+ release was observed in both cell types 
post 2µM thapsigargin treatment. (B) All cells from both cell types responded to 
2µM thapsigargin treatment. Values represent mean ± SD, n=4, >60 cells 
analysed. (A) P>0.05 (B) P>0.05 
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Treating cbCln3+/+ and cbCln3∆ex7/8 cells with 2µM Thapsigargin resulted 
in all observed cells responding. The same amount of Ca2+ was also 
released from the ER store in the two cell types. This data shows that 
while 1µM thapsigargin is enough to completely empty the ER Ca2+ store 
in cbCln3∆ex7/8 cells (figure 6.3), cbCln3+/+ cells require 2µM thapsigargin 
to completely empty their ER Ca2+ store.  
 
6.4.5 Store operated Ca2+ intake into the cells post ER clamping with 
1µM Thapsigargin 
 
Emptying of the ER Ca2+ store with thapsigargin leads to the requirement 
by the cell to refill the depleted store, this occurs via the action of the 
STIM1 and Orai channels that control store operated Ca2+ entry. 
Figure 6.5: (A) Significantly lower levels of store operated Ca2+ intake was 
observed in cbCln3∆ex7/8 cells post ER clamping with 1µM thapsigargin treatment 
when compared with cbCln3+/+ cells. (B) Similar levels of cells from both cell 
types responded to store operated uptake of Ca2+ into the cell. Values represent 
mean ± SD, n=3, >60 cells analysed. *S denotes significant (A) P<0.0001. (B) 
P>0.05. 
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When thapsigargin is added in the absence of extracellular Ca2+, store 
operated Ca2+ entry does not occur as there is no extracellular Ca2+ to be 
transported into the cell. Subsequent addition of 1mM Ca2+ outside the 
cell leads to the influx that can be measured (figure 6.5). Under these 
conditions we observed >50% increase in the amount of Ca2+ being 
brought back into the cell following ER Ca2+ store depletion in the 
cbCln3+/+ cells compared to cbCln3∆ex7/8 cells (figure 6.5). While the 
percentage of cells that underwent store operated Ca2+ re-entry was 
similar in both cell types, the lower amount of Ca2+ uptake seen in the 
cbCln3∆ex7/8 would indicate these cells either have defective store 
operated Ca2+ entry or have adjusted their response to reflect other 
alterations in cellular Ca2+ homeostasis. 
 
6.4.6 Mitochondrial Ca2+ release following 10µM Rotenone treatment 
 
Rotenone is a drug that induces Ca2+ release from the mitochondria by 
causing depolarization of the mitochondrial membrane by interfering with 
the mitochondria electron transport chain. 
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Figure 6.6: (A) Significantly lower levels of mitochondrial Ca2+ release was 
observed in cbCln3∆ex7/8 cells than in cbCln3+/+ cells following the addition of 
10µM Rotenone. (B) cbCln3∆ex7/8 cells were less responsive to the addition of 
Rotenone as few cells responded when compared with cbCln3+/+ cells. Values 
represent mean ± SD, n=3, >50 cells analysed. *S denotes significant (A) 
P<0.001. (B) P>0.05. 
 
Interestingly, cbCln3∆ex7/8 cells were less responsive to rotenone as a 
whole when compared with cbCln3+/+ cells. The cbCln3∆ex7/8 cells that did 
respond released significantly lower levels of Ca2+ from their mitochondria 
than what was observed in the cbCln3+/+ cells (figure 6.6). This would 
suggest that cbCln3∆ex7/8 mitochondria are less able to maintain their 
membrane potential, resulting in lower levels of Ca2+ being stored.  
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6.4.7 Lysosomal Ca2+ content following the addition of 200µM GPN 
 
Using the lysosomotrophic agent GPN we were able to measure the 
lysosomal Ca2+ content in both cbCln3+/+ and cbCln3∆ex7/8 cells. This was 
done to determine if the lysosome Ca2+ content was elevated in the 
cbCln3∆ex7/8 cells as what was observed when using the intra-lysosomal 
Ca2+ probe Oregon Green-BAPTA. 
Figure 6.7: By using the lysosomtrophic peptide GPN, greater levels of Ca2+ was 
detected in cbCln3∆ex7/8 lysosomes when compared with cbCln3+/+ lysosomes. 
Values represent mean ± SD, n=4, >50 cells analysed. *S denotes significant, 
P<0.0001. 
 
Using the lysosomotrophic agent GPN we were able to measure the 
lysosomal Ca2+ content in both cbCln3+/+ and cbCln3∆ex7/8 cells. The ER 
Ca2+ content was first clamped by the addition of 2µM thapsigargin so as 
to not mask the lysosomal Ca2+ levels post GPN addition as lysosomal 
Ca2+ release often induces Ca2+ release from the ER. Post clamping of 
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the ER, the addition of GPN revealed that the Ca2+ content of cbCln3∆ex7/8 
lysosomes was significantly higher than the cbCln3+/+ lysosomes (>60%). 
This result recapitulates our earlier data (Chapter 5, figure 5.12) where 
we used intracellular Ca2+ probes to measure lysosomal Ca2+ levels 
which indicated there was higher Ca2+ levels present in cbCln3∆ex7/8 
lysosomes than in cbCln3+/+ lysosomes. 
 
6.4.8 : Lysosomal Ca2+ induced Ca2+ release from other cellular Ca2+ 
stores following the addition of 300µM GPN in the absence of any 
other Ca2+ agonist to clamp the intracellular stores 
 
The release of Ca2+ from lysosomes has been shown to induce Ca2+ from 
other stores in the cell; primarily from the ER due to the close contact 
points the ER and lysosomes have inside the cell. 
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Figure 6.8: (A) Lysosomal Ca2+ release induces the release of other Ca2+ stores, 
predominantely from the ER due to the close contact points between the 
lysosome and ER. Significantly greater levels of Ca2+ release were detected in 
the cbCln3∆ex7/8 cells compared with cbCln3+/+cells. (B) A greater amount of Ca2+ 
release events was observed in the cbCln3∆ex7/8 cells than in the cbCln3+/+ cells. 
Values represent mean ± SD, n=1, >20 cells analysed. *S denotes significant, 
(A) P<0.001. 
 
GPN induced lysosomal Ca2+ along with the release of Ca2+ from other 
stores (which were not clamped in this experiment) resulted in a 
significantly greater level of Ca2+ release in the cbCln3∆ex7/8 cells when 
compared to cbCln3+/+ cells (figure 6.8). Lysosomal Ca2+ release following 
GPN addition where the other Ca2+ stores are not clamped produces a 
greater Ca2+ release observed than when the other stores are clamped 
before the addition of GPN (figure 6.7). This is due to Ca2+ from other 
stores other than the lysosome. Interestingly, we observed multiple 
spontaneous Ca2+ release events (~2-3 on average) witnessed in the 
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cbCln3∆ex7/8 cells after an elevated Ca2+ release, however only a single 
release event was seen in the cbCln3+/+ cells. 
 
6.4.9 Enhanced NAADP mediated Ca2+ release from cbCln3∆ex7/8 cells 
can be inhibited by the TPC channel inhibitor Ned19 
 
NAADP has been found to be a potent Ca2+ messenger molecule that 
specifically induces Ca2+ release from lysosomes by acting on the  
lysosomal membrane TPC2 channel.
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Figure 6.9: (Ai) Representative traces of the difference in NAADP mediated Ca2+ 
response following clamping of the ER Ca2+ store with 2µM Thapsigargin. (Aii) 
Levels of Ca2+ release from the ER in cbCln3+/+ and cbCln3∆ex7/8 cells. (Aiii) 
Amount of Ca2+ release observed between the two cell types following the 
addition of 500nM NAADP-AM. (AiV) Number of Ca2+ release events seen in 
cells following the addition of 500nM NAADP-AM in the two cell types. (Bi) 
Graph to illustrate the difference in 500nM NAADP-AM Ca2+ mediated response 
between the two cell types when the ER Ca2+ store has not been clamped. (Bii) 
Level of initial Ca2+ release observed in the two cell types after 500nM NAADP-
AM addition without pre clamping of the ER store. (Biii) Number of Ca2+ release 
events observed in the two cell types following the addition of NAADP-AM. (BiV) 
Changes in the resting cytosolic Ca2+ level post NAADP-AM addition to the two 
cell types. (Ci) Ned19 blocks NAADP mediated Ca2+ release from the lysosomal 
TPC channels. Representative trace to show the dampening of the NAADP-AM 
Ca2+ release in the two cell types after the cells are pre-treated for 5minutes with 
5µM Ned19. (Cii) Initial Ca2+ release from cells pre-treated with 5µM NED19. 
(Ciii) Number of Ca2+ release events seen in pre-treated Ned19 cells post 
NAADP-AM addition. (CiV) Changes in the resting cytosolic Ca2+ levels following 
the addition of NAADP-AM to pre-treated Ned19 cells. Values represent mean ± 
SD, n=2 
 
By first clamping the ER Ca2+ store with 2µM thapsigargin, the addition of 
500nm membrane permeant NAADP-AM resulted in a much greater 
release (5 fold) of Ca2+ from the cbCln3∆ex7/8 cells than in the cbCln3+/+ 
cells (figure 6.9 (Aiii)). This would indicate that there is a greater Ca2+ 
release from the lysosome as well as other organelle Ca2+ stores, other 
than the ER in the cbCln3∆ex7/8 cells when compared with cbCln3+/+ cells. 
The number of Ca2+ release events exhibited in the two genotypes was 
the same (figure 6.9 (Aiv)) despite more Ca2+ release in the cbCln3∆ex7/8 
cells. When the ER Ca2+ store is not first clamped prior to the addition of 
NAADP-AM we see a different response in the cells.  
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A similar amount of Ca2+ is released from cbCln3∆ex7/8 cells as was 
observed when the ER Ca2+ store had been clamped. However, a greater 
amount of Ca2+ was released in the cbCln3+/+ cells without ER clamping 
than with ER clamping prior to the addition of NAADP-AM (figure 6.9 (Aiv) 
and (Biii). This would suggest that adding NAADP-AM to the cells by itself 
is triggering subsequent ER Ca2+ release in response to lysosomal Ca2+ 
release in the cbCln3+/+ cells. Interestingly the number of Ca2+ events 
observed was greater in the cbCln3∆ex7/8 cells (~10) than what was seen 
in the cbCln3+/+ cells (~4) when only NAADP-AM is added. As well it is 
important to note that following the addition of NAADP-AM there is over a 
100% increase in the baseline cytosolic Ca2+ level in cbCln3∆ex7/8 cells 
when compared with cbCln3+/+ cells, associated with a failure to return to 
normal baseline cytosolic Ca2+ levels (figure 6.9 (Biv)). This suggests the 
potential for higher levels of cytotoxicity occurring in the CLN3. The pre-
treatment with 5µM Ned19 blocks NAADP mediated Ca2+ release via the 
lysosomal TPC channels. This inhibitory effect is evident as there is a 
greatly diminished Ca2+ release in the cbCln3∆ex7/8 cells to the point that 
they release less Ca2+ following NAADP-AM addition than the cbCln3+/+ 
cells (figure 6.9 (Cii)). The cbCln3+/+ cells also release less Ca2+ following 
pre-treatment with Ned19, but the reduction in NAADP release is not as 
profound as it is in cbCln3∆ex7/8 cells. However, while cytosolic Ca2+ levels 
only increase marginally in Ned19 treated cells following NAADP-AM 
addition, it does not go back to original levels (figure 6.9 (Civ)). This 
experiment also shows that lysosomal Ca2+ release via a secondary 
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messenger is tolerated, and is therefore not the cause of elevated 
lysosomal Ca2+. 
 
6.4.10 Ca2+ induced apoptosis in cbCln3∆ex7/8 cells following NAADP-
AM addition 
 
We next looked at whether the elevated cytosolic Ca2+ levels was 
cytotoxic. Fura 2 probe was used as a vital stain to indicate the cells have 
not undergone necrosis as they retain the probe (not blebbing), and as a 
way to visualize cellular architecture. 
AnnexinA5 (AnxA5) was used as a marker for cells undergoing apoptosis. 
This is through it binding to phosphatidylserine (PS), a lipid that usually 
resides on the inner leaflet of the plasma membrane. When apoptosis is 
triggered, it flips to the extracellular surface and is one of the earliest 
events in the apoptotic cascade. Annexin A5 is a Ca2+ dependent PS 
binding protein, in the presence of Ca2+, and provided the cells are not 
necrotic, it will only bind apoptotic cells where PS has flipped. 
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Figure 6.10: (A) Representative pictures of cbCln3∆ex7/8  cells undergoing 
apoptosis after the addition of NAADP. This was also done on cells that were 
pre-treated with 5µM NED19 prior to the addition of NAADP, and the levels of 
apoptosis in both cell types were observed using the AnxA5 stain. (B) Counts 
done of the % of cells undergoing Annexin5 mediated apoptosis in both cell 
types following the addition of NAADP with or without NED19 pre-treatment. 
Values represent mean ± SD, n=2. 
  
 
Following the addition of NAADP-AM to both cbCln3+/+ and cbCln3∆ex7/8 
cells their Ca2+ responses were measured. The cells were then stained 
with the AnxA5 probe. There was a 8-fold increase in the amount of 
apoptosis triggered in the cbCln3∆ex7/8 cells when compared with when 
they were untreated with NAADP-AM (figure 6.10 (A) and (B)). There was 
a 8-fold increase in the number of observed cells undergoing apoptosis in 
the cbCln3∆ex7/8 cells post NAADP-AM addition than there was in the 
NAADP treated cbCln3+/+. This indicates that there is excitotoxic Ca2+ 
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induced trigger of apoptosis following release due to NAADP-AM induced 
lysosomal Ca2+ release from cbCln3∆ex7/8 cells. This Ca2+ induced 
apoptosis was not observed in the cbCln3+/+ cells though, indicating they 
are capable of maintaining Ca2+ homeostasis following NAADP-AM 
induced Ca2+ release (figure 6.10 (A) and (B)).  
There is a drastic reduction in the levels of apoptotic cbCln3∆ex7/8 cells 
present when these cells have been pre-treated with Ned19 as the 
percentage of cells undergoing apoptosis are now similar levels to what is 
observed in cbCln3∆ex7/8 untreated cells (figure 6.10 (B)). The blocking of 
Ca2+ release from the lysosomal TPC2 channels via Ned19 would seem 
to suggest that this is an effective means of blocking NAADP-AM induced 
cellular toxicity, further supporting that it is Ca2+ induced apoptosis rather 
than necrosis. Surprisingly there was a three-fold increase in the number 
of cbCln3+/+ cells undergoing apoptosis when compared with untreated 
and NAADP-AM treated cbCln3+/+ cells, when the cells were pre-treated 
with Ned19 and the addition of NAADP-AM, indicating that the blocking of 
the TPC2 lysosomal Ca2+ release channel is detrimental to cellular 
viability in healthy cells. 
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6.4.11 5µM glutamate induced Ca2+ release from cbCln3+/+ and 
cbCln3∆ex7/8 cells 
 
Glutamate is an important neurotransmitter that has been found to have 
important roles in Ca2+ signaling in neuronal cells, including triggering the 
generation of NAADP in neurons. 
 
 
Figure 6.11: (A) A significantly greater amount of Ca2+ was released after the 
addition of glutamate in the cbCln3∆ex7/8 cells when compared with cbCln3+/+ 
cells. (B) cbCln3∆ex7/8 cells undergo a greater number of Ca2+ release events 
when compared with cbCln3+/+ cells. (C) Traces of Ca2+ response in cbCln3+/+ 
and cbCln3∆ex7/8 after the addition of Glutamate. Values represent mean ± SD, 
n=1, >20 cells analysed. *S denotes significant, (A) P<0.0001. (B) P<0.0001. 
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A greater Ca2+ response was seen in the cbCln3∆ex7/8 cells as well as 
multiple Ca2+ release events occurred when compared with cbCln3+/+ 
cells (figure 6.11) in a manner similar to NAADP-AM (figure 6.9). 
Interestingly, despite cbCln3∆ex7/8 cells seemingly having greater 
sensitivity to glutamate, exhibited by the greater Ca2+ release and 
multiple Ca2+ release events, few cells responded to glutamate in the 
mutant cells than the cbCln3+/+ cells where every cell analysed responded 
(Data not shown). However the data is only preliminary, as the 
experiment has not been repeated, therefore requires repeating before 
any conclusions can be made. 
  
6.4.12 Nifedipine, an L-type Ca2+ channel inhibitor and weak 
antagonist to TPC2, partially blocks NAADP mediated Ca2+ release 
and rescues cbCln3∆ex7/8 cells from excitoxic cell death 
 
Nifedipine is an FDA approved drug that acts by blocking L-Type Ca2+ 
channels, a family to which the lysosomal TPC channel belongs to. 
Nifedipine may be able to inhibit the excess Ca2+ signalling present in 
cbCln3∆ex7/8 cells following Ca2+ release from the TPC2 channels after 
NAADP treatment. 
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Figure 6.12: (Ai) Ca2+ traces to illustrate the release of Ca2+ in pre-treated 
nifedipine cells following the addition of NAADP. (Aii) Levels of NAADP induced 
Ca2+ release from both cbCln3+/+ and cbCln3∆ex7/8 cells. (Aiii) The number of Ca2+ 
release events observed following the addition of NAADP in the two cell types. 
(B) The percentage of apoptotic cells counted in both cbCln3+/+ and cbCln3∆ex7/8 
nifedipine treated cells following the addition of NAADP using the AnxA5 probe. 
Values represent mean ± SD, n=1. 
 
The pre-treatment of 10µM Nifedipine before the addition of NAADP-AM 
resulted in a similar sustained release of Ca2+ in both the cbCln3+/+ and 
cbCln3∆ex7/8 cells (figure 6.12 (Ai)). There were no spontaneous Ca2+ 
release events observed in the nifedipine treated cells following NAADP-
AM addition. Importantly, the cytosolic Ca2+ levels were also returning to 
baseline levels. This return to normal cytosol Ca2+ levels as well as no 
spontaneous Ca2+ release events may be why no Ca2+ induced apoptosis 
was triggered, as the number of apoptotic cells observed in both cell 
types was similarly low (~10% (figure 6.12). This is again only preliminary 
data, and more repeats are required before any conclusions can be 
made. 
 
6.4.13 Overnight treatment with Ned19 causes increased lysosomal 
Ca2+ in cbCln3∆ex7/8 cells but not cbCln3+/+ cells 
 
Having shown that Ned19 is capable of inhibiting NAADP mediated Ca2+ 
release from lysosomal TPCs in cbCln3∆ex7/8 cells (figure 6.9 (Cii)) we 
utilised a long term treatment with this inhibitor to determine the effects 
on lysosomal Ca2+ content. 
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Figure 6.13: Cells were treated with 2µM Ionomycin before the addition of GPN 
to clamp the other cellular Ca2+ stores (A) levels of lysosomal Ca2+ content using 
200µM GPN following an overnight treatment of 5µM Ned19 in cbCln3+/+ and 
cbCln3∆ex7/8 cells (B) Ca2+ traces to highlight the difference in lysosomal Ca2+ in 
the two cell types. Values represent mean ± SD, n=2, >20 cells analysed. *S 
denotes significant, P<0.0001. 
 
By treating the cells with 5µM Ned19 overnight it should block Ca2+ 
release from the TPC channels on the lysosome. As this is blocked the 
lysosome would have to use a Ca2+ leak channel to maintain its Ca2+ 
homeostasis otherwise the Ca2+ content inside the lysosome would only 
increase as it presumably continuously pumps in more Ca2+. By using 
GPN to measure the Ca2+ content of the lysosome following overnight 
treatment of Ned19 and the clamping of other intracellular Ca2+ stores 
using ionomycin, the lysosomal Ca2+ levels inside cbCln3∆ex7/8 lysosomes 
was significantly higher than what was seen in cbCln3+/+ lysosomes 
(figure 6.13 (A) and (B)). The lysosomal Ca2+ content in cbCln3+/+ cells 
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was similar in level to untreated Ned19 cbCln3+/+ cells (figure 6.7), 
suggesting that despite the major Ca2+ release channel of the lysosome 
(TPC) being blocked they are still able to maintain their lysosomal Ca2+ 
homeostasis, possibly via a leak channel. The lysosomal Ca2+ content of 
NED19 treated cbCln3∆ex7/8 cells increased by ~50% when compared with 
the Ca2+ content of untreated cbCln3∆ex7/8 lysosomes (figure 6.7). This 
would suggest that cbCln3∆ex7/8 cells are unable to leak out lysosomal 
Ca2+ unlike cbCln3+/+ lysosomes. 
 
6.4.14 Alignment of the CLN3 C-terminus  
 
Sequence alignment done on the C-terminus of the CLN3 protein and the 
Ba inhibitor 1 protein as well as the bacterial YetJ protein display high 
levels of similarity when the C-terminus of these proteins are aligned. 
Figure 6.14: Sequence alignment of the C-terminus of the bacterial YetJ, Bax 
inhibitor 1 and CLN3 protein. 
 
The arrow denotes the key aspartate residue (D) that has been found to 
release Ca2+ in the Bax inhibitor protein. Peptides were designed to 
match the key residues of the C-terminus of the CLN3 protein, to detect if 
this was capable of releasing Ca2+. A mutant peptide was also designed 
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where the aspartate had been changed to a glycine to see if this 
abolishes any potential Ca2+ release via the use of this peptide.  
 
6.4.15 Using CLN3 C-terminal peptides to reduce cbCln3∆ex7/8 
lysosomal Ca2+ levels following long term NED19 treatment 
 
cbCln3∆ex7/8 cells were treated overnight with 5µM NED19 to induce 
elevated levels of lysosomal Ca2+ levels as seen in figure 6.13. 
 
Figure 6.15: 24 hour Ned19 treated cbCln3∆ex7/8 cells are loaded with fura2-AM 
followed by a 20 minute incubation with either the wild type or mutant CLN3 
CTP. Lysosomal Ca2+ levels were then measured using GPN post clamping of 
other Ca2+ stores with ionomycin. Lysosomal Ca2+ is reduced following a 20 
minute incubation with wild type CLN3 CTP, but not with the mutant CLN3 CTP. 
n=1 
 
cbCln3∆ex7/8 cells were treated overnight with 5µM NED19 to induce 
elevated levels of lysosomal Ca2+ levels as seen in figure 6.13. Cells 
!
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were loaded with 50µM peptide and incubated for 20 minutes to allow 
time for the peptide to be taken up into the cell and be delivered to the 
late endosome/lysosome. The cells were then treated with 2µM 
ionomycin to clamp other cellular Ca2+ stores before the addition of 
200µM GPN to measure lysosomal Ca2+ content. The addition of the 
CLN3 CTP causes multiple spontaneous Ca2+, and following the addition 
of GPN there was a large reduction in the levels of Ca2+ stored inside the 
lysosome (figure 6.15). The D416G (mutant) CTP did not display 
spontaneous Ca2+ release events and following the addition of GPN we 
observed that cells treated with mutant CTP still had a large lysosomal 
Ca2+ store. This shows that the D416G CTP cannot rescue the elevated 
lysosomal Ca2+ levels, unlike the CLN3 CTP. 
While this is preliminary data it suggests that the wild type CTP is capable 
of alleviating the elevated lysosomal Ca2+ levels, but the mutant peptide 
is not. More repeats will be needed to back up this preliminary data. 
 
6.4.16 Measuring CTP induced leak using intra-lysosomal Ca2+ 
probes 
 
The ability of the CLN3 CTP to induce lysosomal Ca2+ was measured 
with the use of the intra-lysosomal Ca2+ probe Oregon green BAPTA-1. 
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Figure 6.16: Oregon green BAPTA is used as an intracellular lysosomal Ca2+ 
probe, while TRITC-red dextran was used as a loading control. The Addition of 
the CLN3 CTP, but not the CLN3 mutant CTP induces lysosomal Ca2+ leak in 
both cell types. n=1 
 
Both cbCln3+/+ and cbCln3∆ex7/8  cells are co-incubated with the Ca2+ 
probe Oregon green BAPTA-1 and Texas red dextran at 37°C for 6hrs so 
we are able to measure intra-vesicular lysosomal Ca2+ levels. cbCln3∆ex7/8 
cells were incubated for 20 minutes with 50µM of the CLN3 mutant CTP 
to allow trafficking of the peptide to the lysosome. After incubation no 
Ca2+ release was observed in the cells after 20 minutes the cells were 
treated with 50µM of the wild type CLN3 CTP and left for the peptides to 
be trafficked to the lysosome. After a short time there was a reduction in 
the levels of intra-lysosomal Ca2+ detected inside the lysosomes, 
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indicating that Ca2+ was leaking out of the lysosome into the cytosol 
(figure 6.16). A similar response was observed in cbCln3+/+ cells after the 
addition of the CLN3 CTP, but the drop in intra-lysosomal Ca2+ was not 
as high as what was seen in the cbCln3∆ex7/8 cells. Microscopy pictures 
highlight high Oregon green BAPTA-1 staining in cbCln3∆ex7/8 lysosomes 
prior to the addition of the CLN3 CTP, Texas Red dextran was used as a 
loading control to show that Oregon green BAPTA-1 was measuring 
lysosomal Ca2+ and not that of another endocytic organelle, as well as 
showing the lysosomes still retain their integrity and that the probe did not 
just leak out of them). After the addition of the CLN3 CTP in the 
cbCln3∆ex7/8 cells there is a reduction in the fluorescence detected via the 
Oregon green BAPTA-1 stain, indicating that Ca2+ has leaked out of the 
lysosomes, however there was no change in Texas red dextran staining 
indicating the lysosomes were still intact. 
While this is preliminary data, we have shown that by measuring the 
change in Ca2+ from the outside of the lysosome as well as the inside that 
the wild type CTP is capable of inducing lysosomal Ca2+ leak in living 
cells, and can rescue the lysosomal Ca2+ defect in cbCln3∆ex7/8 cells. 
 
6.4.17 Utilising CLN3 CTP and CLN3 mutant CTP to measure Ca2+ 
leak from purified lysosomes. 
 
Lysosomes from both cbCln3+/+ and cbCln3∆ex7/8 cells were magnetically 
purified (as described in chapter 2). 
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Figure 6.17: CLN3 C-terminus synthetic peptide releases Ca2+ from pure 
lysosomes, while the mutant CTP is only capable of releasing lower amounts of 
Ca2+. C2-Ceramide was used to confirm that the lysosomes were still intact prior 
to addition. n=2 
 
~40µg of purified lysosomes were incubated with 2µM of the Ca2+ probe 
Fluo-4 and physiological pH. The experiments were started via the 
addition of the ATP-regenerating system (data not shown). The addition 
of the CLN3 CTP resulted in an increase in the levels of Ca2+ being 
detected by Fluo-4 outside of the purified lysosomes, indicating Ca2+ 
leaking out of the lysosomes in both the cbCln3+/+ and cbCln3∆ex7/8 
purified lysosomes. There was a greater degree of Ca2+ release detected 
in the cbCln3∆ex7/8 lysosomes when compared with the cbCln3+/+ 
lysosomes, indicative of the higher lysosomal Ca2+ content in the 
cbCln3∆ex7/8 lysosomes (figure 6.17). The addition of the CLN3 mutant 
CTP (CLN3 mutCTP) resulted in no Ca2+ being released from the purified 
cbCln3+/+ lysosomes but does seem to release some Ca2+ from the 
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cbCln3∆ex7/8 lysosomes (~66% less Ca2+ release when compared with the 
CLN3 CTP). This suggests that the D416G mutation in the C-terminus 
region of the CLN3 protein may hamper its ability to release Ca2+ but not 
completely block it. The results of this experiment done on purified 
lysosomes suggest that CLN3 CTP can induce Ca2+ release from 
lysosomes. The reduced lysosomal Ca2+ leak detected in the D416G 
mutant may be a factor in the onset of CLN3 disease. At the end of the 
experiment 5µM C2-Ceramide was added (indicated by arrows) to induce 
pores in the lysosomes membrane causing the release of their Ca2+ 
content, which is what was observed in all experiments. This data 
highlights that the CLN3 CTP does not induce Ca2+ release from 
lysosomes by causing the formation of pores in the lysosomal membrane. 
 
6.4.18 Ca2+ uptake into purified lysosomes from cbCln3+/+ cells and 
cbCln3∆ex7/8 cells 
 
Lysosomes from both cbCln3+/+ and cbCln3∆ex7/8 cells were magnetically 
purified. ~20µg of Purified lysosomes were incubated in 2µM Fluo-4 and 
physiological pH. An ATP-regenerating system was added so that the 
lysosomes could re-acidify and maintain a proton motive force necessary 
for Ca2+ uptake. 
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Figure 6.18: Ca2+ uptake is observed in both cbCln3+/+ and cbCln3∆ex7/8 
cells following the addition of the ATP regenerating system. Following the 
addition of wild type CLN3 CTP, lysosomes from both genotypes release 
their Ca2+ content. n=1 
 
The rate of Ca2+ uptake into the lysosomes was following the addition of 
the ATP regenerating, lysosomes from both cell types started to uptake 
Ca2+, indicated by a drop in fluorescence as the probe no longer has Ca2+ 
to bind to as the Ca2+ is now in the lysosome. The rate of Ca2+ uptake 
into the purified lysosomes was the same in both the cbCln3+/+ and 
cbCln3∆ex7/8 cells, which suggests that cbCln3∆ex7/8 do not have an 
impaired Ca2+ uptake problem. This data is only preliminary and more 
repeats are needed before a conclusion can be made. 
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6.5 Discussion 
!
The role of Ca2+ in CLN3 pathogenesis is still not fully understood, and 
there have been very few studies looking into the disease mechanisms 
that are induced by dysfunctional Ca2+ signaling and homeostasis. 
Several studies have suggested CLN3 being protective against 
apoptosis, and it has been found that overexpression of CLN3 helps 
reduce the ER stress response, although the mechanisms behind this are 
not well understood. The links with CLN3 mutation and ER stress have 
been speculated to be due to the mutant CLN3 protein becoming trapped 
in the ER, inducing ER stress possibly via the unfolded protein response 
(Chang et al., 2007). However the elevated lysosomal Ca2+ could indicate 
that CLN3’s correct role in the cell is associated with maintaining 
lysosomal Ca2+, with the ER phenotypes observed could be a knock on 
effect of the CLN3 mutant protein not being trafficked out of the ER 
correctly. The topological similarities CLN3 has with the pH regulated ER 
Ca2+ release channel Bi1 (Bultynck et al., 2012, Mao et al., 2003) could 
suggest that CLN3 maintains lysosomal Ca2+ homeostasis by functioning 
as a lysosomal Ca2+ leak channel and possibly regulate response to 
apoptosis. 
 
6.5.1 Altered Ca2+ homeostasis in cbCln3∆ex7/8 cells 
 
Previous studies found that there is an increase in intracellular Ca2+ 
levels in cells that have siRNA knockdown of CLN3 (An Haack et al., 
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2011). While the elevation in CLN3 depleted cells was not particularly 
large, the study concluded that this was significant and could be a reason 
for neurotoxicity seen in CLN3 mutant cells. However resting intracellular 
Ca2+ levels observed in the cbCln3∆ex7/8 cells were the same as that in 
cbCln3+/+ cells (figure 6.1) (which more closely resembles the human 
disease), suggesting that any Ca2+ defects seen in these cells will arise 
from their Ca2+ stores or is an artefact of siRNA. 
 
6.5.2 Increased sensitivity to the ER Ca2+ releasing drug 
thapsigargin 
 
Our data (figure 5.5) has shown that there is an increase in ER staining in 
the cerebellar cbCln3∆ex7/8 cells, which has been implicated in an increase 
in ER stress. Other work has shown that CLN3 depletion has resulted in 
SH-SY5Y cells becoming more sensitive to thapsigargin (Wu et al., 
2014), possibly due to the mutant CLN3 protein becoming trapped in the 
ER. Our data shows that there is increased sensitivity in cbCln3∆ex7/8 cells 
when they are treated with sub-inhibitory levels of thapsigargin (figure 
6.2) as cbCln3∆ex7/8 cells released >50% higher levels of Ca2+ when 
compared with cbCln3+/+ cells. Also 7x more cbCln3∆ex7/8 cells responded 
and there was multiple Ca2+ releases observed in cbCln3∆ex7/8 cells also. 
As the concentration of thapsigargin was increased however the 
cbCln3∆ex7/8 cells only had a single Ca2+ response. The increased 
sensitivity seen in the cbCln3∆ex7/8 cells at lower levels of thapsigargin, but 
similar responses to cbCln3+/+ at higher thapsigargin concentrations, 
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would suggest that these mutant cells are more sensitive to thapsigargin 
which has been previously reported (Chang et al., 2007). The multiple 
Ca2+ responses observed in the cbCln3∆ex7/8 cells could suggest that they 
have difficulty in regulating the ER Ca2+ store, or that the large initial 
release of Ca2+ has caused the release from other Ca2+ stores in the cell. 
If CLN3 is a Ca2+ leak channel it may be releasing some Ca2+ from the 
ER store, contributing to the multiple Ca2+ release events observed.    
 
6.5.3 Defects in store operated Ca2+ re-entry in cbCln3∆ex7/8 cells 
 
Store operated Ca2+ entry is an important mechanism that cells use to 
restore Ca2+ levels in their stores following a large Ca2+ release. 
Thapsigargin which depletes the ER Ca2+ store leads to a physiological 
requirement within the cell to refill this store. This is done via the action of 
the STIM1 and Orai channels that control the intake of Ca2+ from outside 
the cell. However when store operated Ca2+ entry was tested in the 
cbCln3∆ex7/8 and cbCln3+/+ cells there was a >50% reduction in the levels 
of Ca2+ being brought back into the cell (figure 6.5). The reason behind 
this is unclear, however it is strongly suggestive that there is store 
operated Ca2+ entry defects in cbCln3∆ex7/8 cells. However another reason 
might be that cbCln3∆ex7/8 cells have adjusted their response to reflect 
other alterations in cellular Ca2+ homeostasis. 
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6.5.4 Mitochondrial Ca2+ store levels 
 
A lot of work done on research into CLN3 disease has found that a 
common phenotype that occurs in many CLN3 mutant cell types is the 
accumulation of subunit c of the mitochondria ATPase (Cao et al., 2011). 
It has been shown before that the cbCln3∆ex7/8 cells accumulate subunit c, 
and that this has been linked with a reduction in the levels of 
mitochondrial ATP found in the mitochondria of these cells (Cao et al., 
2011). However our data seems to suggest that there is no change in the 
levels of mitochondria in the cell or the amount of mitochondria produced 
ROS (figure 5.4), suggesting that the mitochondria in the cbCln3∆ex7/8 
cells are still capable of functioning correctly. Interestingly though the 
Ca2+ levels detected in the cbCln3∆ex7/8 cells was significant lower than 
that seen in the wild type cells (a reduction of ~25%). This would seem to 
suggest that the cbCln3∆ex7/8 cells mitochondria have an impaired function 
in transporting Ca2+, which correlates with less ATP found in a previous 
study (Cao et al., 2011).  
 
6.5.5 Lysosomal Ca2+ levels and its effect on lysosomal Ca2+ 
mediated release from other stores 
 
As our previous results have shown (figure 5.12), lysosomal Ca2+ was 
elevated in cbCln3∆ex7/8 cells. While it has been reported before in 
different CLN3 mutant cells that there are defects in lysosomal pH (even 
though our data for the cbCln3∆ex7/8 cells suggests there is not in this 
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case), there has been no work done on measuring the levels of lysosomal 
Ca2+. By using the lysosomtrophic agent GPN we recorded a greater 
elevation in lysosomal Ca2+ than what was seen in cbCln3+/+ cells (figure 
6.7). This supports our earlier data (figure 5.12) where an intracellular 
Ca2+ probe was used to measure lysosomal Ca2+. This elevation in 
lysosomal Ca2+ would strongly suggest that CLN3 has an important role 
to play in lysosomal Ca2+ homestasis, and that its absence clearly leads 
to accumulation of Ca2+ in this organelle. While it is still not known what 
the mechanisms are for how Ca2+ enters the lysosome, it is known 
however that it requires a proton motive force (via the vATPase proton 
pump) to enter (Mindell, 2012). This elevated Ca2+ does suggest that the 
cbCln3∆ex7/8 cells have a functional vATPase otherwise we would most 
likely not see this increase in lysosomal Ca2+. Also our work showing 
cathepsin activity is normal in cbCln3∆ex7/8 cells further backs up our claim 
that there is no lysosomal pH abnormality in the cbCln3∆ex7/8 cells (figures 
5.2 and 5.3). If lysosomal Ca2+ uptake is normal (as suggested by the 
large Ca2+ present in lysosomes) then it can be strongly suggested that 
cbCln3∆ex7/8 lysosomes are incapable of releasing Ca2+, to maintain 
normal lysosomal Ca2+ levels. This elevated lysososmal Ca2+ might 
account for the faster endocytic trafficking observed in these cells (figures 
5.10 and 5.11) as late endosome-lysosome fusion requires Ca2+ (Luzio et 
al., 2009), and with elevated Ca2+ already present in the lysosome it 
would need less time to refill its Ca2+ store for further fusion. 
By inducing Ca2+ release from lysosomes with out clamping for other 
stores first it results in a ~60% increase in the levels of Ca2+ released 
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from the lysosome as well as other stores (figure 6.8). Lysosomal Ca2+ 
has been suggested to be required for major Ca2+ signaling events in the 
cell. The elevated lysosomal Ca2+ in cbCln3∆ex7/8 cells results in a greater 
amount of Ca2+ being released from the cells other Ca2+ stores, which 
might be one of the factors that result in cellular toxicity that is often 
observed in CLN3 deficient cells, and could be a new therapeutic target.   
As mentioned previously (Chapter 1 intro) NAADP is a major intracellular 
messenger that has been found to induce Ca2+ release from the TPC2 
release channel on the lysosome. This naturally occurring messenger 
would suggest that there are times when the cell needs to release large 
concentrations of Ca2+ from the lysosome to induce a major biological 
action (e.g. for cell division) (Galione et al., 2014). By inducing NAADP 
mediated Ca2+ release from the lysosome it resulted in a greater Ca2+ 
release in the cbCln3∆ex7/8 cells after the ER had been clamped (figure 6.9 
Aiii) most likely due to the elevated lysosomal Ca2+ present. However 
when NAADP was added to the cells without the ER Ca2+ store being 
clamped it resulted in a greater level of Ca2+ release seen in the 
cbCln3∆ex7/8 cells as well as multiple Ca2+ release events (figure 6.9 Bii 
and Biii). The multiple release events observed in the cbCln3∆ex7/8 cells 
following NAADP addition would suggest that they cannot maintain 
correct Ca2+ homeostasis once a Ca2+ release is induced from a store. It 
was also observed that the cytosolic Ca2+ level did not return to normal in 
the cbCln3∆ex7/8 cells (figure 6.9 Bi and BiV), and that there was a greater 
amount of apoptosis occurring in the cbCln3∆ex7/8 cells than what was 
seen in cbCln3+/+ cells (figure 6.10). cbCln3∆ex7/8cells defective 
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capabilities in maintaining Ca2+ homeostasis after a large lysosomal Ca2+ 
would strongly suggest that Ca2+ induced apoptosis is occurring in these 
cells when they undergo large Ca2+ events. The addition of the TPC2 
inhibitor NED19 reduced the level of NAADP mediated Ca2+ release from 
the lysosomes and subsequently reduced the levels of apoptosis 
observed in the cbCln3∆ex7/8 cells (figure 6.10). This data strongly 
indicates that elevated NAADP induced Ca2+ release from lysosomes, 
and the subsequent defects in maintaining Ca2+ homeostasis in the 
cbCln3∆ex7/8 cells following a large release, is a major contributor to Ca2+ 
induced apoptosis. 
Also the elevated NAADP release cbCln3∆ex7/8 indicates that they can 
release Ca2+ in response to an agonist, so that only leaves a leak 
problem. Like the ER, the lysosome needs constitutively active leak 
channels to remove excess Ca2+ during the absence of a secondary 
messenger.  
 
A study has found that the important neurotransmitter glutamate elevates 
cellular NAADP levels. When cbCln3∆ex7/8 cells were treated with 
glutamate there was a greater Ca2+ in these cells when compared to 
cbCln3+/+ cells (figure 6.11). Multiple Ca2+ release events were also 
observed. This might indicate that glutamate might be having a similar 
impact in inducing Ca2+ mediated autophagy in the brains of CLN3 
disease patients. However it should be noted that these experiments 
require repeating before a stronger hypothesis can be postulated. 
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6.5.6 L-type Ca2+ channel inhibitor: Nifedipine 
 
As mentioned before a study found that using different L-type Ca2+ 
channel inhibitors resulted in a reduction in the elevated intracellular Ca2+ 
levels in siRNA CLN3 knock down cells (Warnock et al., 2013). Nifedipine 
is a FDA approved drug that is used to treat cluster headaches, and is 
safe to take up to 60mg a day. By treating cells with nifedipine we were 
able to rescue Ca2+ induced apoptosis in the cbCln3∆ex7/8 cells following 
NAADP treatment, as the cytosolic Ca2+ levels returned to normal (figure 
6.12). This return to baseline Ca2+ levels as well as there being no 
multiple Ca2+ releases occurring may explain why apoptosis is not being 
triggered. While more work needs to be done, this provides a potential 
treatment for CLN3 disease patients if NAADP mediated Ca2+ release is 
one of the main contributing factors behind CLN3 disease pathogenesis. 
As well as this, it shows that nifedipine is acting directly on the TPC 
channels; to alleviate the abnormal NAADP induced Ca2+ release from 
the lysosomes. 
 
6.5.7 CLN3: potentially a Ca2+ leak channel 
 
As mentioned previously (Chapter 6 introduction) the topography of CLN3 
is similar to the ER Ca2+ leak channel Bax inhibitor 1. Bi-1 is a highly 
conserved protein in mammals and is found on the ER membrane, where 
it is suggested to take in protons into the ER lumen in exchange for Ca2+ 
to reduce ER stress (Bultynck et al., 2012). As our data suggests that 
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lysosomal Ca2+ is elevated in cbCln3∆ex7/8 cells, it may be possible that 
CLN3 is a Ca2+ leak channel, and that its absence in the lysosome leads 
to Ca2+ accumulation. By using a long treatment with the TPC inhibitor 
Ned19 to block Ca2+ release from these channels produced a ~60% 
increase in the levels of lysosomal Ca2+ in the cbCln3∆ex7/8 cells (figure 
6.13). However interestingly the lysosomal Ca2+ levels did not increase, 
which suggests that with the TPC channels inhibited the lysosome is able 
to release Ca2+ from another channel on the lysosomal membrane.  
Work done by our group (Personal communivation) using alignment 
software found that CLN3 has a 27% identity and ~50% similarity with Bi1 
protein (Lloyd-Evans lab data, unpublished). Previous work done on Bi1 
has found that it is the C-terminus of the protein that is responsible for 
Ca2+ release, and it was shown that by mutating aspartate (Asp-213) in 
the Ca2+ channel pore in the C-terminus resulted in the Bi1 protein to be 
unable to release Ca2+, highlighting this residue as critical for Ca2+ for this 
channel. Interestingly this key residue is also found in the C-terminus 
domain in the CLN3 protein, with this residue being conserved in all 
upper eukaryotes (figure 6.15). As the topography of Bi1 and CLN3 are 
similar, especially the orientation of the C-terminus, and with CLN3 also 
possessing this key aspartate residue it implies that CLN3 might be a 
Ca2+ leak channel and that its absence from the lysosomal membrane 
results in an increase in lysosomal Ca2+.  
To determine if the C-terminus of the CLN3 protein was capable of 
inducing Ca2+ leak, peptides were designed where a wild type CLN3 
amino acid sequence, comprising of the key aspartate residue, as well as 
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a mutant CLN3 peptide where the aspartate residue has been changed to 
a glycine (figure 6.15). Both these peptides contained the native dileucine 
lysosomal targeting motifs that are believed to be important in correct 
CLN3 processing to the lysosome. These were used to detect if the wild 
type peptide could induce Ca2+ leak and the mutant peptide could not.  
Utilising the lysosomal magnetic purification assay that I have developed 
over the course of my PhD lysosomes were purified from cbCln3+/+ and 
cbCln3∆ex7/8 cells. By adding the wild type peptide to the 
cbCln3∆ex7/8purified lysosomes there was a release of Ca2+ from them 
(figure 6.18). However the mutant CLN3 peptide only released a small 
amount of Ca2+ from these purified lysosomes. The wild type peptide was 
also capable of releasing Ca2+ from cbCln3+/+ cells, however there was 
not as high a release, possibly due to the cbCln3+/+ lysosomes already 
possessing a functional Cln3 protein.  
Intra-lysosomal Ca2+ measurements in whole cells also resulted in a 
decrease in the levels of lysosomal Ca2+ present in cbCln3∆ex7/8 
lysosomes following the addition of the wild type peptide (figure 6.17). 
Also the wild type peptide was able to rescue the elevated lysosomal 
Ca2+ levels after long term Ned19 treatment, whilst the mutant peptide 
could not (6.17). 
While this is only preliminary data, we have shown that the c-terminus of 
the CLN3 protein is capable of inducing Ca2+ release. The importance of 
utilising the lysosomal magnetic purification technique has highlighted 
that these peptides can anchor themselves into the lysosomal membrane 
! 265!
and induce Ca2+ release from the lysosomal Ca2+ store, and that that the 
peptide is not acting on another Ca2+ store that reduces lysosomal Ca2+.  
 
6.5.8 Overview 
 
Work done on determining Ca2+ abnormalities in cbCln3∆ex7/8 cells has 
shown that there are numerous defects in Ca2+ homeostasis present in 
these cells. The ER Ca2+ defect may be due to the presence of the 
mutant Cln3 protein trapped there, leading to an increase in ER stress. 
The elevated lysosomal Ca2+ may be a contributing factor to NAADP 
induced Ca2+ release that results in Ca2+ induced apoptosis in 
cbCln3∆ex7/8 cells. However by treating the cells with the L-type Ca2+ 
channel inhibitor nifedipine the Ca2+ abnormalities and Ca2+ induced 
apoptosis were abolished, indicating that nifedipine may be potentially a 
viable therapeutic drug for treating CLN3 mutant induced Ca2+ 
irregularities. 
Also by utilising the lysosomal magnetic purification method to purify 
lysosomes we have been able to show that the aspartate residue located 
on the c-terminus of the CLN3 protein is able to mediate Ca2+ leak from 
purified lysosomes.  
While this work is in its early stages, it is the first characterisation for 
CLN3’s role in the cell and how its loss results in the formation of Ca2+ 
abnormalities that can lead to apoptosis and a loss of neurons in JNCL. 
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Figure 6.19: A possible mechanism for CLN3. The lysosome continuously fills 
with Ca2+ via an unknown channel and when the TPC channels aren’t active the 
lysosome needs to maintain it’s Ca2+ homeostasis via the use of a Ca2+ leak 
channel (CLN3). When CLN3 is mutated it is unable to get to the lysosome, so 
the lysosome no longer has a means of maintaining it’s Ca2+ homeostasis via 
leak, therefore in CLN3 disease the lysosomal Ca2+ content increases. 
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Chapter 7: General Discussion and final conclusions 
 
The importance of lysosomal research can be highlighted by the severity 
of lysosomal storage diseases, which arise when a lysosomal protein is 
defective. The need to understand the functions of the defective 
lysosomal proteins could help further our understanding in the disease 
mechanisms that arise during the onset of these diseases in patients. 
With better understanding of these diseases, it could result in the 
development of potential therapies for patients with lysosomal storage 
diseases. 
 
The ability to study lysosomes and their components has somewhat been 
hampered by the difficulty in purifying lysosomes and studying them in an 
isolated environment. Established techniques such as density gradient 
centrifugation have commonly been used, but to little success as the 
lysosomes are often contaminated with other organelles as well as them 
no longer being structurally functional. The need to purify contaminant 
free lysosomes is obvious, however with recent discovery that the 
lysosomal is the second largest Ca2+ store in the cell, as well as how pH 
dysregulation in lysosomes can lead to the onset of other common 
neurodegenerative diseases such as Alzheimer’s disease shows the 
requirement to purify lysosomes that are still capable of maintaining their 
Ca2+ content as well as pH levels once purified.  
During the 1990s the idea that lysosomes could be purified via magnetic 
iron particles being loaded into them offered some hope into a new 
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technique that overcomes the problems of other methods of lysosomal 
purification (as discussed in Chapter 3). However, while the methodology 
behind exploiting the endocytic system to deliver these particles to 
lysosomes was good, unfortunately the particles themselves proved to be 
highly unstable once in the acidic environment of the lysosome and 
resulted in being toxic to cells. 
By using a new type of highly magnetic iron based particle which is 
functionalised with a dextran coat, we wanted to see if we could improve 
upon previous techniques of magnetic lysosomal purification and develop 
our own method to produce high yields of lysosomes that are free of 
contamination from other organelles such as the ER, and importantly that 
the lysosomes are functional. First though it was important to determine 
that these SPIONs were not toxic to cells, as any toxicity would damage 
the lysosomal membrane resulting in lower yields of purified lysosomes 
and abnormalities in them being able to retain their Ca2+ and pH levels. 
From this study we were able to show that the SPIONs produced by the 
company Liquids Research Ltd were the safest particles to use and that 
they were stable in the lysosome for a long time when compared with 
another commercially available SPION. We were also able to highlight 
with using a similar iron based particle from previous studies, the high 
levels of cellular toxicity it induces. 
Using our lysosomal magnetic purification method we have been able to 
consistently purify high yields of pure lysosomes and have been able to 
show that they are still functional post purification via the use of pH re-
acidification assays and Ca2+ uptake assays (Chapter 3 results). Using 
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these assays on both purified wild type and NPC CHO lysosomes that 
there is no re-acidification problem occurring in NPC null CHO M12 cells, 
which supports previous data on there being no pH problem in NPC null 
lysosomes. With the Ca2+ uptake assay we have been able to show that 
there is a Ca2+ defect in NPC null lysosomes, supporting previous 
findings that have shown this intracellularly. While this is not new data, it 
highlights the benefits of being able to measure Ca2+ and pH defects in 
lysosomal storage disease lysosomes which would benefit different labs 
across the world.  
As the lysosomal magnetic purification method has now been finalised it 
has been distributed to >20 labs across the world. These labs have been 
able to produce good yields of lysosomal protein that have low levels of 
contamination from other organelles using the method I developed. 
The use of this method has benefited us in our research into the neuronal 
ceroid lipofuscinosis disease CLN3 disease. While our work on 
cbCln3∆ex7/8 cells has revealed that at storage level there is not much 
difference present, from a Ca2+ side of it there are large differences 
present. 
Our findings that cbCln3∆ex7/8 cells have elevated Ca2+ as well as 
abnormal Ca2+ homeostasis, led us to believe that CLN3 has a role in 
Ca2+ regulation, possibly via the lysosome. Our labs further finding that 
CLN3 has similar homology to the Bi1 protein, and ER leak channel, 
where the key Ca2+ releasing residue in the C-terminus of the Bi-1 protein 
is conserved in all upper eukaryotic organisms CLN3 protein led us to 
hypothesis that CLN3 might be acting as a lysosomal Ca2+ leak channel. 
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By using the lysosomal magnetic purification assay, as well as designing 
C-terminal peptides that possess the key residue on the C-terminus of 
wild type CLN3 proteins, we have been able to show that the C-terminus 
of the CLN3 protein is capable of releasing Ca2+. While this work is still in 
its infancy, it is the first strong suggestion of CLN3’s role in the cell is. 
Utilising the lysosomal magnetic purification assay developed, it offers 
potential to further aid our understanding of not only the CLN3 protein but 
other important lysosomal proteins that have still not been characterised. 
 
 
 
 
 
 !!!!!!!!
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